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CHAPTER I 
 
GENERAL INTRODUCTION & OBJECTIVES 
 
1 GENERAL INTRODUCTION 
1.1 Disposables in Biopharmaceutical Manufacturing 
During recent years, the number of disposables that are available for biopharmaceutical 
manufacturing has increased substantially and more and more biopharmaceutical companies start 
establishing disposable concepts [1–7]. Disposables are defined as single-use components that are 
typically provided gamma-sterilized and therefore ready-to-use. Nowadays, available disposables 
include single-use bioreactors, bioprocess bags, mixing systems, tubing, pumps, sensors, connectors, 
filter cartridges, and chromatography systems [5,6]. Disposables can be implemented during any step 
of biopharmaceutical production [4,8,9] – from cell culture and fermentation to purification, 
formulation, storage and filling. Hence, a fully disposable manufacturing site has become feasible 
[7,10]. Figure I-1 visualizes the potential layout of a fully disposable compounding site. Stainless steel 
tanks only act as support for the flexible disposable bags that are made from plastic materials and 
used for intermediate storage or mixing. The transfer of drug product is realized with disposable 
silicone tubing and a peristaltic pump. For the future, it is anticipated that disposables will 
increasingly replace traditional stainless steel manufacturing equipment or at least be essential parts 
of hybrid settings that combine the benefits of both traditional and disposable elements [4]. 
 
 
Figure I-1: Possible set-up of a fully disposable biopharmaceutical manufacturing site for the final 
formulation step. Reproduced from http://microsite.sartorius.com/single-use-technology/engineering/ 
configurable-single-use-systems.html (accessed May 9th, 2015). 
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1.2 The Benefits and Challenges Associated with Single-Use Systems 
The main benefit of disposable systems arises from the lower risk of cross-contaminations and thus 
increased patient safety [11]. Sites that use stainless steel equipment have to carry out time-
consuming cleaning validation studies or implement dedicated equipment in order to avoid such 
risks. Initial capital investments for a disposable plant are typically lower than for costly stainless 
steel equipment, resulting in capital expenditure savings of up to 60-70 % [12,13]. In general, the 
savings associated with disposables depend on the production scale and seem to be favorable mainly 
for small-scale production, e.g. for early clinical phases [14]. Since cleaning-in-place and sterilization-
in-place cycles are not required for disposables, product change-over times can be significantly 
shortened [4,5]. By implementing single-use 3D bags for buffer preparation, Weitbrecht et al. were 
able to increase the number of produced batches per week significantly due to time savings of 4 to 6 
hours per batch [2]. In a case study by Liderfelt et al., the total downstream process time for mAb 
purification could be shortened from 45.5 h to 23 h by using disposables [15]. Moreover, waiving 
cleaning cycles leads to substantial savings with regards to electricity, water, and cleaning material 
[16]. As a conclusion, operation expenditures can be reduced by 20-25 % [12] and the overall carbon 
dioxide balance for disposable processes is assumed to be lower than for traditional processes 
employing stainless steel despite the increased amount of waste that is produced with disposables 
[10,16–18]. When handling highly toxic drugs, disposables might help to protect the manufacturing 
personal from contact with the drug [5]. In times of personalized medicine with a variety of highly 
potent drugs that are manufactured in volumes well below those of traditional ‘blockbusters’, the 
flexibility associated with disposables is highly appreciated [1,4]. Therefore, disposable concepts are 
often favored for pilot plants and the production of material for clinical Phases I and II [6,19]. 
Moreover, flexibility in terms of the layout of the manufacturing site is increased and the facility 
footprint is reduced [20]. A modular approach with flexible tubing and mobile tanks enables a 
customized configuration of unit operations that can be adapted in a product-specific way [12,21]. In 
this context, the “ballroom concept” as a facility layout consisting of one large, unclassified 
manufacturing area with minimal segregation due to the use of movable and functionally contained 
equipment was introduced [22]. How all of these factors can combine to significant savings in R&D 
and manufacturing costs is shown in different case studies [23–25]. 
 
Potential challenges include the implementation of an efficient waste management system [17,18] 
and the higher ongoing costs for consumables. Since standardization of disposables is not established 
yet, vendor dependency is highly increased and considered business critical [9,11]. Proper supplier 
qualification and auditing is essential in order to ensure that disposables are manufactured to 
defined quality standards [26], especially with regards to sterility, lack of endotoxins, extractables 
and leachables [27], and particle contamination [28]. The volume per batch is limited by the bag sizes 
that are maximally realizable with plastic materials due to physical constraints [4]. The brittleness of 
single-use bags with tubing connectors that are stored frozen requires careful handling by well-
educated personal. The most important challenge is the lack of experience which is currently still 
associated with disposable use [6]. More comprehensive studies are needed in order to evaluate a 
possible impact on the quality of a drug product prior to implementation of disposables. 
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1.3 Possible Interactions between Disposables and Drug Product 
In general, possible interactions between contact materials and a drug product are classified into 
sorption, migration, and diffusion events (Figure I-2). Surfaces and their leachables can impair the 
stability of biopharmaceuticals in various ways [29,30]. 
 
Figure I-2: Possible interactions between drug product and contact material. 
Sorption processes may include the adsorption as well as absorption of drug product components by 
the contact material. Especially proteinaceous drugs and excipients like surfactants are prone to 
adsorption [31–33]. In extreme cases, sorption can lead to substantial losses of the active ingredient 
[34,35] or excipients. This needs to be avoided in order to meet the specifications and to ensure 
stability and efficacy of the final drug product. With regards to proteins, also desorption events of 
potentially altered protein structures need to be considered [36,37]. More details regarding protein 
adsorption will be discussed in Chapter II and III. 
Migration of packaging components into the drug product solution is of increased concern with 
polymeric materials and therefore carefully evaluated during extractables and leachables studies 
with disposables [38]. Extractables are all potential substances than can be extracted from plastic 
materials using solvents and possibly harsh extraction conditions like increased temperature or 
extreme pH values [39,40]. Also the impact of gamma irradiation has to be considered in this context 
[41]. Leachables are defined as the substances that can be found in the finished drug product during 
its intended use and are often a subset of all possible extractables [39,40]. However, reactions 
between migrating substances and the drug product can result in leachables that were not pre-
defined as extractables [39,42]. Extractables and leachables can be of organic (monomers, anti-
oxidants, plasticizers, stabilizers, degradation products) [43] as well as of inorganic (e.g. metals) 
origin [40]. Extraction studies and a toxicological evaluation of potential leachables together with a 
safety risk assessment are demanded by the authorities for packaging components and all other 
contact materials encountered during manufacturing [39,43–46]. Currently, the leachables topic is 
considered as one of the most critical issue associated with disposables [3]. Since harmonized 
extractable and leachables guidelines and standardized testing methods do not exist so far [4,39], a 
comparative evaluation of the extractable data provided by the manufacturers is hardly feasible. 
Pharmaceutical companies have to define an appropriate way of how to perform extractable and 
leachable studies themselves [42,47]. The assessment of leachables is product-specific and was 
therefore not in the focus of this thesis, but included whenever reasonable. Migration might not only 
include substances on a molecular basis like leachables, but also particles (Chapter IV and V). 
Diffusion of oxygen, water vapor, carbon dioxide or other volatile substances can occur in two 
directions and is potentially increased with disposables since plastic materials are characterized by a 
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higher permeability than glass or stainless steel. Diffusion of oxygen into the headspace of sensitive 
products can accelerate oxidation [48]. Loss of water vapor eventually leads to a concentrating of the 
drug. Preservatives in multi-use drug products are typically volatile substances that might also diffuse 
through the packaging material [49,50] (Chapter VI and VII). 
2 OBJECTIVES OF THE THESIS 
It is the aim of this thesis to contribute to a better knowledge around disposables with regards to the 
properties of employed materials and in particular to possible interactions with the drug product 
itself. The materials investigated included single-use bioprocess bags and tubing used for peristaltic 
pumping. The general outline of this thesis is depicted in Figure I-3.  
 
Figure I-3: Outline of the thesis. 
Investigations with single-use bags focused on the characterization of the two commonly used bag 
materials ethylene-vinyl acetate (EVA) and ultra-low density polyethylene (ULDPE) as well as the 
quantification of monoclonal antibody adsorption (Chapter II). In addition, the quartz cyrstal 
microbalance (QCM) technique was implemented to gain a deeper understanding of the kinetics of 
mAb adsorption (Chapter III).  
Silicone tubing was extensively characterized for its particle shedding behavior during peristaltic 
pumping (Chapter IV). A possible impact of shed particles on the stability of two model monoclonal 
antibodies was evaluated by means of spiking studies (Chapter V). The permeability of silicone tubing 
for preservatives was assessed with sorption experiments (Chapter VI). An alternative tubing material 
that can help to avoid preservative losses during filling is presented and its performance in terms of 
sorption and particle shedding was evaluated (Chapter VII). 
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CHAPTER II 
 
ADSORPTION OF A MODEL ANTIBODY TO 
SINGLE-USE BIOPROCESS BAGS 
 
ABSTRACT 
During implementation of single-use bioprocess bags in biopharmaceutical drug product 
manufacturing, protein adsorption has to be considered and studied in detail. In order to quantify 
protein adsorption, we adapted a previously introduced method for studying protein adsorption to 
glass vials (Mathes & Friess 2011) to bags with EVA and ULDPE contact layers. The correct HP-SEC 
analysis relies on the quantitative desorption of adsorbed protein with SDS which was proven for an 
IgG using gold staining. To enhance a better understanding of the ongoing adsorption process of a 
model IgG1 antibody, bag surfaces and the antibody were characterized in terms of morphology, 
surface free energy and surface charge, respectively. Additionally, studies with varying incubation 
time, pH, and ionic strength were conducted. Adsorption reversibility was investigated using 
fluorescently labelled antibody molecules. It was found that not only hydrophobic interactions are of 
importance during protein adsorption, but especially electrostatic interactions led to an increased 
adsorbed amount of IgG on the more polar EVA bag surface in comparison to the nonpolar ULDPE 
surface. Adsorption isotherms indicated that the antibody shows a higher affinity to the ULDPE 
polymer. Depending on the pH value, adsorbed amounts were in the range of 2 to 5 mg/m2. Loss due 
to protein adsorption was demonstrated not to be of concern, especially with higher concentrated 
formulations and at maximal bag filling volumes. 
 
 
 
 
 
 
Parts of the following chapter are intended for publication. 
 
Protein adsorption measurements to ULDPE bags as well as the characterization of these surfaces 
was performed by Stephanie Marlene Burisch during her Master thesis project entitled “IgG 
adsorption to single-use bioprocess bags with ULDPE contact layer” (2014).  
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1 INTRODUCTION 
1.1 Single-Use Bioprocess Bags 
1.1.1 Implementation of Single-Use Bags during Different Steps of the Manufacturing 
Process 
Single-use bag systems have become available for many applications in biopharmaceutical 
manufacturing where traditionally containers made from glass or stainless steel are employed. The 
most basic form of single-use bags are tank liners. They are well suited for buffer and media 
preparation in open container systems and create a barrier between the liner content and the 
container wall. Rather flat, “two-dimensional” bags as shown in Figure II-4a facilitate sampling, 
storage, freezing and transportation of limited volumes (usually 50 mL to 50 L) of drug substance, 
buffer and media. Different bag types vary in the position and number of ports, connectors, pinch 
clamps, tubing, and filters which can be customized for individual purposes. A suitable handling 
system, e.g. stackable trays, for safe storage and transportation might be needed. “Three-
dimensional” cubical or cylindrical bags with integrated stirring units as shown in Figure II-4b have 
been designed specifically for mixing purposes and larger liquid volumes of up to 2500 L. An outer 
container as mechanical support is mandatory [1]. Single-use bioreactors with ports for (single-use) 
pH and oxygen sensors can be implemented during cell cultivation and fermentation [2]. Bags of any 
type are usually provided fully assembled and gamma sterilized, and are therefore ready-to-use. 
1.1.2 Characteristics and Manufacturing of Single-Use Bags 
Single-use bags are fabricated from polymeric materials that may have drawbacks in terms of 
product compatibility, gas permeability, or mechanical instability, when compared to traditional 
materials like glass and stainless steel. The performance in terms of required container properties of 
typically used polymers like polyvinyl chloride (PVC), low-density polyethylene (LDPE), and ethylene 
vinyl acetate (EVA) is listed in Table II-1. 
Table II-1: Performance of major plastic polymers in terms of required container properties. Modified from 
Sacha et al. 2010 [3]. 
Property PVC LDPE EVA 
Compatibility with contained drug products Poor Good Fair 
Resistance to moisture permeation Very poor Good Very poor 
Heat sterilization Fair Poor Very poor 
Transparency Good Fair Fair 
Collapsibility Excellent Poor Good 
Disposability Poor Good Fair 
 
In order to obtain bags with optimal performance in all quality attributes, bag films are manufactured 
as multilayers from several polymeric materials. Generally, such multilayer films are composed of a 
fluid contact layer, a barrier layer, and an outer layer providing mechanical stability [4]. 
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The most important feature of the fluid contact layer is its inertness and compatibility with the 
contained product. In early years, PVC was commonly used for plastic containers. PVC films usually 
contain high amounts of plasticizers, e.g. diethylhexylphthalate (DEHP), at levels up to 40 % which 
can result in substantial amounts of extractables and leachables [3]. Due to this poor compatibility 
with the contained product, PVC is nowadays typically replaced by materials like ultra-low density 
polyethylene (ULDPE), polypropylene (PP), and EVA. However, PVC is still commonly used in 
intravenous (IV) and blood bags [5]. Bags with ULDPE and EVA contact layers were investigated in this 
study. More details on characteristics of these polymers are provided in the next section. 
Plastic films are manufactured by extrusion techniques. During extrusion, the raw material in the 
form of polymer granules is melted, homogenized and finally reshaped into a film. When applying 
blown film extrusion or cast film extrusion, multilayer films can directly be produced via coextrusion. 
Otherwise, during extrusion lamination a suitable tie layer is extruded between already existing films. 
Different tie-layer materials can be incorporated as adhesives between the individual layers. Other 
additives can be incorporated into the polymer mixture to improve bag performance or 
manufacturability, but manufacturers often do not disclose the exact composition of their films. 
Other possibly present, but unwanted compounds might include unreacted monomers, solvents, 
polymerization catalysts, surfactants, or polymer degradation products. Therefore, extractables and 
leachables studies are important to qualify the single-use bag prior to implementation. 
Materials used for film manufacturing are thermosetting polymers and can thus be simply welded 
together to form the final bag geometry. Other parts like connectors are shaped separately via 
injection molding. In a final assembly step, these fitments are joined to the bag via welding, 
mechanical fastening or chemical bonding with e.g. cyclohexanone [3]. In the end, functional 
elements (e.g. filters, clamps, sampling bags) are connected to the fitments via tubing sets. Gamma 
sterilization of the assembled bag system needs to be carefully validated as this process can increase 
cross-linking inside the polymers or lead to polymer degradation. 
Bag manufacturers include many companies like Thermo Fisher Scientific, Sartorius Stedim, ATMI Life 
Sciences, Millipore, Xcellerex, Meissner, HyNetics Corporation, and GE Healthcare. Composition and 
quality of the bag materials vary with the bag manufacturer. Also offered designs, bag volumes, and 
available functionalization via ports, tubings, and in-line filters depend on the manufacturer. 
Typically, standard as well as customer-specific solutions are provided [5]. 
1.1.3 Investigated Bags and the Characteristics of their Fluid Contact Layers 
In this study, investigated bags included the Flexboy® bag with EVA contact layer (Sartorius Stedim, 
Stedim 71) as well as two bags with ULDPE contact layer, namely Flexel® bags (Sartorius Stedim, 
Stedim 40) and bags made from PureFlex™ film (Millipore). Film compositions as well as total film 
thicknesses of these bags are listed in Table II-2. 
2D Flexboy® bags from Sartorius Stedim (Figure II-4a) are intended for the preparation, storage, and 
transport of biopharmaceutical solutions, intermediates, and final bulk products. This bag type is 
available in bag chamber volumes between 5 mL and 50 L [6].  
The Flexel® series for LevMixer® comprises cubical 3D bags that have a magnetic impeller inside 
(Figure II-4b). Together with the corresponding stainless steel container Palletank® and the 
LevMixer® drive unit, this bag can be employed for mixing during buffer and media preparation, bulk 
CHAPTER II 
12 
intermediate resuspension, product (re-)formulation, or pooling. Nominal bag capacities of Flexel®  
bags for LevMixer® range from 50 L to 1000 L [7], other Flexel® 3D bags are available for nominal fill 
volumes of up to 3,000 L [8]. 
The Mobius® system by Millipore provides integrated disposable platform solutions including bags 
made from PureFlex™ films. Millipore uses this coextruded bag material throughout all applications 
during drug manufacturing, from media and buffer preparation, cell culture, mixing, product storage, 
to sterile sampling. For large volume operations of more than 500 L, the PureFlex™ Plus film was 
developed. This film consists of a LLDPE outer layer with otherwise identical film composition and an 
increased film thickness of 300 µm [9]. 
(a) (b) 
 
Figure II-4: Images of (a) a 2D Flexboy® bag and (b) a 3D Flexel® bag for Levmixer® with magnetic impeller 
inside a stainless steel Palletank® support tray. Images from http://www.sartorius.com. 
 
Table II-2: Multilayer composition of investigated bags. PET: Polyethylene Terephthalate, PA: Polyamide, 
EVOH: Ethyl Vinyl Alcohol, ULDPE: Ultra-Low Density Polyethylene, EVA: Ethylene Vinyl Acetate. 
Layer 
Flexboy®  
(Sartorius) [10] 
Stedim 71 film 
Flexel®  
(Sartorius) [11] 
Stedim 40 film 
PureFlex™  
(Millipore) [9] 
Fluid contact layer EVA ULDPE ULDPE 
Gas barrier layer EVOH EVOH EVOH 
Outer layer EVA PA PET 
EVA 
ULDPE 
Total thickness 300 ± 25 µm (360 ± 45 µm for 50 L bag) 200 ± 25 µm 250 µm 
 
The fluid contact layer of Flexboy® bags is made from EVA, which is a copolymerization product of 
ethylene and vinyl acetate units. The properties of this random copolymer mainly depend on the 
vinyl acetate (VA) content, which is limited to 25 % for use in containers for parenterals by the 
European Pharmacopeia [12]. For film applications, the VA content usually ranges from 4 to 18 % [5]. 
With higher VA content, crystallinity, melting point, and stiffness decrease, whereas density and 
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toughness increase. Higher VA level grades are used as contact or heat sealing layers in coextrusion 
of multilayer structures. Due to its mechanical resistance at low temperatures, it is also used for 
freeze / thawing bags like Celsius®-Paks from Sartorius [13]. According to Vanhamel and Masy [5], 
EVA is the primary replacement material for PVC. 
Both, the Flexel® bag (Stedim 40) and the PureFlex™ film, are produced with a ULDPE contact layer. 
ULDPE belongs to the polyethylene (PE) family and mainly consists of polymerized ethylene units. 
Different types of PE can be fabricated through varying reactor type, reaction conditions, presence 
and type of catalyst, and addition of co-monomers. ULDPE is obtained from polymerization with 
octene as a co-monomer in levels ranging from 10 to 30 % (w/w) [5]. ULDPE is a special case of linear 
low-density polyethylene (LLDPE), which is produced with a metal coordination catalyst [14]. The 
production process results in many short-chain branches on the linear polymer and the final density 
of the material is in the range of 0.880-0.915 g/cm3. ULDPE copolymers are characterized by good 
mechanical properties, sealability, flexibility, and transparency. Its oxygen permeability is higher than 
for other PEs, but similar to values for EVA. The water vapor transmission rate of ULDPE is similar to 
those of other PEs [13]. Due to its mechanical flexibility which is superior to EVA, ULDPE is considered 
a good choice for contact layers in disposable bag films [5]. 
All investigated bags feature an ethylene vinyl alcohol (EVOH) gas barrier layer. EVOH is produced by 
controlled hydrolysis of EVA. EVOH is characterized by outstanding oxygen and odor barrier 
properties. Varying the ethylene content impacts barrier properties as well as mechanical properties. 
Due to its sensitivity towards humidity, EVOH always needs to be embedded between two layers 
with good humidity barrier properties [5,13]. Another suitable material for gas barrier layers is 
polyvinylidene dichloride (PVDC). 
Outer layer materials are meant to increase the mechanical stability of the whole bag film. Apart 
from EVA and ULDPE, polyamide (PA) and polyethylene terephthalate (PET) are commonly used. PA 
and PET additionally show good barrier properties and temperature stability [5]. 
1.2 Protein Adsorption to Solid Surfaces 
One of the challenges associated with drug product manufacturing is protein adsorption. Proteins are 
large, amphiphilic molecules and intrinsically surface active [15]. Therefore, proteins readily adsorb 
to any kind of exposed surface. Only with structurally stable proteins and equally charged interaction 
partners, adsorption might not be a concern [16]. The underlying driving force for adsorption is the 
higher standard free energy of an interface in comparison to the bulk phase. A thermodynamic 
equilibrium is thus achieved by the adsorption of substances that are different from the solvent 
molecules [17].  
Protein adsorption and subsequent desorption consists of several steps (Figure II-5) [18,19]. Firstly, 
transport to the surface is governed by diffusion and convection and influenced by the charge 
conditions on the surface. Even in a well-stirred system, this step can be rate-determining due to the 
stagnant layer close to the surface. Subsequent interactions of the protein with the surface foster 
protein attachment to the surface. With increasing surface coverage, attachment of newly arriving 
molecules is significantly influenced by lateral interactions with already adsorbed proteins. During 
this step, changes in the secondary or tertiary structure of the protein can occur. This results in an 
increase of the number of protein – surface interaction sites over time and can cause substantial 
alterations in the protein structure. The generally accepted irreversibility of protein adsorption is 
suggested to be a result of these structural changes. All of the formed interaction bonds between 
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protein and surface would have to break at the same time in order to enable desorption. 
Nevertheless, desorption can be induced by changes of pH or ionic strength. Generally, at least a 
fraction of adsorbed protein is expected to be in exchange with protein molecules in the bulk. 
Moreover, lateral diffusion of adsorbed proteins can occur. As a result from desorption, 
conformationally altered protein molecules might arrive in the bulk. In this context, immunogenicity 
issues are discussed. However, in many cases the protein might as well recover its native state [18]. 
 
Figure II-5: Kinetic model of protein adsorption. Modified from Felsovalyi et al. 2011 [20], Norde & Haynes 
1995 [19], and Wahlgren & Arnebrant 1991 [18]. 
The main contribution to protein attachment arises from hydrophobic interactions and the 
corresponding entropy gain upon dehydration of the surface. Further important interactions occur 
via dispersion and electrostatic forces. Moreover, structure loss of the protein leads to additional 
entropy gain [21]. The extent to which the different interaction forces contribute to protein 
adsorption depends on factors that are often specific for the studied system, namely the protein 
itself, the surface under investigation, and formulation as well as environmental conditions. Some of 
these influencing factors are listed in Table II-3. 
 
Table II-3: Main factors that influence interaction forces and thus protein adsorption to surfaces. 
Protein properties Surface properties General formulation factors 
Charge / Isoelectric point (IEP) Charge / Zero point of charge (ZPC) pH 
Size Hydrophilicity / Hydrophobicity Ionic strength (IS) 
Stability (“hard” or “soft”) Chemical composition Temperature 
Hydrophobicity Roughness Time 
Steric conformation  Concentration 
 
 
 
 
 
Native-like rearrangement 
Structural rearrangements 
Desorption 
 
Adsorption 
Transport Transport 
 
Further  
structural rearrangements 
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Protein adsorption is a widely studied phenomenon. Nakanishi et al. give a detailed overview of 
published adsorption studies including experimental conditions, adsorbed amounts and applied 
analytics [17]. However, most of the studies so far investigated adsorption of model proteins like 
lysozyme and albumin. The employed surfaces were often chosen according to their suitability for 
methods like ellipsometry or for measuring adsorption via depletion. Thus, modified silica, gold, 
mica, or particles made from polystyrene or glass are typical sorbents for adsorption studies [22]. 
Another main focus is on adsorption of plasma proteins to biomaterials. In this context, Young et al. 
published on adsorption of albumin, transferrin, three model antibodies, fibrinogen, and α2-
macroglobulin to polyethylene, silicone rubber, and polyvinylchloride (PVC) tubing [23,24]. Only few 
studies actually assess adsorption of therapeutic proteins to relevant surfaces encountered during 
manufacturing or storage of a drug product. For example, Mathes and Friess addressed IgG 
adsorption to glass vials and the follow-up study by Höger et al. dealt with IgG adsorption to 
siliconized glass vials [25,26]. McLeod and coworkers quantified the loss of factor VIII activity upon 
contact to PVC mini-bags [27]. Eu et al. visualized adsorption of a therapeutic protein to siliconized 
glass prefilled syringes with gold nanoparticles [28]. Vials made from plastic CZ-resin (Daikyo Crystal 
Zenith) were evaluated as packaging material for protein-based parenteral formulations by Qadry et 
al., also in terms of protein adsorption [29]. In summary, there is limited knowledge about 
adsorption of relevant therapeutic proteins like monoclonal antibodies (mAb) to bioprocess materials 
so far. Only few methods exist that can be applied to real, imperfect surfaces. Although influences of 
pH and ionic strength on protein adsorption were studied manifold, the impact on mAb adsorption to 
single-use bag surfaces is hard to predict due to the unique characteristics of a specific protein – 
surface system. Experiments with varying formulation parameters and a thorough characterization of 
the interacting partners is thus needed in order to elaborate the applicability of general concepts 
(e.g. impact of hydrophobicity and electrostatic interactions) to the system under investigation. 
The present study introduces a setup that can be applied to quantify adsorption of a therapeutic 
immunoglobulin G (IgG) to single-use bioprocess bags. In total, three different bags with EVA and 
ULDPE contact layers were employed. Via gold staining, the effectivity of the applied desorption 
method is proven. The influence of factors like incubation concentration, incubation time, and 
desorption time was studied in order to further evaluate the method. The impact of varying pH and 
ionic strength was interpreted in conjunction with charge characteristics of sorbent and adsorbate in 
order to gain a deeper understanding of the underlying interaction mechanisms. In this context, 
adsorption isotherms helped to elucidate differences in IgG adsorption to the two contact layer 
materials. Moreover, the significance of morphology, hydrophobicity, and chemical composition of 
the three contact layers on adsorption was considered. Reversibility of protein adsorption was 
addressed with exchange studies employing labeled and unlabeled IgG molecules. Finally, 
conclusions about expected protein losses due to adsorption are drawn and possible risks arising 
from structural alterations and the inherent reversibility of adsorption are discussed. 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
NaHCO3, Na2CO3, and dimethylsulfoxid (DMSO) were purchased from Merck Chemicals (Darmstadt, 
Germany). NaCl, KCl, Na2HPO4, and NaH2PO4 were supplied by VWR International (Darmstadt, 
Germany). NaOH (1 M), HCl (1 M), sodium dodecyl sulfate (SDS), and Rhodamine B isothiocyanate 
(Rh B ITC) were obtained from Sigma-Aldrich (Taufkirchen, Germany). Polysorbate 20 (PS 20) was 
kindly donated by Croda GmbH (Nettetal, Germany). Tetrahydrofurane (THF) was obtained from J.T. 
Baker (Deventer, Netherlands). Highly purified water used for buffer preparation was obtained from 
an arium® pro DI Ultrapure Water System (Sartoris Stedim Biotech GmbH, Goettingen, Germany) or a 
USF ELGA PURELAB Plus UV/UF purification system (ELGA LabWater, Celle, Germany). Buffer 
filtration (volumes ≥ 500 mL) was performed with pressurized nitrogen and 0.2 μm cellulose acetate 
filters (47 mm ø, Sartorius Stedim Biotech GmbH). 
2.1.2 Model Antibody 
A 33.4 mg/mL IgG1 antibody (148 kDa) drug substance solution in 20 mM histidine buffer (pH 5.4) 
was kindly donated by Roche GmbH (Penzberg, Germany). 
2.1.3 Investigated Bags 
Investigated bags included Flexboy® bags (50 L, Ref. FFB102340, Lot 10A22412) and a Standard 
Flexel® cubical Levmix bag (50 L, Ref. FXB111567, Lot 13A16150), both manufactured by Sartorius 
Stedim Biotech SA (Aubagne, France), as well as a PureFlex™ bag from Millipore Corporation 
(Billerica, MA, USA). 
2.2 Methods 
2.2.1 Bag Characterization 
2.2.1.1 Laser Microscopy 
Inner bag surface morphology was visualized using a Keyence VK-X210 3D laser scanning microscope 
(Keyence GmbH, Neu-Isenburg, Germany). The roughness parameters arithmetic mean roughness Ra 
and maximum height Rz were calculated according to the JIS standard B0601:2001 in the multi-line 
roughness mode with VK Analyzer Plus software version 3.3.0.0 from an average of 2·n+1 horizontal 
lines with n=30 and 10 skipped lines in-between. Cut-off values were set to λc = 2.5 mm and 
λs = 8 µm. Curvature was corrected via the ‘correct tilt – sec curved surf. (auto)’ function. 
2.2.1.2 ATR-IR Microscopy 
Infrared (IR) spectra of the inner bag surfaces as well as EVA reference films were recorded using the 
ATR-IR microscope Hyperion 2000 (Bruker Optics, Ettlingen, Germany) attached to a Bruker Tensor 
27 Fourier Transform IR spectrometer. In order to reduce spectral contributions from atmospheric 
water vapor and carbon dioxide the system was purged with dry nitrogen and cooled with liquid 
nitrogen. The absorbance of every sample was recorded from 4000 to 1000 cm-1 at three different 
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spots on the surface. Spectra were recorded with 120 scans using an ATR crystal at a contact 
pressure setting of 1 and a resolution of 4 cm-1. Spectral data was evaluated using the Bruker Opus 
6.5 software. All displayed spectra were vector normalized, smoothed (performed with 17 smoothing 
points), and baseline corrected via the concave rubberband method using 100 iterations. The three 
spectra obtained for one bag were averaged. 
For the determination of the vinyl acetate (VA) content of the EVA layer of the Flexboy® bag, EVA 
reference films were cast from Elvax materials (see Table II-4). All Elvax grades were kindly donated 
by DuPont Packaging & Industrial Polymers (Neu-Isenburg, Germany). 0.1 g of each reference 
material (n=2) were dissolved in 10 mL of THF under stirring and heating to max. 60°C. The resulting 
solutions were poured into cleaned glass petri dishes (ø of 5 cm) and the solvent was allowed to 
evaporate under the fume hood. For further drying, the films were stored in an exsiccator for one 
week at room temperature. IR spectra of each reference film were recorded as described above. 
After vector standardization, the ratio of the peak heights at the absorption maxima at around 
1737 cm-1 and 1465 cm-1 were calculated and plotted against the VA content. 
Table II-4: EVA reference materials used for film casting. 
Reference material VA content  [%] 
Elvax 660A 12 
Elvax 3150A 15 
Elvax 460A 18 
Elvax 3190A 25 
Elvax 265A 28 
2.2.1.3 Contact Angle Measurements 
A Kruess Drop Shape Analyzer DSA25 (Kruess GmbH, Hamburg, Germany) was used to measure the 
contact angles of deionized water and diiodomethane on the EVA surface of the Flexboy® bag and on 
the ULDPE surface of the Flexel® bag via the sessile drop method. Using water, a drop of 2 µL was 
placed on the surface under investigation, for diiodomethane the drop volume was set to 1 µL. After 
manual baseline adjustment, contact angles on both sides of the drop were fitted by the Ellipse 
(Tangent-1) method. For every drop, three measurements were performed 20 seconds after the drop 
formation with 1 second delay between measurements. For the determination of the surface free 
energy of the polymer surfaces, the Owens-Wendt-Rabel-Kaelble analysis was applied to the contact 
angle data. This measurement procedure was repeated on three different spots on the two tested 
bags. Data evaluation was obtained using the ADVANCE software v1.1.0.2 and the surface tension 
values for the test liquids as stated in Table II-5. 
Table II-5: Surface tension parameters of the test liquids used for contact angle measurements (according to 
Ström [30]). 
Liquid Surface tension  [mN/m] 
Polar component  
[mN/m] 
Dispersive component  
[mN/m] 
Water 72.8 51.0 21.8 
Diiodomethane 50.8 0.0 50.8 
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2.2.1.4 Determination of Surface Tension with Test Inks 
Alternatively, blue arcotest® test inks (Arcotest GmbH, Mönsheim, Germany) with defined surface 
tensions from 18 to 32 mN/m were applied to the Flexboy® and Flexel® bag surface for the 
determination of surface tension. 
2.2.1.5 Zeta Potential Measurements 
Zeta potential of the inner Flexboy® bag surface was measured using a SurPASS device (Anton Paar, 
Graz, Austria). Two bag pieces were fixed on opposite metal stamps using an adjustable gap cell with 
the inner surfaces pointed towards the measuring cell. The gap was adjusted so that the flow rate 
was between 100 and 150 mL/min under a maximum pressure of 300 mbar. A flow check was 
applied to obtain a constant flow in both directions. Before starting the measurement, the pH value 
of the 1 mM KCl model electrolyte solution was adjusted to pH 10.5 using 1 M NaOH. Automated 
titration from pH 10.5 to pH 2.25 was performed using 0.1 M HCl. 
For measuring the zeta potential of a polyethylene surface similar to the Flexel® ULDPE contact layer, 
PE particles were produced with a Retsch CryoMill ball mill (Retsch®, Haan, Germany) from bag 
pieces made of pure polyethylene (Stomacher®, VWR, Darmstadt, Germany). The stainless steel 
milling jar with two milling balls (15 mm ø) was continuously cooled with liquid nitrogen before and 
during the milling process. After an initial cooling phase of 10 minutes at 5 Hz, two milling cycles of 
5 minutes at 24 Hz with an intermediate cooling phase of 3 minutes at 5 Hz were applied. About 
80 mg of the obtained PE particles were suspended in 11 mL of a filtrated (0.2 µm PES) solution of 
10 mM NaCl with 0.02 % polysorbate 20. The non-ionic surfactant had to be added to ensure proper 
particle wetting. Using 0.01 M NaOH and 0.01 M HCl, the pH was adjusted to defined values of 2, 3, 
4, 6, 8, and 10. Zeta potential measurements of 800 µL aliquots of these samples were performed in 
disposable folded capillary cells using a Zetasizer Nano-ZS (Malvern Instruments Ltd., Herrenberg, 
Germany) with three runs of 10 to 30 sub runs each.  Analysis was performed at 25°C and a voltage 
of 50 V with automatic attenuator selection. Zeta potentials were calculated by the Zetasizer 
software v6.32 applying Smoluchowski theory and the ‘auto mode’ analysis model. 
2.2.2 IgG Charge Characterization 
2.2.2.1 Zeta Potential Measurements 
The model IgG was dialyzed into 1 mM KCl using Vivaspin 20 ultrafiltration spin columns (Sartorius 
AG, Göttingen, Germany) with a molecular weight cut-off of 30,000 Da. Centrifugation was 
performed at 4000 rpm and 4°C for several times until buffer replacement was completed. The final 
IgG concentration was adjusted to 6 mg/mL. A filtrated (0.2 µm PES) aliquot of 9 mL was transferred 
into a stirred polypropylene tube and by means of a Malvern MPT-2 Autotitrator, the pH of the 
sample was titrated from pH 2 to pH 10 in increments of 0.5 using 0.1 M NaOH and 0.1 M HCl. Zeta 
potential was measured in a connected disposable zeta cell placed inside a Zetasizer Nano-ZS 
(Malvern Instruments Ltd., Herrenberg, Germany) with three measurements per pH value of 10 to 30 
sub runs each. Analysis was performed at 25°C and at a voltage of 50 V in ‘monomodal mode’ with 
automatic attenuation selection. The IEP of the IgG was calculated by the Zetasizer Software v6.32. 
ADSORPTION OF A MODEL ANTIBODY TO SINGLE-USE BIOPROCESS BAGS 
19 
2.2.2.2 Isoelectric Focusing (IEF) 
For the determination of the isoelectric point (IEP) of the model IgG, isoelectric focusing was 
performed on a Multiphor Il™ electrophoresis system with an EPS 3501 XL power supply and a 
Multitemp III thermostatic circulator (GE Healthcare Europe GmbH, Freiburg, Germany). Precast 
Servalyt® Blank Precotes® electrophoresis gels with a pH gradient from 6 to 9 were used (Serva 
Electrophoresis GmbH, Heidelberg, Germany). As protein standard, 5 μL of the Serva Liquid Mix IEF 
Marker 3-10 were used. The protein concentration of the sample was 2 mg/mL in 20 mM histidine 
buffer pH 5.4. A volume of 10 μL was loaded on the gel. The Serva Violet 17 staining kit was used for 
gel staining. The staining protocol as recommended by the manufacturer was followed. 
2.2.3 Sample Preparation 
Adsorption isotherm experiments were conducted with diluted IgG solutions of concentrations 
between 0.1 and 5 mg/mL in 20 mM histidine buffer pH 5.4. In all following studies, IgG 
concentration was set to 2 mg/mL. Experiments with varying adsorption and desorption times were 
performed without further additives. For studies with varying pH and ionic strength (IS), various 
20 mM histidine buffers were prepared via pH adjustment with 1 M NaOH and 1 M HCl. Ionic 
strength was set to either 50 or 100 mM via the addition of adequate amounts of NaCl. The iterative 
calculation process for the required amounts of salt is described in detail by Mathes [31]. The spread 
sheet template was adapted to the histidine buffer system with pKa1 = 1.8, pKa2 = 6.0 and pKa3 = 9.3 as 
given by Lieberman, Marks and Peet [32]. IgG stock solution was diluted using the corresponding 
buffer to the final concentration of 2 mg/mL. The pH of all samples was checked using a Mettler 
Toledo MP220 pH meter (Mettler Toledo, Greifensee, Switzerland). Finally, all samples were filtered 
(0.2 µm PES). Protein concentration was verified by UV absorption at 280 nm using a Nanodrop 
Micro-Volume UV-Vis spectrometer (Nano Drop 2000, Thermo Scientific, Wilmington, USA) and an 
extinction coefficient of 1.51 cm2/mg. 
2.2.4 HPLC Adsorption Studies 
2.2.4.1 Standard Adsorption and Desorption Procedure 
Pieces of 1.2 cm width and 2.2 cm length were cut out of the polymer bags. The outer faces of two 
pieces were mounted together using double-sided adhesive tape (tesa® Verlegeband, Ref. 05681-
00018, Beiersdorf, Hamburg, Germany). Care was taken not to touch the inner surface of the bag at 
any time. Each piece was transferred into a flat base tube (VWR International, Darmstadt, Germany). 
The dimensions of the bag pieces were chosen so that they fitted exactly into the tube. Each bag 
piece was incubated with 3 mL of the appropriate IgG solution at room temperature for at least two 
hours (n=3). For isotherm determination, the equilibrium IgG concentration in the supernatant after 
incubation was determined using UV spectroscopy as described above. Subsequently, incubated bag 
pieces were rinsed five times with 3.5 mL of the corresponding placebo buffer. Therefore, tubes were 
centrifuged upside down using short spins of up to 1000 rpm between each washing step to remove 
excessive liquid. After cutting off the bag piece edges, each sample was transferred into a fresh tube 
and 2.8 mL of desorption medium (10 mM phosphate buffer with 145 mM NaCl and 0.05 % SDS, 
pH 7.2) was added. After desorption at room temperature for at least two hours, aliquots from the 
supernatant were transferred into HPLC glass vials (VWR, Darmstadt, Germany) and the IgG content 
was quantified via HP-SEC. The measures of each incubated bag piece were calipered and the 
corresponding adsorbed amount per unit surface area was determined. 
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For comparison, 5 mL Flexboy® bags were employed for adsorption studies. Incubation was 
performed with 4 mL of a 2 mg/mL IgG solution in 20 mM histidine buffer pH 5.4. For better 
handling, one side of the small-scale bags was cut open prior to performing seven washing steps with 
4 mL placebo buffer each. Desorption medium volume was 4 mL. 
2.2.4.2 HP-SEC Analysis of Desorbed IgG 
The desorbed amount of IgG was determined via high-performance size-exclusion chromatography 
(HP-SEC) with an Agilent 1200 device (Agilent Technologies GmbH, Boeblingen, Germany) equipped 
with a HP 1046A fluorescence detector (Hewlett Packard, Palo Alto, CA, USA). A TSK Gel G3000 SWXL 
column with a SEC guard column was used (Tosoh Bioscience GmbH, Stuttgart, Germany). The mobile 
phase equaled the desorption medium (0.05 % SDS in 10 mM phosphate buffer pH 7.2 with 145 mM 
sodium chloride). Flow rate was set to 0.7 mL/min and injection volume was 300 μL. A 6-point 
calibration curve was included in every run with reference concentrations of 0.01, 0.005, 0.001, 
0.0005, 0.0002 and 0.0001 mg/mL IgG in desorption medium. All chromatograms were integrated 
manually using ChemStation software Rev. B.02.01-SR2 (Agilent Technologies GmbH).  
Fluorescence characteristics of the model IgG were evaluated with a Varian Cary Eclipse fluorescence 
spectrophotometer (Varian Deutschland GmbH, Darmstadt, Germany). IgG solutions at a 
concentration of 0.05 mg/mL in 20 mM histidine buffer pH 5.4 as well as in desorption medium 
containing 0.05 % SDS were analyzed as described by Mathes [31]. The resulting spectra shown in 
Figure II-6 indicate increased fluorescence intensity in the presence of SDS and the maximum 
quantum yield was obtained at an excitation wavelength of 279 nm and an emission wavelength of 
336 nm. Accordingly, fluorescence quantification during HPLC analysis was performed at these 
wavelengths. 
(a) (b) 
Figure II-6: Fluorescence spectra of IgG in (a) 20 mM histidine and (b) 10 mM phosphate buffer with 145 mM 
NaCl and 0.05% SDS. 
2.2.5 Gold Staining of Adsorbed IgG 
In order to visualize protein adsorbed to the different bag surfaces after incubation or remaining 
protein after SDS desorption, gold staining was performed. Bag pieces for staining were obtained via 
the above described adsorption and desorption process from incubation with IgG samples of pH 2, 6, 
and 10, all at 100 mM ionic strength. All pieces were washed using the corresponding placebo buffer 
and subsequently with deionized water in order to remove residual salts on the surface that might 
interfere with the gold staining [33]. Each bag pieces was transferred into a new tube and 3 mL gold 
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staining solution (Colloidal gold total protein stain, BioRad Laboratories, Munich, Germany) were 
added. After incubation at room temperature for 3 days, specimen were washed with deionized 
water and dried. For semi-qualitative information, reference staining included bag pieces that were 
incubated with IgG solutions of 0.0001 mg/mL, 0.001 mg/mL, and 0.01 mg/mL in 20 mM histidine 
buffer pH 5.4. 
2.2.6 Replacement Studies with Fluorescently-Labeled IgG 
Fluorescent labeling of IgG was performed using Rhodamine B isothiocyanate (Rh B ITC) dye (Sigma 
Aldrich GmbH, Taufkirchen, Germany). The model IgG was dialyzed into 1 M bicarbonate buffer pH 9 
using a Vivaspin 20 tube (Sartorius Stedim biotech GmbH, Goettingen, Germany) with a molecular 
weight cut-off of 30,000 Da and centrifugation at 4000 rpm and 5°C. The final concentration was 
adjusted to 6 mg/mL. While stirring slowly, 105.6 μL of a 20 mg/mL Rh B ITC stock solution in DMSO 
(Merck Chemicals, Darmstadt, Germany) were added to 10 mL of IgG solution under light protection. 
After incubation for 2 hours at room temperature, the conjugation buffer was again replaced by 
20 mM histidine buffer pH 5.4 using ultrafiltration. Several centrifugation steps were performed to 
remove excess dye from the sample. The labeled IgG solution was filtered (0.2 µm PES) and the final 
IgG concentration as well as the degree of labeling (DOL) were determined from UV absorbance at 
280 nm and 557 nm using a Nanodrop Micro-Volume UV-Vis spectrometer. Calculations were 
performed as described elsewhere [34]. For replacement studies, the labeled IgG solution (IgG-Rho B, 
9 mg/mL and DOL of 15 %) was diluted 1:500 with unlabeled IgG and concentration was adjusted to 
2 mg/mL. 
Bag pieces with 1.2 cm length and 0.8 cm width were cut out of the polymer bags. During incubation, 
the outer bag surface was covered with adhesive tape (tesa®, Beiersdorf, Hamburg, Germany), which 
was removed prior to microscopy due to its strong background fluorescence. In a first step, bag 
specimens were incubated with unlabeled IgG (2 mg/mL) for two hours. After washing with histidine 
buffer, samples were transferred into new 2 mL reaction tubes (Eppendorf AG, Hamburg, Germany) 
and subsequently incubated under light protection with the diluted IgG-Rho B solution for fixed time 
frames of 5 minutes to 48 hours. The same procedure was performed in reversed order (incubation 
with IgG-Rho B first followed by incubation with unlabeled IgG, both under light protection). After 
final rinsing with histidine buffer and deionized water, the dried bag pieces were fixed to a carefully 
cleaned object slide with the inner bag surface directed upwards. The positive control was incubated 
with fluorescently-labeled IgG only and the negative control with unlabeled IgG only for 48 hours. 
Microscopic measurements were accomplished using a Biozero BZ-8000 fluorescence microscope 
(Keyence GmbH, Neu-Isenburg, Germany) with a TexasRed filter system (λex / λem: 560 nm / 630 nm) 
and 10x magnification. With a blank specimen that was in contact with histidine buffer only, 
exposure time was adjusted to 0.5 seconds. 
2.2.7 Data Analysis and Statistics 
Unless otherwise stated, results are presented as mean values with standard deviations (n=3). F-tests 
(equality of variances) were conducted with p=0.95. Significance testing was performed via the t-test 
function in Microsoft Excel 2010. Significance levels are indicated by asterisks: p < 0.05 (*), 
p < 0.01 (**), and p < 0.001 (***). Adsorption isotherms were calculated in Origin 8G (OriginLab 
Corporation, Northampton, MA, USA) using non-linear least square curve fitting with the Levenberg-
Marquardt algorithm. Displayed HP-SEC chromatograms were obtained after curve smoothing using 
the Savitzky-Golay function in Origin 8G.  
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3 RESULTS 
3.1 Characterization of the Fluid Contact Layers 
3.1.1 Morphology 
The micrographs shown in Figure II-7 depict significant differences in the morphology of the three 
tested bag types. The inner surface of the Flexboy® bag revealed a grid-like structure (see Figure II-
8a). In contrast, the Flexel® surface exhibited a completely flat sheet structure with regular marks 
probably arising from polymer foil handling with rollers during film production [35]. The PureFlex™ 
film revealed unregular elevations of approximately 2 µm (see Figure II-8b). Rz and Ra values of the 
different bag surfaces were determined to be 1.108 µm / 0.167 µm for the Flexboy® bag, 0.736 µm / 
0.091 µm for the Flexel® bag, and 1.137 µm / 0.129 µm for the PureFlex™ film. 
(a) (b) (c) 
Figure II-7: The inner surface of (a) Flexboy®, (b) Flexel®, and (c) PureFlex™ bags examined with 3D laser 
microscopy with 10x magnification. 
(a)  
 
(b) 
 
Figure II-8: (a) Photograph of the inner surface of a Flexboy® bag showing the regular grid-like morphology. 
(b) 3D display of the elevations on the surface of a PureFlex™ bag. 
3.1.2 ATR-IR Microscopy 
In order to confirm the composition of the fluid contact layers of the different bags, specifically to 
determine the vinyl acetate (VA) content of the inner Flexboy® bag surface, IR spectra were recorded 
in attenuated total reflection mode with an IR microscope (see Figure II-9). All spectra showed typical 
peaks arising from ethylene adsorption bands at 2920, 2850, and 1465 cm-1 [36]. In the Flexboy® bag 
spectrum, additional peaks from the vinyl acetate subunits could be identified at 1740, 1375, 1240, 
and 1020 cm-1 [12]. The PureFlex™ spectrum revealed two smaller extra peaks at 1639 and  
1560 cm-1, which might be related to not further specified additives [3,37,38]. 
1 mm 
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Figure II-9: FT-IR spectra of the inner surface of (a) the EVA contact layer of a Flexboy® bag and (b) the ULDPE 
contact layers of a Flexel® and a PureFlex™ bag. 
As shown in Figure II-10, the VA content of the Flexboy® bag surface could be determined via the 
peak height ratio of the valence vibration of the carbonyl group in the VA subunit at 1737 cm-1 and 
the deformation vibration of the C-H bond in the ethylene subunit at 1465 cm-1 [39]. With a peak 
ratio of 2.75 ± 0.04, the VA content of the bag material was 24.0 %. For EVA materials used for 
containers, the European Pharmacopeia limits the VA content to 25 % [12]. 
(a) (b) 
Figure II-10: (a) IR spectra of EVA reference films with varying VA content. (b) Plot of peak height ratio of the 
bands at 1737 and 1465 cm-1 versus VA content in %. Linear fit: y = -7.7E-4 + 0.11466 · x (R2 = 0.97508). 
3.1.3 Surface Free Energy 
3.1.3.1 Contact Angle Measurements 
The surface free energy as an important solid surface property can be obtained via measuring the 
contact angles with liquids of different surface tension and polarity. Drop shape analysis of the 
contact angles obtained for water and diiodomethane on Flexboy® and Flexel® bag pieces are shown 
in Figure II-11. The corresponding contact angles are summarized in Table II-6. Both bag surfaces 
exhibited high water contact angles of 87° and 97°, respectively. Upon contact with diiodomethane, 
the contact angles were 60° for the Flexboy® bag and 50° for the Flexel® surface. 
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(a) 
 
(b) 
 
(c)
 
(d)
 
Figure II-11: Contact angle measurements with (a+b) Flexboy® and (c+d) Flexel® bag pieces. On the left side, 
drops of water on the bag surface are shown, the right side depicts measurements with diiodomethane. 
 
Table II-6: Contact angles of Flexboy® and Flexel® bags with water and diiodomethane (n=3 with 3 sub 
measurements each). 
Bag Water Diiodomethane 
Flexboy 86.6 ± 1.1° 60.0 ± 2.6° 
Flexel 96.9 ± 3.5° 49.9 ± 1.3° 
 
Using the dispersive and polar components of the test liquid surface tensions as stated in Table II-5, 
the Owens-Wendt-Rabel-Kaelble analysis (see Table II-7) demonstrated that the polar components 
contributed about 12 % to the overall surface tension of 31.8 mN/m for the Flexboy® bag. The 
surface tension value for the Flexel® bag was slightly higher with hardly any polar contribution. 
Table II-7: Surface free energy of the bag surfaces as obtained from the Owens-Wendt-Rabel-Kaelble 
analysis. 
Bag Surface tension [mN/m] 
Polar component 
[mN/m] 
Dispersive component  
[mN/m] 
Flexboy 31.8 ± 1.0 3.7 ± 0.2 28.2 ± 0.7 
Flexel 34.9 ± 0.5 0.5 ± 0.5 34.3 ± 0.9 
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3.1.3.2 Determination of Surface Tension with Test Inks 
The surface tension of the polymer bags was additionally tested with a second method. Drops of test 
inks with defined surface tensions were placed on the surface of a Flexboy® and a Flexel® bag. As 
shown in Figure II-12, the test ink with 29 mN/m spread on both surfaces, whereas the test ink with 
32 mN/m formed a defined drop and did not wet. Thus the surface tension of the two bag surfaces 
must be higher than or equal to 29 mN/m, but lower than 32 mN/m. 
(a) (b) 
 
Figure II-12: Two different test inks (left: 29 mN/m and right: 32 mN/m) on the surface of the (a) Flexboy® 
bag and (b) Flexel® bag. 
3.2 Charge Characterization of IgG and Contact Layer Materials 
 (a) (b) 
Figure II-13: (a) Electric charge of IgG, Flexboy® bag and PE particles depending on pH value determined from 
zeta potential measurements. (b) Isoelectric focusing gel for IEP determination of the model IgG. Marker (M) 
bands correspond to IEP values of I) 10.7, II) 9.5, III) 8.3, IV) 8.0, V) 7.8, VI) 7.4, VII) 6.9, VIII) 6.0, IX) 5.3, X) 5.2, 
XI) 4.5, XII) 4.2. 
For the interpretation of electrostatic interaction forces between bag and protein, the surface charge 
of the bag surfaces and the IgG was determined via zeta potential measurements (see Figure II-13a). 
Below their zero point of charge at around pH 3.5, both polymer surfaces bear a limited positive 
charge. At pH 10, the zeta potential of PE particles was around -15 mV. The EVA surface of the 
Flexboy® bag was more negatively charged with a zeta potential of -54 mV. The IEP of the model IgG 
as determined from automatic titration with concurrent zeta potential measurement was 8.5. At 
lower pH values, IgG molecules are positively charged with a maximum of 23 mV at pH 2. At alkaline 
conditions of pH 10, the IgG molecules elicited a negative zeta potential of -14 mV. 
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Depending on the titration sequence, the IEP of the protein was found to vary slightly. Therefore, IEP 
was confirmed with isoelectric focusing (IEF). The IgG sample showed a dominant band between 
marker bands III and IV, indicative for an IEP between 8.0 and 8.3 (Figure II-13b). Only rather faint 
isoform bands were visible below and above the main band. 
3.3 Adsorption Studies with HP-SEC Quantification 
3.3.1 Adsorption Isotherms 
The influence of IgG concentration on the adsorbed amount and therefore IgG affinity to the bag 
surfaces is shown in Figure II-14. Saturation was reached at around 2 mg/mL for the Flexboy® bag 
surface, for the Flexel® pieces surface coverage was already maximal at an IgG concentration of 
1 mg/mL. Consequently, the IgG incubation concentration was chosen to be 2 mg/mL for all following 
experiments. 
(a) (b) 
Figure II-14: Adsorption isotherms of the model IgG for adsorption to (a) Flexboy® and (b) Flexel® bag pieces. 
Adsorption isotherms can be described by several fit functions including the Langmuir and the 
Langmuir-Freundlich fit. The Langmuir adsorption model was originally developed for the adsorption 
of gases to homogeneous and independent interaction sites on solids and is described by the 
following equation [40,41]: 
? = ????????1 + ????  
Γ(max) equals the (maximum) adsorbed amount per unit surface area, K is described as equilibrium 
constant and ceq is the equilibrium concentration of the adsorbing molecule, in this case the IgG 
concentration in the supernatant. As the assumptions made by the Langmuir model are often argued 
to be inadequate for describing the process of protein adsorption [41,42], a modification in the form 
of the Langmuir-Freundlich model was derived [43]: 
? = ????(?????)
?
1 + (?????)?  
In this model, Km represents the mean binding affinity and equals K in the Langmuir equation for 
n = 1 [42]. The Langmuir-Freundlich fit assumes heterogeneous binding affinities that follow a quasi-
Gaussian distribution function. The width of this distribution function is characterized by the 
heterogeneity index n with 0 < n < 1 [42,44]. According to this definition, n values of less than 1 
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indicate surface heterogeneity. The mathematically equivalent Hill equation accounts for adsorption 
to homogeneous surfaces [44]. In this case, n is defined as the Langmuir-Freundlich coefficient 
number that serves as an indicator for the type and extent of adsorption cooperativity due to lateral 
interactions between the adsorbing molecules [41,44,45]. 
Table II-8: Parameters obtained by applying non-linear curve fitting to IgG adsorption isotherms. 
Bag 
Langmuir fit Langmuir-Freundlich fit 
Γmax [mg/m2] K [mL/g] R2 Γmax [mg/m2] Km [mL/g] n R2 
Flexboy 4.01 5.90 0.899 3.98 5.95 1.03 0.887 
Flexel 3.09 14.41 0.996 2.98 19.66 1.18 0.997 
 
Both models resulted in fittings of comparable quality as indicated by the coefficient of 
determination R2 in Table II-8. Independent of the applied model, the maximum adsorbed amount of 
IgG (in 20 mM histidine buffer pH 5.4, without further additives) was calculated to be 4 mg/m2 for 
the Flexboy® bag surface and 3 mg/m2 for the Flexel® bag. In both cases, the K or Km values for IgG 
adsorption to the Flexel® surface were about three times higher than the constants for IgG 
adsorption to Flexboy® bags. This fact was accompanied by a slightly increased n-value in the 
Langmuir-Freundlich fit parameters for the Flexel® bag. 
3.3.2 Influence of Adsorption and Desorption Time 
To further characterize the IgG adsorption process, the incubation time was varied. The results in 
Figure II-15a indicate that IgG adsorption to the EVA surface of the Flexboy® bag pieces was 
completed after two hours. Longer incubation period did not lead to an increase in the amount of 
adsorbed IgG. For the Flexel® bag, the maximum adsorbed amount was already reached within the 
first hour of IgG incubation (see Figure II-15b). All samples contained 2 mg/mL of IgG in 20 mM 
histidine buffer pH 5.4. 
(a)  (b)  
Figure II-15: Influence of incubation time on the adsorbed amount of IgG for (a) Flexboy® and (b) Flexel® bag. 
Upon contact with the desorption buffer containing 0.05 % SDS, IgG was readily desorbed from the 
Flexboy® bag surface (see Figure II-16a). Desorption from the Flexel® bag surface took up to one hour 
to be completed (see Figure II-16b). In both cases, longer desorption periods did not result in an 
increase in the amount of IgG available for quantification. In contrast, increasing desorption times 
lead to increased tape extractable peaks in HP-SEC chromatograms as shown in Figure II-17. This 
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extra peak might impact IgG peak integration negatively and therefore desorption times should be 
kept to a minimum. 
(a) (b) 
Figure II-16: Influence of desorption time on the amount of IgG available for HP-SEC quantification for 
(a) Flexboy® and (b) Flexel® bag. 
(a)  (b)  
Figure II-17: HP-SEC chromatograms after IgG desorption from (a) Flexboy and (b) Flexel bag pieces. The peak 
at around 11 min RT corresponds to the IgG, the second peak at a RT of approx. 17 min was due to 
extractables from the double-sided adhesive tape used for bag piece preparation. 
3.3.3 Influence of pH and Ionic Strength on IgG Adsorption 
All previous experiments were conducted to gain insights into adsorption kinetics and to establish 
the experimental parameters for reliable quantification of IgG adsorption to bag films. By varying the 
formulation pH and ionic strength, the relevance of electrostatic interactions as potential driving 
forces for the adsorption process was evaluated. 
Figure II-18a demonstrates the pronounced effect of pH on the adsorbed amount of IgG to the 
Flexboy® bag surface. For an ionic strength of 50 mM, the adsorption maximum was at pH 6 with an 
adsorbed amount of around 4 mg/m2. Towards more acidic and more alkaline pH values, the 
adsorbed amount decreased to 2 mg/m2. Samples with an increased ionic strength of 100 mM 
tended to result in slightly higher adsorbed amounts. Due to the overall rather high relative standard 
deviations of up to 30 %, this trend is only significant for pH 4 (p < 0.05). Hardly any influence of pH 
on the adsorbed amount to the Flexel® bag surface was observed (see Figure II-18b). Over the range 
of pH 3 to 9, the adsorbed amount was constantly between 2.7 and 3.8 mg/m2, independent of the 
ionic strength of the applied formulation. At pH 2, the adsorbed amount was more than 4.5 mg/m2 
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and therefore comparably higher for both tested ionic strength values. The adsorbed amount at pH 
10 was slightly decreased in comparison to all other tested pH values. 
(a)  (b)  
Figure II-18: Influence of pH and ionic strength (IS) on the adsorbed amount of IgG for (a) Flexboy® and 
(b) Flexel® bag. 
IgG adsorption to the two bags with ULDPE contact layer, the Flexel® bag from Sartorius and the 
PureFlex™ bag from Millipore, was compared at pH 6 with 50 and 100 mM ionic strength. Figure II-19 
shows that adsorption to the PureFlex™ film was slightly higher than adsorption to the Flexel® bag, 
especially for elevated ionic strengths of 100 mM (p < 0.01).  
   
3.3.4 IgG Adsorption to 5 mL Flexboy® Bags 
The setup with pieces produced from bag material was established due to its easy handling, the 
possibility for higher sample through-put, and for economic reasons as well. The validity of this 
model setup was confirmed by comparative testing with 5 mL small-scale Flexboy® bags as a whole 
on the other side. The adsorbed IgG amounts (see Figure II-20) were not identical, but comparable as 
indicated by significance testing (p > 0.05). 
Figure II-19: Comparison of the adsorbed amount of 
IgG to two different bags with ULDPE contact layer: 
(a) Flexel® bag from Sartorius, (b) PureFlex™ film 
from Millipore. 
Figure II-20: Comparison of adsorbed amounts 
obtained for adsorption to (a) model bag pieces from 
Flexboy® bags and (b) 5 mL small-scale Flexboy®
bags. 
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3.4 Verification of SDS Desorption Efficiency via Gold Staining 
Analysis of IgG adsorption with the described setup relies on quantitative desorption of previously 
adsorbed IgG with SDS containing buffer. For verification of this assumption, gold staining as 
described by Eu et al .[28] was performed. Photographs of stained bag pieces of all three tested bag 
types before and after SDS desorption as well as reference stainings for semi-quantitative evaluation 
of the remaining amount of IgG after desorption are depicted in Figure II-21.  
(a) 
 
(b) 
 
 
Figure II-21: Photographs of gold stained bag pieces. (a) Comparison of staining before and after desorption 
with SDS buffer. (b) References for semi-quantitative evaluation of the amount of IgG on the surface of 
stained bag pieces. 
After incubation with IgG, gold staining of bag pieces resulted in a dark blue coloring (see Figure II-
21a). Flexboy® bag pieces incubated at pH 10 appeared darker than after incubation at pH 2 or 6. For 
the ULDPE bag types, the coloring after IgG incubation with various pH values was comparable. After 
desorption with SDS containing buffer, the Flexboy® bag piece incubated at pH 2 was nearly 
colorless. All bag pieces incubated at pH 6 showed a light blue staining after desorption, whereas the 
coloring of both Flexel® and Flexboy® bag pieces incubated at pH 10 was slightly darker. Comparison 
with the references (see Figure II-21b) led to the conclusions that already highly diluted incubation 
solutions caused a significant blue coloring of the bag pieces. The amounts of IgG adsorbed onto 
Flexboy® and Flexel® bag pieces after incubation with these defined concentrations could be 
estimated with the calculated adsorption isotherms (see 3.3.1). The results are stated in Table II-9. 
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Table II-9: Received adsorbed amounts [mg/m2] on reference bag pieces determined using the Langmuir-
Freundlich equation and corresponding fitting parameters. 
adsorbed amount [mg/m2] 
Reference concentration [mg/mL] 
0.0001 (Ref 1) 0.001 (Ref 2) 0.01 (Ref 3) 
Flexboy® 0.0020 0.021 0.21 
Flexel® 0.0019 0.029 0.38 
 
Comparison of the degree of staining of bag pieces after desorption with the references enabled 
estimation of the amount of IgG remaining on the bag surface after desorption. For nearly all 
conditions, desorption efficiency was calculated to be 99 % or higher (see Table II-10). As anticipated 
from the slightly darker staining of samples incubated at pH 10, desorption efficiency – especially for 
the Flexboy® bag samples – was decreased, but still well above 90 %.  
Table II-10: Calculation of SDS desorption efficiency. 
 
3.5 Reversibility of IgG Adsorption 
After buffer rinsing, IgG adsorbed to the bag surfaces could only be removed by means of a 
detergent like SDS. Nevertheless, IgG adsorption is claimed to be reversible in a sense that already 
adsorbed IgG molecules are in constant exchange with free IgG molecules from the bulk [22,46]. 
Replacement studies with fluorescently-labeled and native IgG molecules were performed in order to 
visualize this suggested reversibility. Figure II-22 clearly shows that samples pre-equilibrated with 
native IgG revealed faint fluorescence already after 30 minutes of contact with labeled IgG. The 
fluorescence signal increased steadily with longer contact times to labeled IgG solutions. Figure II-23 
visualizes this reversibility for the replacement of labeled IgG molecules by native IgG as fluorescence 
signals diminished with increasing secondary incubation times. This control served as proof that 
replacement in the first experiment was not only due to an increase in the hydrophobicity of the IgG 
due to labelling [47]. In general, fluorescence signals were not evenly spread across the micrographs, 
but distinct clusters and structures with notably stronger fluorescence were observable. 
Bag piece 
Flexboy® Flexel® PureFlex™ 
pH 2 pH 6 pH 10 pH 2 pH 6 pH 10 pH 6 
Total adsorbed 
amount [mg/m2] 2.3 4.6 2.9 4.4 3.8 2.9 5.3 
Staining 
comparable to Ref 1 Ref 2 Ref 3 Ref 1 Ref 1 Ref 2 Ref 1 
Remaining 
protein [%] 0.09 0.45 7.2 0.04 0.05 1.0 0.04 
Desorption 
efficiency  [%] 99.9 99.5 92.8 > 99.9 > 99.9 99.0 > 99.9 
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Figure II-22: Micrographs of bag pieces after pre-incubation with unlabeled IgG and subsequent incubation 
with Rhodamine B-labeled IgG. Incubation with labeled IgG was varied from 5 minutes to 48 hours. 
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Figure II-23: Micrographs of bag pieces after pre-incubation with Rhodamine B-labeled IgG and subsequent 
incubation with unlabeled IgG. Incubation with unlabeled IgG was varied from 5 minutes to 48 hours. 
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4 DISCUSSION 
4.1 The Influence of IgG and Surface Characteristics on IgG Adsorption 
In the course of this study, the surfaces of single-use bioprocess bags as well as the model antibody 
were characterized in order to gain a detailed picture of the adsorption process. The characteristics 
of the interacting partners strongly influence the extent and also the kinetics of protein adsorption. 
In this context, important surface properties include morphology, surface energy, polarity, and 
charge [22]. 
The three investigated bags revealed distinct differences in surface morphology upon microscopic 
investigation. The EVA Flexboy® surface and the ULDPE PureFlex™ film were found to have similar 
surface roughness values, whereas R values for the Flexel® bag were on average 30 to 45 % lower. A 
possible influence of surface roughness on the adsorbed amount of protein has to be considered 
when comparing adsorption data. As an example, adsorption to the PureFlex™ surface was slightly 
increased in comparison to adsorption to the Flexel® bag despite otherwise identical chemical 
composition of the fluid contact layer. There are several studies that indicate enhanced protein 
adsorption with increasing surface roughness which is beyond the corresponding increase in specific 
surface area. The focus here is on roughness in the nano-scale range [48,49]. Rechendorff et al. [50] 
report increased adsorption for the anisotropically shaped fibrinogen to evaporated tantalum films 
when increasing root-mean-square roughness from 2.0 to 32.9 nm. However, adsorption of bovine 
serum albumin, a nearly globular protein, was less influenced by surface roughness. Elter et al. [51] 
demonstrated that the adsorbed amount of fibronectin to silicon wafers was higher on areas with a 
topographic nanostructure than on the planar reference. Deligianni et al. [52] also found higher 
adsorbed amounts of fibronectin on titanium alloys of increased surface roughness (Ra values of 
0.320, 0.490, and 0.874 µm), whereas human serum albumin was adsorbed preferentially onto the 
smooth substrate. In contrast, from their studies on collagen adsorption to surfaces of controlled 
topography and surface chemistry, Denis and coworkers [53] concluded that surface topography 
does not influence the adsorbed amount, but the supramolecular organization of the adsorbed layer. 
The determination of surface free energies via contact angle measurements is well accepted [54]. 
However, results have to be interpreted with care since surface roughness and chemical 
heterogeneity might have an impact on observed contact angles [55–57]. Moreover, it is often stated 
that the number and type of standard liquids as well as the calculation method strongly influence the 
obtained surface free energy values [55,58,59]. The surface free energy values obtained for the bag 
surfaces are nonetheless considered reliable since widely accepted standard test liquids were used 
and also the applied Owens-Wendt-Rabel-Kaelble analysis is known to result in useful and 
qualitatively reasonable data [58,59]. Additionally, experimentally determined value of 32 and 
35 mN/m for EVA and PE, respectively, were close to the surface tension values obtained with test 
inks and to reported literature values. Owens and Wendt [60] report a surface tension of 33.2 mN/m 
for low-density polyethylene with a hydrogen bonding component of zero. Surface tension values 
between 17 mN/m and 32 mN/m were measured by Ali for various LDPE/EVA blends [61]. Michalski 
states a surface free energy value for EVA with 70 % VA content of 27.4 mN/m, with a nondispersive 
component contribution of 6.6 mN/m [59]. In a study by Devallencourt et al., the surface free energy 
of an EVA film with 19 % VA content is given with 30.4 mN/m [62]. Although surface tension values 
for both bags were comparable, it became clear that the surface free energies of EVA and ULDPE 
differ in the contribution from polar components: ULDPE is a completely nonpolar material and 
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mainly hydrophobic interactions are expected during protein adsorption. By contrast, with EVA 
distinct contributions from polar interactions are anticipated.  
A common rule of thumb claims that the more hydrophobic the surface, the greater is the extent of 
protein adsorption [15,17]. In the present case, this would implicit higher adsorbed amounts on 
ULDPE bags than on the EVA bag. When comparing the maximum adsorbed amounts Γmax obtained 
from isotherm fitting at pH 5.4, this hypothesis cannot be confirmed in our case. 4 mg/m2 of IgG 
adsorbed to the EVA surface of the Flexboy® bag, whereas only 3 mg/m2 were quantified on the 
ULDPE surface of the Flexel® bag. Only at a relative extreme acidic pH of 2 that induces protein 
unfolding, this relation is inverted. Indeed, Uettwiller et al. [63] did find higher adsorbed amounts on 
LDPE than on EVA with a bovine IgG formulated at 1 mg/mL in phosphate-buffered saline (PBS) pH 
7.2. But there are several examples in literature that also give exceptions to this rule of thumb. Van 
der Veen et al. [64] measured higher plateau values for α-lactalbumin adsorption to the hydrophilic 
interface than to the hydrophobic one when choosing a protein concentration of 0.1 g/L. This effect 
was ascribed to faster spreading rates on the hydrophobic surface. In a study by Ho and Hlady [65] 
on the adsorption of low-density lipoprotein to a gradient surface with hydrophilic silica at one end 
and a self-assembled C-18 monolayer at the other, higher adsorption capacities and affinities were 
found at the hydrophilic end. Adsorption processes may therefore not always be entirely determined 
by hydrophobicity [15,66]. 
The zeta potential titration curves clearly indicated pH ranges for which electrostatic attraction or 
repulsion has to be considered. With a zero point of charge around 3.5, the zeta potential profiles of 
EVA and PE resemble typical polymer titration curves [67]. The absolute charge value for the PE 
particles was generally lower than for the EVA surface of the Flexboy® bag. This seems reasonable as 
the PE surface is very nonpolar, whereas EVA with a VA content of 24 % possesses a significant 
number of polarizable chemical groups. Of course, the influence of the varying solution properties 
employed during zeta potential measurements should be considered. However, it seems unlikely that 
a slightly increased ionic strength and the presence of a non-ionic surfactant during measurements 
with the PE particles would make up for such a considerable difference in absolute zeta potential 
values [67]. The presence of protein isoforms as visible in the IEF gel arises from protein 
fermentation and cannot be avoided [68]. For this model IgG, one isoform was strongly prevailing 
and the additional isoform bands were limited and rather faint. In conclusion, below a pH of 3.5 and 
above the IgG’s IEP of around 8.0-8.5, both interaction partners were equally charged and 
electrostatic repulsive forces dominate. In-between these pH values, IgG and the bag surface were 
oppositely charged and electrostatically attracted each other. Due to the absolute charge values, this 
effect should be more pronounced with the EVA surface. Indeed, pH variations considerably affected 
the extent of IgG adsorption to EVA and resulted in an adsorption maximum at pH 6. Conversely, the 
adsorbed amount on the ULDPE bag surface stayed rather constant over a broad pH range. Likewise, 
an increase in ionic strength did not influence adsorption to the Flexel® bag, but slightly increased 
adsorption to the EVA surface. From his early studies on bovine serum albumin adsorption to 
hydrophobic and hydrophilic silica surfaces, MacRitchie also concluded that adsorption at a more 
hydrophilic surface is more sensitive to electrical factors [69].  
However, the fact that even under electrostatic repulsive conditions a significant amount of IgG 
adsorbs to the polymer surfaces underpins the prevailing theory that not electrostatic forces but 
rather hydrophobic interactions are the main driving force for protein adsorption [16]. The entropy 
gain due to the release of surface bound water molecules and salt ions as well as due to 
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conformational changes of the protein compensates electrostatically unfavorable forces [22,70,71]. 
Especially immunoglobulins are considered to be “soft” proteins that readily undergo structural 
alterations during adsorption [17,22]. Moreover, nonuniformity of a protein’s local charge 
distribution in the 3D structure enables adsorption under overall repelling charge conditions as 
surface attachment can be promoted via distinct regional charge patches of opposite sign [72]. The 
often observed adsorption maximum at the protein’s IEP [22] could not be confirmed in this study. It 
is argued that at the IEP, electrostatic protein-protein repulsions are minimized and therefore a 
higher packing density on the surface is enabled [22]. For EVA, the adsorbed amount at pH 8, which is 
close to the IgG’s IEP, was lower than at pH 6, and for ULDPE the adsorbed amount was constant in 
the range of pH 3 to 9. An adsorption maximum shifted away from the IEP of the protein was also 
found by other authors. Mathes and Friess [25] investigated a monoclonal IgG1 with an IEP of 
approx. 8 and located the maximum of adsorption to glass vials at pH 4. Likewise, the maximum 
adsorbed amount of IgG1 on siliconized glass vials in a study by Höger et al. [26] was located at pH 4 
to 5, with a second smaller maximum around the IEP of the protein. 
4.2 Adsorption Isotherms and the Interplay of Hydrophobic and 
Electrostatic Forces 
Electrostatic interactions also impact adsorption kinetics. The adsorption rate is anticipated to be 
higher with electrostatic attraction due to an accelerated protein migration towards the surface [22]. 
Analyzing the influence of incubation time on the amount of adsorbed IgG revealed that adsorption 
to the nonpolar ULDPE bag surface was completed within one hour. Saturation of the EVA surface 
was not achieved until two hours of incubation time. Consequently, the hydrophobicity aspect might 
be once again more important in this case. Besides, a denser packing of 4 mg/m2 on EVA compared 
to 3 mg/m2 on ULDPE may be a result of re-arrangement of individual IgG molecules, which simply 
might take more time. Overall, IgG adsorption was fast as already after a few minutes a substantial 
amount of IgG was found on the investigated surfaces. In his review, Gray schedules initial protein 
adsorption events even to microseconds to milliseconds [72]. 
The fact that hydrophobicity is an important factor for IgG affinity to the bag surfaces can also be 
concluded from the three times higher ULDPE equilibrium constant K / mean binding affinity Km 
obtained from isotherm calculations (see 3.3.1). An increased K value indicates a higher adsorption 
than desorption rate [66]. Moreover, adsorption saturation at the ULDPE surface was reached at 
lower equilibrium concentrations. Both observations might direct towards increased spreading and 
structural adaptions of IgG molecules on the more hydrophobic ULDPE surface. Generally, structural 
alterations are supposed to be more likely with soft proteins and hydrophobic surfaces [16] as well as 
at low surface-coverages [18]. Upon spreading, the IgG molecule’s footprint on the adsorbing surface 
increases and saturation is achieved with less IgG molecules and thus lower adsorbed amounts. It 
might also be argued that IgG adsorption to EVA and ULDPE occurs in different favored molecular 
orientations including end-on with Fab-up or Fab-down orientation, side-on, and flat-on [15,73,74]. 
For cytochrome c, Lee and Saavedra [74] showed that molecular orientation and therefore adsorbed 
amounts indeed can vary with surfaces of different chemical properties. Since the jamming limit of 
surface coverage is usually unknown, calculating the favored orientation based on actual adsorbed 
amounts seems rather speculative. Although protein adsorption was observed to result in mainly 
monolayers, surface filling can range from closely-packed molecules to incomplete surface coverage 
[70,75]. Hlady and Buijs [76] indicate that under most conditions, IgG adsorbs in an end-on 
orientation probably with the Fc part directed towards the surface. Under the assumption of an end-
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on orientation in a closely-packed monolayer, Buijs et al. state adsorbed IgG amounts between 2.6 
and 5.5 mg/m2 [77]. The results for IgG adsorption to both ULDPE and EVA were within this range. 
Additionally, the absence of steps or inflection points in the adsorption isotherms supports the 
suggested formation of a monolayer only [78]. 
For both bag materials isotherms approached a plateau, which is typical for protein adsorption 
[16,17]. Coefficients of determination were comparable for both applied fitting functions, namely the 
Langmuir and the Langmuir-Freundlich fit. Therefore, the Langmuir model seemed to be suitable for 
the description of IgG adsorption in this case despite its inappropriate postulates based on the 
reversible adsorption of gases to solids [79]. However, this agreement might be only accidental and 
isotherms should be interpreted carefully [40,69]. Due to the fact that during protein adsorption 
each molecule usually forms several surface interaction sites, interacts with other protein molecules, 
and adsorbs irreversibly to the surface, many authors prefer the Langmuir-Freundlich fit [41–43,66]. 
This fitting function includes the parameter n, which can be an indicator for cooperativity during 
adsorption. The value of n is influenced by both interactions between protein and surface and lateral 
interactions between adsorbing proteins. Luo and Andrade describe the degree of cooperativity to be 
partially positive for n values between 1 and 1.5 [45]. The values obtained for IgG adsorption to the 
EVA and ULDPE bag surfaces were within this range. Koopal et al. confirmed that positive 
cooperativity in general is more common than negative cooperativity [44], although e.g. J. Mathes 
and K. Höger obtained n values of less than 1 for IgG and lysozyme adsorption to borosilicate glass 
vials [31,80]. Due to the two different possible definitions for n with regards to cooperativity or 
heterogeneity, the calculated, apparent n value might be influenced by contributions from both 
intrinsic heterogeneity of the surface and adsorbate-specific nonideal behavior. The extended 
Langmuir-Freundlich equation for monocomponent adsorption by Koopal et al. takes both factors 
into account [44]. Moreover, Luo and Andrade found cooperativity to be dependent on protein 
concentration when studying adsorption of several model proteins like lysozyme, BSA, transferrin, 
and lactoferrin onto hydroxyapatite. With the help of Hill plots, they could define three stages of 
cooperativity in most of the studied adsorption isotherms [45]. The calculated n values of 1.03 and 
1.18 for EVA and ULDPE, respectively, might thus represent an overall cooperativity value only and 
individual n values for different stages during adsorption might partly be even higher. Similarly, Rabe 
et al. discuss apparent non-cooperativity as a result from balanced positive and negative cooperative 
effects [22]. The different phases during protein adsorption and the corresponding interaction forces 
that determine cooperativity will be discussed in more detail in the next chapter. 
4.3 Impact of IgG Adsorption on Protein Loss in the Bulk 
From an industrial point of view, protein losses are of main interest in adsorption studies. Protein 
losses in percent were calculated based on the maximum adsorbed amount of 4 mg/m2 as 
determined for IgG adsorption to the Flexboy® surface and the inner surface areas of various bag 
sizes as stated by the manufacturer (Table II-11). For the calculations, nominal fill volumes were 
assumed. Especially with higher concentrated IgG solutions of 100 mg/mL, the expected loss is below 
0.04 ‰ in any case and therefore most likely not even detectable. Only in small bags with higher 
surface area to volume ratios and at low protein concentrations in the bulk or only partial filling, 
protein loss might be measurable. For example, at an IgG concentration of 1 mg/mL, the loss upon 
storage in a 5 mL bag was calculated to be 0.4 %. For a bag filled at only 25 %, losses would increase 
to 1.3 %. For IgG adsorption to Flexel ULDPE bag, even lower percentages of losses are to be 
expected. In this case, the maximum adsorbed amount was only 3 mg/m2 and bag capacities range 
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from 50 up to 1000 L. These findings are confirmed by Uettwiller et al., who calculated IgG losses 
(1 mg/mL, 5°C storage) to be 0.22 % in a 30 mL Celsius-Pak with EVA contact layer and 0.011 % in a 
50 mL Flexel 3D bag with LDPE contact layer. The basis for this extrapolation were adsorbed IgG 
amounts of 4.8 mg/m2 for the Stedim 71 (EVA) material and 5.6 mg/m2 for the Stedim 40 (LDPE) film 
material [63].  
In summary, loss due to protein adsorption is negligible for the studied system. An overview given by 
Nakanishi et al. indicates that for most systems studied in literature, adsorbed amounts were in the 
lower mg/m2 range [17]. Therefore, as a general rule, loss due to protein adsorption does not seem 
to be crucial [20]. Exceptions to that rule are of course highly diluted protein solutions. As an 
example, Hawe and Friess [81] report losses of a hydrophobic cytokine formulated at 0.25 mg/mL 
due to adsorption to glass vials of up to 10 %, and McLeod et al. [27] attributed Factor VIII activity 
losses of up to 60 % upon storage in PVC mini-bags to adsorption effects. 
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Table II-11: Anticipated protein loss in the bulk due to adsorption to the bag surfaces based on a m
axim
um
 
adsorbed am
ount of 4 m
g/m
2. *: nom
inal filling according to stated bag size. A 15 %
 overfill can typically be 
applied. 
Loss in bulk [%]  
at 25 % filling 
100 
mg/mL 
IgG 
0.0134 
0.0046 
0.0029 
0.0021 
0.0014 
0.0011 
0.0007 
0.0006 
0.0006 
0.0004 
0.0003 
10 
mg/mL 
IgG 
0.1344 
0.0458 
0.0293 
0.0211 
0.0145 
0.0113 
0.0072 
0.0062 
0.0056 
0.0039 
0.0026 
1 mg/mL 
IgG 
1.3440 
0.4576 
0.2933 
0.2106 
0.1446 
0.1131 
0.0718 
0.0617 
0.0564 
0.0386 
0.0259 
loss in 
concentratio
n at 25% 
filling 
[µg/mL] 
13.44 
4.58 
2.93 
2.11 
1.45 
1.13 
0.72 
0.62 
0.56 
0.39 
0.26 
Loss in bulk [%]  
at nominal filling 
100 
mg/mL 
IgG 
0.0034 
0.0011 
0.0007 
0.0005 
0.0004 
0.0003 
0.0002 
0.0002 
0.0001 
0.0001 
0.0001 
10 
mg/mL 
IgG 
0.0336 
0.0114 
0.0073 
0.0053 
0.0036 
0.0028 
0.0018 
0.0015 
0.0014 
0.0010 
0.0006 
1 
mg/mL 
IgG 
0.3360 
0.1144 
0.0733 
0.0526 
0.0362 
0.0283 
0.0179 
0.0154 
0.0141 
0.0097 
0.0065 
loss in 
concentration 
at nominal* 
filling [µg/mL] 
3.36 
1.14 
0.73 
0.53 
0.36 
0.28 
0.18 
0.15 
0.14 
0.10 
0.06 
adsorbed 
IgG [mg] 
0.017 
0.057 
0.110 
0.132 
0.181 
0.283 
0.538 
0.772 
1.411 
1.930 
3.242 
inner 
surface 
[cm2] 
42 
143 
275 
329 
452 
707 
1346 
1929 
3528 
4826 
8106 
Bag 
size 
5 mL 
50 mL 
150 m
L 
250 
mL 
500 m
L 
1 L 
3 L 
5 L 
10 L 
20 L 
50 L 
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4.4 Evaluation of the Applied Quantification Method 
As the relative amount of adsorbed protein was low, it was not possible to measure the adsorbed 
amount via depletion in the bulk solution. The depletion method combined with simple UV 
quantification of the protein content with or without preceding SEC analysis was applied in many 
studies using model surfaces with high surface areas like polystyrene latex particles [82], micro- and 
nanoparticles made from various materials [83], or glass beads [84,85]. For real container surfaces, 
more sensitive detection methods have to be applied. With the help of radioisotope-labeled 
molecules, adsorption can be measured directly on the surface of interest [86–88] or again via 
depletion in the incubation solution [89]. Other methods like total organic carbon (TOC) analysis after 
oxidative hydrolysis use rather harsh conditions in order to remove adsorbed protein quantitatively 
from the sorbent surface [31,90]. Such harsh conditions are not applicable to plastic polymers of 
single-use bags due to compatibility issues. Therefore, Uettwiller and coworkers [63] analyzed the 
adsorbed amounts of IgG and BSA on single-use containers via quantitative amino acid analysis 
including a desorption step with 5% acetic acid under sonication. Subsequently, acid hydrolysis with 
6 N HCl was performed at 110°C for 24 hours followed by amino acid derivatization with 
phenylisothiocyanate (PITC). PITC conjugation made amino acids accessible to UV quantification after 
reversed-phase HPLC. In contrast, the herein described method is rather simple, fast, and at the 
same time applicable to the real bag surface. Adsorbed protein was available for quantification via 
HP-SEC with fluorescence detection after one single desorption step with a phosphate buffer 
containing 0.05 % SDS. This method was adapted from previous studies by J. Mathes [31] and K. 
Höger [80] and benefits from the high sensitivity of fluorescence spectroscopy in combination with 
higher quantum yields in the presence of SDS. Via gold staining before and after IgG desorption and 
upon visual comparison with stained references, the almost quantitative desorption of IgG from the 
studied EVA and ULDPE bag surfaces by the detergent SDS was proven. Adsorption isotherms 
together with the stained references were employed to estimate the amount of protein remaining 
on the bag surfaces after desorption. In most cases, desorption efficiency was determined to be 99 % 
or higher. As an exception, IgG adsorbed to the EVA surface at pH 10 could be removed less 
efficiently at an extent of 92.8 %. The maximum desorbed amount available for quantification was 
obtained within one hour of incubation with SDS. In literature it is described that SDS is very well 
suited to desorb proteins from various surfaces. Brash and Horbett claim that one possible 
mechanism for this process is solubilization involving complex formation between adsorbed proteins 
and surfactant [15]. In their studies, Liu and Craig showed that a buffer solution containing 17 mM 
SDS was able to remove 90% of lysozyme from a hydrophobic model surface [91]. Likewise, Mulzer 
and Brash used tris buffer containing 2 % SDS for the desorption of plasma proteins adsorbed to glass 
beads [92]. 
For experimental validation and qualification studies during the implementation of bag systems, 
commercially available small-scale bags, but also bag pieces as described here can be used for 
adsorption studies. During the course of this study, adsorbed amounts were not only quantified with 
Flexboy® bag pieces, but also with 5 mL Flexboy® bags. Thus, the validity of results obtained from 
studies with bag pieces was verified. Adsorbed amounts were slightly, but not significantly reduced 
when performing adsorption studies with 5 mL bags. This tendency might have different reasons. The 
surface area to volume ratio for the small-scale bag setup was 0.1 cm2/mL and therefore only half as 
for the setup with bag pieces in tubes (surface area to volume ratio of 0.2 m2/mL including tube 
walls). Moreover, diffusion of IgG molecules to the surface might be hindered in small-scale bags. 
Despite near maximal filling, the 5 mL bag remained rather flat and especially in the edge regions 
ADSORPTION OF A MODEL ANTIBODY TO SINGLE-USE BIOPROCESS BAGS 
41 
capillary effects might inhibit free diffusion of protein molecules to unoccupied spots on the inner 
bag surface. Wahlgren and Arnebrant describe transport to the surface as the first important step 
during the whole adsorption process [18]. Several authors claim that this step might even be 
adsorption rate-determining [24,87]. Incubation time was chosen long enough to achieve saturation, 
but when keeping the ongoing spreading of adsorbed proteins on the respective surface in mind, it 
becomes clear that hindered diffusion might indeed reduce the amount of adsorbed protein [16]. 
Consecutively, rather slowly arriving molecules might not be able to occupy initially free space on the 
surface because in the meantime, this spot might be covered by previously adsorbed, spreading 
molecules [64]. In conclusion, the established model setup with bag pieces was found to be 
appropriate to study protein adsorption. With this setup, sample handling is facilitated and higher 
sample through-put than with small-scale bags is feasible. Additionally, resource consumption in the 
form of protein solution and bag material is reduced. 
4.5 Adsorption Reversibility and Consequences 
One of the paradoxes in protein adsorption described by Ramsden is the shown concentration 
dependency of adsorption that is normally expected for a reversible process only [75]. It is well 
accepted that the adsorption process is usually not reversible upon dilution or rinsing with buffer 
[15–17,87], because the multiple interaction sites between protein and surface would all have to 
break at the same time to enable desorption [15]. Nevertheless, at equilibrium a constant exchange 
of adsorbed molecules with molecules from the bulk solution is assumed [22,46]. In this context, 
fibrinogen turnover on glass was demonstrated by Chan and Brash via replacement studies with 
differently radioisotope-labeled proteins [86]. In the present study, IgG replacement between 
adsorbed and free molecules was studied with fluorescently-labeled IgG molecules. Artefacts can 
arise from increased hydrophobicity of labeled molecules and the thus increased propensity for non-
specific adsorption [22,47]. This was taken into account by utilizing two experimental setups: 
incubation of bag surfaces with labeled IgG molecules and subsequent exposure to unlabeled IgG, 
and vice versa. With both incubation schemes, replacement of the previously adsorbed species 
during the second incubation step could be observed. This confirms the prevailing theory that 
adsorbed proteins diffuse back into the bulk solution [18–20]. It is discussed whether detached 
molecules which became structurally perturbed at the surface can have negative immunogenic 
effects or serve as seeds for aggregation.  
Fluorescence of adsorbed IgG-Rho B was not evenly distributed over the investigated bag areas. On 
the contrary, localized spots with high fluorescence signals indicated some kind of clustering of 
adsorbed IgG molecules. Rabe et al. ascribe this surface clustering of molecules to either diffusion of 
surface bound molecules towards precursor aggregates or the direct adsorption of bulk monomers in 
close proximity to already adsorbed molecules or aggregates. This guiding of newly arriving 
molecules implies cooperativity between adsorbed and adsorbing molecules. Alternatively, protein 
assemblies formed in solution can direct deposit onto the surface and result in clusters [22]. Using 
atomic force microscopy (AFM), Herrig et al. were able to visualize surface clusters of the protein 
ezrin when adsorbed to supported lipid bilayers [93]. AFM pictures from studies by Hoehne et al. [85] 
and Mathes [31] also indicate an uneven distribution of model antibodies upon adsorption to glass. 
The phenomenon of cluster formation is especially well studied for lysozyme adsorption on mica 
surfaces [94–96]. 
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5 SUMMARY AND OUTLOOK 
The described setup is well-suited for quantifying adsorption of therapeutic proteins to disposable 
bag materials. Bag pieces for incubation were prepared by sticking two film sheets together using 
double-sided adhesive tape, with the inner bag surfaces facing outside. After incubation with the 
protein solution under investigation and few washing steps, adsorbed protein was readily desorbed 
with SDS containing buffer. Subsequently, the IgG content could easily be analyzed with HP-SEC and 
fluorescence detection. Desorption efficiency was visualized by gold staining and for most cases 
estimated to be ≥ 99 %. Initial adsorption as well as desorption events occurred within minutes and 
were completed within one to two hours at a maximum. Adsorbed amounts obtained with small-
scale bags were comparable and thus confirmed the validity of the more convenient experimental 
setup with bag pieces. 
The present study showed that adsorption of a model IgG (IEP of approx. 8.2) to single-use bag 
surfaces with ULDPE and EVA contact layer was governed by hydrophobic as well as electrostatic 
interactions. With the more polar surface EVA, electrostatic interactions were more important than 
for the non-polar ULDPE surface. The adsorption maximum for the EVA surface was located at pH 6 
and increased ionic strength led to slightly higher adsorbed amounts of around 5 mg/m2. On ULDPE, 
adsorbed amounts were consistently around 3.5 mg/m2 for pH values between 3 and 9, variations in 
ionic strength did not have any impact at all. With the help of adsorption isotherms, the higher 
affinity of the model IgG to the more hydrophobic ULDPE was shown.  
“General truths” that attribute adsorption maxima to the IEP or commonly expect increased 
adsorption on more hydrophobic surfaces could thus not be confirmed. These assumptions have to 
be verified on a case-by-case basis, since adsorption is strongly influenced by surface and protein 
properties. Even the amount of adsorbed protein on the two ULDPE surfaces differed slightly, 
indicating that different bag types indeed have specific characteristics based on their production and 
final processing conditions [5]. Polymer surfaces can be comprehensively characterized by the 
described methods. Surface morphology was visualized using 3D laser scanning microscopy, FT-IR 
measurements confirmed the chemical composition of the polymers, surface charge was analyzed 
with zeta or streaming potential measurements, and surface tensions were determined using contact 
angle measurements and test inks. The model protein was characterized in terms of its overall 
surface charge at different pH values. When comparing adsorption of different proteins, further 
influencing factors like size, stability, and hydrophobicity of each protein have to be investigated as 
well.  
Depending on pH, adsorbed amounts were in the range of 2 to 5 mg/m2. Loss due to protein 
adsorption at relevant conditions was therefore demonstrated to be negligible, especially with higher 
concentrated formulations and at maximal filling volumes. More critical might be structural 
alterations due to adsorption in conjunction with the proven exchange of adsorbed molecules with 
molecules in the bulk. However, assessing structural alterations directly when adsorbed to real, 
imperfect surfaces is challenging. The detection of desorbed protein in the bulk is equally ambitious, 
since the fraction of exchanged and perturbed molecules in the bulk is expected to be rather small. 
Moreover, most spectroscopical methods perform an averaging of protein structure signals over the 
observed protein population [15,76]. The occurrence and the extent of structural perturbations 
might be different for every single molecule, depending on its residence time and available space on 
the surface [97]. Brash and Horbett assume that the structure of adsorbed proteins ranges from 
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native to, at most, partially unfolded [15]. Nevertheless, several authors found significantly 
perturbed structures for desorbed proteins using circular dichroism. Soderquist and Walton report 
marked decreases in α-helical content of albumin and fibrinogen after desorption from 
copolypeptide and silicone surfaces. Similarly, γ-globulin lost most of its β-sheet structure [98]. Chan 
and Brash eluted human fibrinogen from a Pyrex glass surface using a highly concentrated Tris buffer 
(1 M) and suggest a 50 % loss in α-helical content due to adsorption [99]. After desorbing bovine 
serum albumin (BSA) and hen’s egg lysozyme from silica particles via displacement with morpholine, 
Norde and Favier found reduced α-helical contents at low surface coverages. At saturation 
conditions, the reduction in α-helical content was insignificant for lysozyme, and BSA recovered most 
of its native structure during displacement [100]. With regards to therapeutic proteins, Hoehne et al. 
investigated structural changes of three humanized antibodies upon adsorption to glass particles. 
Infrared spectroscopy and front-face fluorescence quenching measurements revealed only minor 
perturbations in secondary and tertiary structure, respectively [85]. In the context of possible 
structural alterations arising from protein adsorption, immunogenicity of adsorbed proteins is 
discussed. Shomali et al. [101] as well as van Beers et al. [102] addressed this issue in 
immunogenicity studies with mice by injecting glass and other particles with adsorbed antibodies or 
recombinant human interferon beta, respectively. Immunogenicity resulting from protein adsorption 
could not be proven conclusively, especially as a potential immunogenic impact of the particles 
themselves should be considered. 
Apart from investigations on protein structure after adsorption, more detailed insights into 
adsorption kinetics and the adsorption process itself are of interest. An elaborated study on IgG 
adsorption kinetics using quartz crystal microbalance (QCM) with ULDPE and EVA model surfaces is 
described in the next chapter. 
  
CHAPTER II 
44 
6 ABBREVIATIONS 
ATR-IR attenuated total reflectance infrared 
ceq  equilibrium concentration of the adsorbing molecule 
CZ Crystal Zenith 
DEHP diethylhexylphthalate 
DMSO dimethylsulfoxid 
DOL degree of labeling 
EVA ethylene vinyl acetate 
EVOH ethyl vinyl alcohol 
HP-SEC high-performance size-exclusion chromatography 
IEF isoelectric focusing 
IEP isoelectric point 
IgG immunoglobulin G 
IgG-Rho B IgG labeled with Rhodamine B 
IS ionic strength 
IV intravenous 
K equilibrium constant 
Km  mean binding affinity 
LDPE low-density polyethylene 
LLDPE linear low-density polyethylene 
M molar 
mAb monoclonal antibody 
n heterogeneity index / Langmuir-Freundlich coefficient number 
NaCl sodium chloride 
ø diameter 
PA polyamide 
PBS phosphate-buffered saline 
PE polyethylene 
PES polyethersulfone 
PET polyethylene terephthalate 
PP polypropylene 
PS 20 polysorbate 20 
PVC polyvinyl chloride 
PVDC polyvinylidene dichloride 
Ra arithmetic mean roughness 
RhB ITC Rhodamine B isothiocyanate 
rpm revolutions per minute 
RT retention time 
Rz maximum height 
SDS sodium dodecyl sulfate 
THF tetrahydrofuran 
ULDPE ultra-low density polyethylene 
VA vinyl acetate 
ZPC zero point of charge 
Γ(max) (maximum) adsorbed amount per unit surface area  
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CHAPTER III 
 
STUDYING PROTEIN ADSORPTION WITH 
QUARTZ CRYSTAL MICROBALANCE (QCM) 
 
ABSTRACT 
Adsorption of a model antibody (IgG) to model surfaces made from EVA and PE polymers was studied 
in situ using QCM measurements. In this setup, spin-coated polymer surfaces on QCM chips should 
mimic typical contact layers of single-use bioprocess bags. Depending on pH and ionic strength, 
adsorbed amounts of IgG were in the range of 7 to 10 mg/m2. Applying the Sauerbrey equation was 
assumed to be valid since formed IgG layers in most cases were rigid. Furthermore, calculated 
adsorbed amounts were confirmed by independent measurements using HP-SEC quantification after 
IgG desorption. With the help of ΔΓ vs. Δf plots, three distinct phases during the adsorption process 
were identified for most formulation conditions. Rigid attachment was assumed during the first 
phase, followed by fast adsorption of more loosely bound protein in a second step and a subsequent, 
final rigidification phase. The adsorption process was found to be mainly governed by electrostatic 
interactions, therefore variations in pH and ionic strength led to slightly modified adsorption profiles. 
The three nonionic surfactants polysorbate 20, polysorbate 80, and poloxamer 188 were able to 
reduce adsorption to the EVA surface only during co-incubation. In conclusion, QCM studies with 
model surfaces helped to gain a deeper understanding of the adsorption process but cannot replace 
adsorption studies with real surfaces encountered during drug product manufacturing, since 
adsorbed amounts from HP-SEC (see previous chapter) and QCM analysis differed substantially.  
 
 
 
 
 
 
Parts of the following chapter are intended for publication. 
 
Data on mAb adsorption to PE surfaces at pH 2, 6 and 10 was collected by Stephanie Marlene Burisch 
during her Master thesis project entitled “IgG adsorption to single-use bioprocess bags with ULDPE 
contact layer” (2014).  
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8 INTRODUCTION 
8.1 Methods for Studying Protein Adsorption in Situ 
Apart from simply quantifying protein adsorption, deeper insights into adsorption kinetics foster a 
better understanding of this omnipresent phenomenon. There is a variety of methods, especially 
with spectroscopic background, that enable the observation of protein adsorption in situ and in a 
time-dependent manner. In the following section, the most commonly used methods including 
possible advantages and shortcomings are shortly introduced. 
During ellipsometry studies, changes in the phase and amplitude of polarized monochromatic light 
are measured after reflection from a surface on which a thin, homogeneous film is built due to 
adsorption. Changes are recorded for both the parallel and perpendicular polarized light 
components. From these changes, the refractive index of the film as well as its thickness is calculated 
via mathematical fitting. This method can only be applied to light-reflecting surfaces and films that 
do not adsorb light to a measurable extent, otherwise the complex refractive index of the film must 
be known or estimated [1]. Examples for ellipsometry studies that monitor protein adsorption to 
solid surfaces in a timely manner include the work of McArthur et al. [2] with Cu-Al films, Svensson 
and Arnebrandt’s studies on antibody adsorption to polystyrene surfaces [3], and experiments by 
Giacomelli and coworkers on albumin adsorption to titanium oxide electrodes [4]. 
Infrared spectroscopy can be applied to protein films on solid supports in the form of infrared 
reflection-adsorption spectroscopy (IRRAS) or as total internal reflection fluorescence (TIRF) 
measurements. IRRAS is a highly sensitive method that measures changes in polarized, infrared light 
in reflectance mode with high incidence angles. In analogy to ellipsometry, it is mainly applicable to 
highly-reflecting surfaces like metals, but also the adsorption at the air-water interface is widely 
studied with this technique [5]. IRRAS can give additional information on the orientation of molecules 
adsorbed on these surfaces [1]. Omanovic and colleagues, for example, employed polarization-
modulation IRRAS analysis for monitoring fibrinogen adsorption kinetics to stainless steel [6] and also 
albumin to gold [7]. In a typical TIRF setup, the light beam incidents from the outside and is totally 
reflected at the solid-liquid interface. An evanescent wave penetrates into the liquid phase and 
surface-associated protein is excited [8]. For quantitative evaluation of the emitted fluorescence 
intensities, rather complex calibration procedures have to be developed [9]. Most often 
fluorescently-labeled molecules are employed during TIRF studies, but also the intrinsic fluorescence 
of proteins can be exploited [10]. One critical factor here is the penetration depth of the evanescent 
wave. It should be long enough to capture the entire adsorption layer, but short enough to reduce 
unwanted signal contributions from the bulk solution [11]. In literature, time-resolved TIRF studies 
are reported amongst others by Buijs and Hlady for human growth hormone and lysozyme 
adsorption on clean and modified silica [12] and by Daly et al. for lysozyme adsorption to silica [13]. 
The most often used technique is surface plasmon resonance (SPR). In SPR, a light beam passes a 
glass prism and undergoes total internal reflection at the interface to a metal (typically gold) coating. 
An evanescent wave passes through the metal film and excites plasmons on the outer side of the 
film. Excitation occurs at a specific angle of incidence only and causes a reduction in the intensity of 
the reflected light. The incidence angle changes if protein binds due to a change in the dielectric 
properties, and thus the refractive index dependent on the thickness of the adsorbing protein layer 
[14]. Most often, simply the change in SPR angle is reported since a correlation with the amount of 
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adsorbed mass needs specific calibration [15]. Studying adsorption to other materials than metals is 
feasible with very thin film coatings on top of the metal surface. However, such thin coatings might 
not be achievable with polymers [10]. Using SPR; real-time microscale bioadhesion events were 
monitored by Aldred et al. [16] and Green et al. analyzed three plasma proteins for their adsorption 
behavior on the sensor’s silver surface and on a model polystyrene film [14]. 
Likewise, the interaction of an evanescent field generated by diffracted laser light with deposited 
molecules is measured by optical waveguide lightmode spectroscopy (OWLS). This rather new 
method is claimed to have intrinsic sensitivity superior to SPR. However, due to the limited 
propagation of the evanescent wave of only 100 to 200 nm, very thin coatings are necessary, too. A 
major benefit results from the possibility of determining the thickness as well as the refractive index 
of the adsorbed layer. Assumptions about this latter parameter are necessary for other optical 
methods like SPR and ellipsometry and can lead to uncertainties in the final results [17]. Calonder 
and coworkers extensively employed OWLS to study the history dependence of fibronectin and 
cytochrome c adsorption kinetics with multistep experiments on Si(Ti)O2 [18,19]. 
Studies with a quartz crystal microbalance (QCM) rely on the analysis of the propagation properties 
of acoustic waves as measuring principle. Acoustic waves are generated by a piezoelectric sensor and 
enable the observation of adsorption events as well as changes in the viscoelastic properties of the 
surrounding medium and the adsorbed layer [20]. Since this method is independent of the optical 
properties of the surface under investigation, adsorption events on a variety of coatings can be 
investigated [21]. Although the thin film requirement needs to be equally fulfilled for a correct 
modelling of QCM data, limitations for rigid coatings are considered not as strict as for SPR or OWLS. 
This method was therefore chosen for the in situ and real-time adsorption monitoring of a model 
therapeutic antibody to polymer surfaces in this study. Surfaces coated with polyethylene (PE) and 
ethylene vinyl acetate (EVA) were produced as surrogates for typical fluid contact layers of single-use 
bioprocess bags.  
All herein mentioned methods are strictly applicable to homogeneous layers only. However, this 
might not always hold true for adsorbed protein. Analysis of the lateral distribution of adsorbed 
molecules is achievable with atomic force microscopy (AFM). However, AFM measurements require 
very smooth adsorbent surfaces like mica or gold. Moreover, this method suffers from limitations for 
real-time measurements as well as from possible artifacts arising from the mechanical interference 
of the AFM tip with the adsorption process and the adsorbed layer [22,23]. 
8.2 Adsorption Studies with Quartz Crystal Microbalance (QCM) 
QCM devices employ an AT-cut quartz crystal (cut angle of 35.25° with respect to the quartz’s optical 
axis) sandwiched between two gold electrodes as sensor. The cutting of quartz in this specific 
direction relative to its crystallographic axes results in so-called thickness-shear mode oscillations 
when applying alternating voltage via the gold electrodes. The anti-parallel movement of both sensor 
surfaces results in acoustic waves that propagate perpendicular to the surface into the bulk solution. 
The resonance frequency of the sensor depends on its mass, a dependence which is given by the 
Sauerbrey equation. A QCM in this sense acts as a microweighing device only. By including a second 
information, namely dissipation, information on the viscoelastic properties of the adsorbed layer can 
be gained. Instruments that include a recording of dissipation signals are often referred to as QCM-D 
devices. For QCM-D analysis, the driving voltage is intermittently switched off and from the decay 
curve of the oscillation both the resonance frequency f and the energy dissipation D are calculated 
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[21]. In this study, the equivalent parameter ‘damping’ was evaluated. The damping signal is the 
corresponding bandwidth Γ of the resonance peak in the spectrum obtained during impedance 
analysis. Bandwidth Γ and dissipation D are proportional to each other (D = 2Γ/f) [24]. There are 
studies that report resistance values R, which are also proportional to the other two parameters and 
can thus be interpreted in a similar way [20]. 
Possible signal changes that are encountered during QCM measurements are depicted in Figure III-
24. It has to be kept in mind that the frequency shift is influenced by changes in the adsorbed mass 
as well as by changes in the density and viscosity of the surrounding medium or the adsorbed layer. 
Hence, care needs to be taken during quantitative evaluation of frequency shifts. The damping signal 
reflects changes in the viscoelastic properties only and gives valuable additional information that is 
not accessible with the other spectroscopic methods mentioned above. 
 
Figure III-24: Measurement signals obtained during QCM studies. (1) Upon attachment of a thin and rigid 
layer, a frequency shift is recorded whereas the damping signal D does not change. (2) A purely viscous 
change in the surrounding medium results in comparable frequency and damping shifts. (3) A viscoelastic 
layer leads to frequency as well as damping shifts, although damping shifts are reduced in this case. Graphics 
are taken from 3T analytik brochure [25]. 
As mentioned above, QCM benefits from the flexibility in the choice of substrate material. In 
principle, any material that can be coated or deposited onto the sensor in the form of a sufficiently 
thin layer (nm to µm range) can be employed [21]. Sensor modifications can be achieved by spin-
coating, sputtering, evaporation, and casting procedures. In consequence, QCM sensors can be 
widely employed, e.g. as biosensors, for the estimation of affinity constants, for biocompatibility 
testing, and for studying cell adhesion processes. Possible applications are reviewed in detail by 
Dixon [21], Marx [26], as well as Speight & Cooper [27]. The QCM technique is increasingly used to 
study protein adsorption to polymer surfaces. The studies reported in literature mainly focus on 
biopolymers, synthetic polymers with biomedical applications, molecular imprinted polymers and 
polymer brushes, but not on polymers used in bioprocess materials [27]. 
It is the aim of this study to gain deeper insights into the adsorption process of a therapeutic 
monoclonal antibody (mAb) to PE and EVA surfaces that are common contact materials of single-use 
bags. In the previous chapter, protein adsorption to these surfaces was characterized quantitatively 
via desorption and subsequent HP-SEC quantification. This QCM study aims not only at quantification 
of the protein on PE and EVA films but also at the evaluation of the adsorption reversibility and of the 
time-dependent viscoelastic properties of the formed protein layer. Formulation pH and ionic 
strength were varied in order to get a more detailed understanding of the contributions from 
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electrostatic interactions on the adsorption process. Furthermore, the capability of three nonionic 
surfactants (polysorbate 20, polysorbate 80, poloxamer 188) to reduce protein adsorption in 
sequential and co-incubation mode was evaluated. Finally, adsorbed amounts on polymer-coated 
QCM chips are critically compared to adsorbed amounts on real bag surfaces as presented in the 
previous chapter for assessing the suitability of QCM as an orthogonal method. 
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9 MATERIALS AND METHODS 
9.1 Materials 
9.1.1 Chemicals 
NaCl, Na2HPO4, and NaH2PO4 were obtained from VWR International (Darmstadt, Germany). NaOH 
(1 M), HCl (1 M) and sodium dodecyl sulfate (SDS) were obtained from Sigma-Aldrich (Taufkirchen, 
Germany). Polysorbate (PS) 20 and 80 as well as trichloroethylene were purchased from Merck KGaA 
(Darmstadt, Germany), Poloxamer 188 (Pol 188) was from BASF (Ludwigshafen, Germany). 
Tetrahydrofurane (THF) was obtained from J.T. Baker (Deventer, Netherlands). Highly purified water 
used for buffer preparation was obtained from an arium® pro DI Ultrapure Water System (Sartoris 
Stedim Biotech GmbH, Goettingen, Germany) or a USF ELGA PURELAB Plus UV/UF purification system 
(ELGA LabWater, Celle, Germany). Buffer filtration (volumes ≥ 500 mL) was performed with 
pressurized nitrogen and 0.2 μm cellulose acetate filters (47 mm, Sartorius Stedim Biotech GmbH). 
9.1.2 Model Antibody 
A 33.4 mg/mL IgG1 antibody (148 kDa) drug substance solution in 20 mM histidine buffer (pH 5.4) 
was kindly donated by Roche GmbH (Penzberg, Germany). 
9.1.3 Polymers for QCM chip coating 
Ethylene vinyl acetate (EVA) granules of the type Elvax 3190A were kindly donated by DuPont 
Packaging & Industrial Polymers (Neu-Isenburg, Germany). This EVA material with a vinyl acetate 
(VA) content of 25 % should mimic the EVA surface of the previously tested Sartorius Flexboy® bags 
(see Chapter II). As a model for the ULDPE surfaces of Sartorius Flexel® and Millipore PureFlex™ 
multilayer bags, bags made from pure PE were purchased (Stomacher®, VWR, Darmstadt, Germany). 
The identity and purity of the PE bag was confirmed via ATR-IR microscopy as described in Chapter II 
(see Figure III-25). 
 
Figure III-25: IR spectrum of the PE Stomacher® bag. 
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9.2 Methods 
9.2.1 QCM Chip Coating 
Gold-covered quartz sensors mounted on a thin polymer sheet were obtained from 3T Analytik (3T 
GmbH & Co. KG, Tuttlingen, Germany). The crystals were 8.5 mm in diameter. The area exposed to 
liquid was 38 mm2, the active electrode area is stated to be 19.6 mm2 [25]. 
EVA was dissolved in THF at 5 mg/mL under stirring and heating to approximately 50°C. For creating a 
homogenous EVA layer, 10 x 8 μl aliquots of the EVA solution were added to the crystal sensor while 
rotating in a SCI 20 spin coater with a customized sample stage (Schaefer Technologie GmbH, Langen, 
Germany) at 100 rpm. Pieces of the PE bag (0.5 g) were heated in 20 mL THF under stirring at 50°C. 
The PE coating was established by spin-coating 10 x 10 µL aliquots of the supernatant of this mixture 
on a QCM chip. After every measurement, the QCM chip surface was cleaned with trichloroethylene 
solution by gently patting the surface with a commercially available cotton swab. A new coating was 
produced prior to every measurement. Before coating and before insertion into the QCM device, the 
coated chip was cleaned and dried using filtered (Acro 50, 0.2 μm PTFE, Pall Corporation, Port 
Washington, USA), pressurized air. 
9.2.2 Microscopy 
Coating homogeneity was monitored by default via light microscopy (Keyence VHX-500F, Neu-
Isenburg, Germany) at 30x magnification. Morphology was visualized at higher resolution using a 
Keyence VK-X210 3D Laser Scanning Microscope with a 20x objective.  
9.2.3 Sample Preparation 
For obtaining 20 mM histidine buffers with varying pH and ionic strength (IS), pH adjustments were 
conducted with 1 M NaOH and 1 M HCl. Ionic strength was set to either 100 or 300 mM via the 
addition of adequate amounts of NaCl. The calculation of the corresponding amounts of salt is 
described in detail by Mathes [28]. The spread sheet template was adapted to the histidine buffer 
system with pKa1 = 1.8, pKa2 = 6.0 and pKa3 = 9.3 as given by Lieberman, Marks and Peet [29]. IgG 
stock solution was diluted using the corresponding buffer to a final sample concentration of 
2 mg/mL. Experiments with surfactants (PS 20, PS 80 and Pol 188) were performed at pH 6 without 
any addition of sodium chloride and at a constant surfactant concentration of 0.02 % (w/V). The pH 
of all samples was checked using a Mettler Toledo MP220 pH meter (Mettler Toledo, Greifensee, 
Switzerland). Calibration with purchased standard buffers of pH 2.0 and 7.0 was performed prior to 
every use. Finally, all samples were filtered using a 0.2 µm PES syringe filter (VWR, ID of 25 mm). 
Protein concentration was verified by UV absorption at 280 nm using a Nanodrop Micro-Volume UV-
Vis spectrometer (Nano Drop 2000, Thermo Scientific, Wilmington, USA), applying an extinction 
coefficient of 1.51 cm2/mg. 
9.2.4 QCM Measurements 
QCM measurements were performed at 25°C with a qCell T from 3T Analytik (Tuttlingen, Germany) 
connected to an Ismatec peristaltic pump operated at a flow rate of 100 µL/min. The system was 
controlled using qGraph software. Before starting the actual experiment, the coated QCM chip was 
pre-equilibrated in air and subsequently in highly-purified water. The sequence of a typical QCM 
experiment is shown in Figure III-26. The influence of pH and ionic strength on IgG adsorption was 
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studied in triplicates. Buffer rinsing was performed with the corresponding blank buffer that matched 
pH and ionic strength of the IgG sample. The desorption buffer was composed of 10 mM phosphate 
with 145 mM NaCl and 0.05 % SDS. Each solution was allowed to stay in contact with the crystal until 
a stable baseline in frequency (± 1 Hz within 10 minutes) and damping (± 10 Hz within 10 minutes) 
was reached. Equilibration with buffer was performed in flow mode. IgG samples equilibrated 
statically after the introduction of a limited sample volume of 290 µL. Care was taken not to 
introduce any air into the system upon changing samples. The formation of air bubbles within the 
measuring cell was further reduced by degassing all samples in an exsiccator connected to a vacuum 
pump (Laboport, KNF Neuberger GmbH, Freiburg, Germany) prior to use. 
 
Figure III-26: Frequency and damping shifts as a function of time for a typical QCM experiment. The different 
steps include: 1 - buffer rinsing, 2 - incubation with IgG, 3 - buffer rinsing, 4 - desorption with buffer 
containing 0.05 % SDS, 5 - buffer rinsing. 
The sample sequence applied for studying the influence of surfactants on IgG adsorption is displayed 
in Table III-12. Injection of a limited volume of 290 µL for all samples containing surfactant and / or 
IgG was followed by static incubation. For this study, QCM measurements were performed in 
duplicates. 
Table III-12: Sample sequence for QCM studies with surfactants. 
Sequence Rinsing Incubation I Rinsing Incubation II Rinsing 
#1 buffer surfactant (0.02%) buffer IgG (2 mg/mL) buffer 
#2 buffer IgG (2 mg/mL) buffer surfactant (0.02%) buffer 
#3 buffer IgG (2 mg/mL) + surfactant (0.02%) buffer 
 
9.2.5 Calculations 
The adsorbed amount was calculated from the frequency shift during adsorption by applying the 
Sauerbrey equation [30]. The presence of a thin, homogeneous, and rigidly adsorbed layer was 
assumed, as the Sauerbrey equation is valid for such systems only [21].  
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∆? = 	 2??
?
???? × ∆? 
Δf: frequency shift [Hz] 
f0: resonant frequency of the crystal (about 10 MHz) [25] 
A:  active electrode area (0.196 cm2) [25] 
ρ: density of quartz (2.648 g/cm3) [31] 
μ: shear modulus of quartz (2.947 x 1011 g/cm·s2) [31] 
Δm: adsorbed mass [g] 
 
By combining the constant terms, the adsorbed mass was directly calculated using the instrument 
specific crystal sensitivity constant C: 
 
∆? = ? × ∆? 
 
with C = 0.86 ng/Hz [25] and Δf being the frequency shift between incubation step (1) and (3) as 
shown in Figure III-26. The amount of IgG that was desorbed upon rinsing with the SDS containing 
buffer was calculated from the frequency shift between step (3) and (5). The adsorbed amount per 
unit area was obtained by normalization to the active electrode area. 
 
Layer thickness h of the coating as well as adsorbed IgG and surfactant layers was calculated as 
follows: 
ℎ = 	? × ∆?? × ?  
with Δf being the change in frequency upon coating after equilibration in air for the determination of 
the coating thickness or the frequency shift between the two buffer rinsing steps before and after 
incubation with IgG (step (1) and (3) as described in Figure III-26) or surfactant (rinsing before and 
after incubation I in sequence #1, as described in Table III-12). The value for ρ was chosen accordingly 
(see Table III-13). 
Table III-13: Densities of the different layer materials used for the calculation of layer thickness. 
Layer material Density ρ [g/cm3] Reference 
EVA coating 0.95 DuPont™ Elvax® 3190 Product Data Sheet [32] 
PE coating Approx. 0.9 Sepe 2012 [33] 
IgG 1.35 Fischer et al. 2004 [34] 
Polysorbate 20 1.1 Merck Millipore Product Information [35] 
Polysorbate 80 1.07 Merck Millipore Product Information [35] 
Poloxamer 188 1.06 BASF Product Information [36] 
 
Reversibility [%] of IgG adsorption was calculated from the frequency shifts upon incubation with IgG 
and the subsequent rinsing step [37]: 
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????????????? = 	∆?	(????	(3) − ????	(2))∆?	(????	(1) − ????	(2)) × 100% 
Viscoelastic properties of the adsorbed layer were evaluated with the obtained damping signals Γ 
[20]:  
∆?
∆? =
∆?	(????	(3) − ????(1))
∆?(????(1) − ????(3))  
The higher the value for ΔΓ/Δf, the more viscous is the adsorbed layer. If only the viscosity of the 
sample changes and adsorption events do not occur, e.g. when filling the dry chamber with water, 
this quotient is maximal. A value of zero indicates the formation of a completely elastic layer with 
rigidly attached molecules. 
9.2.6 IgG Size Determination with Dynamic Light Scattering (DLS) 
IgG size determination was performed by dynamic light scattering using the Zetasizer Nano-ZS 
(Malvern Instruments Ltd., Herrenberg, Germany). The undiluted, freshly filtrated (0.02 µm, PES) 
samples (IgG at 2 mg/mL in 20 mM histidine buffer pH 2 / 6 / 10 with 100 mM IS) were measured in 
disposable Plastibrand semi-micro PMMA cuvettes (Brand GmbH, Wertheim, Germany) at a 
backward scatter of 173° at 25°C and with water as dispersant. Positioning, attenuation selection and 
measurement duration as well as number of sub runs for the three performed measurements per 
sample were optimized automatically for each run by the Zetasizer Software 6.32. Z-average and 
polydispersity index (PdI) were calculated from the correlation function applying the ‘General 
purpose (normal resolution)’ analysis model. 
9.2.7 Viscosity measurements 
The viscosities of both the IgG and surfactant incubation solutions were determined using a m-VROC 
viscometer (RheoSense, San Ramon, CA, USA). Measurements were performed with sample volumes 
of 150 μL and a flow rate of 150 μL/min at 20°C.  
9.2.8 HP-SEC Quantification of IgG Adsorbed to the QCM Chip Surface 
EVA-coated QCM chips were incubated with IgG (pH 2 / 6 / 10, 100 mM IS) in the qCell T device as 
described above. After the second buffer rinsing step (step (3) in Figure III-26), the QCM chip with 
adsorbed IgG was removed from the flow cell and replaced by a cleaning insert. After thoroughly 
rinsing the whole QCM system with desorption buffer containing 0.05 % SDS, the previously 
incubated QCM chip was transferred into the measuring chamber again. IgG adsorbed to the QCM 
chip surface was desorbed by introducing 80 µL of the desorption buffer into the measuring 
chamber. As soon as a stable frequency signal was achieved, the desorption solution was pumped 
backwards and collected in a sample tube (Eppendorf GmbH, Hamburg, Germany). Two further 
rinsing steps with 20 µL desorption buffer each were performed and these fractions were added to 
the collected sample. The amount of desorbed IgG in the sample was quantified via HP-SEC on an 
Agilent 1200 device (Agilent Technologies GmbH, Boeblingen, Germany) with fluorescence detection 
(excitation at 279 nm, emission at 336 nm). A TSK Gel G3000 SWXL column with a SEC guard column 
was used. The mobile phase was composed of 0.05 % SDS in 10 mM phosphate buffer pH 7.2 with 
145 mM NaCl. The flow rate was 0.7 mL/min. The injection volume was 40 μL. A five-point calibration 
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curve was included for quantification with concentrations of 0.05, 0.025, 0.005, 0.0025, and 
0.001 mg/mL. All chromatograms were integrated manually using ChemStation software. 
9.2.9 HP-SEC Quantification of IgG Adsorbed to Bag Pieces In the Presence of 
Surfactant 
As QCM is not able to differentiate between mass contributions from different types of molecules, 
the total amount of IgG adsorbed to Flexboy® bag pieces after consecutive incubation, pre-
incubation or co-incubation with surfactants as described in Table III-12 was quantified using HP-SEC. 
Pieces of 1.2 cm width and 2.2 cm length were cut out of a Flexboy® bag (Sartorius Stedim Biotech 
SA, Aubagne, France). The outer faces of two pieces were mounted together using double-sided 
adhesive tape (tesa® Verlegeband, Ref. 05681-00018, Beiersdorf, Hamburg, Germany). Care was 
taken not to touch the inner surface of the bag at any time. Each piece was transferred into a flat 
base tube (VWR International, Darmstadt, Germany). The dimensions of the bag pieces were chosen 
so that they fitted exactly into the tube. Each bag piece was incubated with 3 mL of the appropriate 
incubation solution (‘Incubation I’ in Table III-12) at room temperature for four hours (n=3). 
Subsequently, incubated bag pieces were rinsed five times with 3 mL of 20 mM histidine buffer pH 6. 
Therefore, tubes were centrifuged upside down using short spins of up to 1000 rpm between each 
washing step in order to remove excessive liquid. 3 mL of the second incubation solution 
(‘Incubation II’ in Table III-12) were added and removed after four hours by the mentioned washing 
procedure. After cutting off the bag piece edges, each sample was transferred into a fresh tube and 
2.8 mL of desorption medium (10 mM phosphate buffer with 145 mM NaCl and 0.05 % SDS, pH 7.2) 
was added. After desorption at room temperature for at least two hours, aliquots from the 
supernatant were transferred into HPLC glass vials (VWR, Darmstadt, Germany) and the IgG content 
was quantified via HP-SEC with the above mentioned system. In this case, injection volume was 
300 µL and the calibration curve encompassed samples with concentrations of 0.01, 0.005, 0.001, 
0.0005, 0.0002 and 0.0001 mg/mL of IgG in desorption medium. To calculate the correct adsorbed 
amount per square meter bag surface, the measures of each incubated bag piece were calipered and 
the corresponding surface area was determined. 
9.2.10 Statistics 
Unless otherwise stated, results are presented as mean values with standard deviations (n ≥ 2). F-
tests (equality of variances) were conducted with p = 0.95. Significance testing was performed via the 
t-test function in Microsoft Excel 2010. Significance levels are indicated by asterisks: p < 0.05 (*), 
p < 0.01 (**), and p < 0.001 (***). Statistics are depicted in the figures only for differences discussed 
in the text. 
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10 RESULTS 
10.1 QCM Chip Coating Development and Morphology 
Light microscopy was used as standard method to verify chip surface coverage and coating 
homogeneity. Figure III-27a shows the pure gold surface of a QCM chip. After coating with EVA, the 
surface appeared slightly shiny (Figure III-27b), whereas the PE coating was clearly visible as opaque 
layer (Figure III-27c). A new coating was produced prior to every measurement. 
(a) (b) (c) 
Figure III-27: Light microscopy pictures of QCM chips. (a) Uncoated, (b) with EVA coating, and (c) with PE 
coating. 
Surface morphology of the coating was investigated in more detail using 3D laser scanning 
microscopy (Figure III-28). The QCM chip surface itself was completely smooth apart from scratches 
that were introduced by the cleaning technique over time. The EVA coating in Figure III-28b revealed 
structural features that arose from the coating process. The less smooth morphology of the PE 
coating is depicted in Figure III-28c. 
(a) (b) (c) 
Figure III-28: 3D laser scanning micrographs of QCM chips. (a) Uncoated, (b) with EVA coating, and (c) with PE 
coating. 
The frequency shift upon coating was recorded prior to every measurement as an indicator for the 
thickness of the applied coating (Table III-14). On average, EVA coatings were 252 nm thick, whereas 
PE coating mean thickness was 37 nm. Coating thicknesses varied strongly between experiments. 
Coating thicknesses were calculated with the Sauerbrey equation assuming a rigid coating. For EVA, 
the average ΔΓ/Δf quotient of 0.041 ± 0.036 (n=34) confirms coating rigidity. The quotient could not 
be calculated for all prepared coatings due to casual drifts in the damping signal. For PE, in most 
cases a negative shift in the damping signal after coating was recorded. Therefore, ΔΓ/Δf values could 
not be evaluated. Höök et al. ascribe negative shifts in the dissipation signal to interfacial friction 
phenomena between the overlayer (in our case the PE coating) and the surrounding liquid [38]. 
Applying the Sauerbrey equation might thus underestimate the actual coating thickness since the 
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viscoelastic properties of the PE coating layer are unclear. Both coatings were found to be stable 
upon contact with water, buffer, and SDS desorption buffer since resonant frequencies were stable 
during rinsing with these solutions (data not shown).  
Table III-14: Frequency shifts [Hz] upon coating and corresponding coating thicknesses [nm]. Calculations 
were performed applying the Sauerbrey equation. 43 EVA coatings and 44 PE coating were evaluated. 
Coating material  Minimum Maximum Mean value 
EVA Frequency shift [Hz] 2724 12504 5465 
 Coating thickness [nm] 126 578 252 
PE Frequency shift [Hz] 140 2178 758 
 Coating thickness [nm] 6 106 37 
 
10.2 QCM Method Development 
The robustness of the QCM method with specific focus on variations in EVA coating thickness was 
tested with a 2 mg/mL IgG incubation solution of pH 6 (20 mM histidine, 100 mM IS) and flow mode 
incubation (Table III-15). Independent of the applied coating thickness both tested QCM chips gave 
rather identical frequency shifts after equilibration with IgG solution. The overall mean frequency 
shift was 258 Hz with a standard deviation of only 8 Hz. This represents a relative variability of 
± 3.2 %. The variabilities for the three runs performed with the same chip were in the same range 
(RSD of 3.3 %).  
Table III-15: Influence of QCM chip number and EVA coating thickness on QCM results obtained during flow 
mode incubation (2 mg/mL IgG, 20 mM histidine, pH 6.0, 100 mM IS). 
Chip No. Frequency shift due to coating [Hz] 
Coating thickness 
[nm] 
Frequency shift due to IgG 
adsorption [Hz] 
5 11590 535 -257 
5 6534 302 -271 
5 3198 148 -255 
2 3732 172 -247 
2 6354 293 -256 
2 14178 655 -264 
 
The QCM method was developed as an orthogonal analytical technique for the previously presented 
adsorption studies with HP-SEC quantification (see Chapter II). Therefore, the final experimental 
parameters were adapted in a way that mimicked the incubation procedure with bag pieces best. 
Table III-16 lists exposed polymer surface, incubation volume, and incubation mode for the setup 
described in the previous chapter. Given a defined QCM chip surface area, the incubation volume 
was chosen accordingly to result in the same surface area to sample volume ratio. Similarly, 
incubation with protein solution was performed statically. After introducing the incubation solution 
to the measuring chamber, the pump was stopped and the sample was equilibrated until frequency 
and damping signals were stable. In contrast, rinsing of the QCM chip was performed in flow 
injection mode. 
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Table III-16: Experimental parameters for adsorption studies with HP-SEC and QCM quantification. 
Method Polymer surface exposed to incubation solution 
Volume of incubation 
solution Incubation mode 
HP-SEC 528 mm
2 
(2 x 12 mm x 22 mm) 3.0 mL static 
QCM 38 mm2 216 µL  + dead volume (74 µL) static 
 
10.3 Influence of pH on IgG Adsorption 
QCM measurements were applied to study the influence of different formulation pH values on IgG 
adsorption. IgG concentration in the incubation solution was constantly set to 2 mg/mL in 20 mM 
histidine buffer, ionic strength was 100 mM. 
10.3.1 Adsorbed Amount 
(a)  (b)  
Figure III-29: Frequency shifts (n=3, *: n=2) upon IgG adsorption (2 mg/mL IgG, 20 mM histidine, 100 mM IS) 
and desorption with SDS for (a) EVA and (b) PE. Corresponding adsorbed amounts were calculated using the 
Sauerbrey equation. 
In contrast to HP-SEC measurements, QCM can measure frequency shifts directly during adsorption. 
Figure III-29 depicts frequency changes resulting from IgG adsorption as well as subsequent 
desorption with SDS.  
For EVA, frequency shifts during adsorption ranged from 204 Hz at pH 2 to 229 Hz at pH 8. Applying 
the Sauerbrey equation, this corresponds to adsorbed amounts of 8.9 mg/m2 to 10.1 mg/m2. For a 
homogeneous IgG layer (density of 1.35 g/cm3), this results in a layer thickness of 6.6 nm to 7.5 nm. 
The frequency shift during desorption showed a stronger pH dependency. At pH 2, 80.5 % of 
adsorbed IgG was desorbed upon rinsing with SDS. For all other pH values, the fraction that could be 
desorbed was 90 % or higher. The highest desorbed amount was 94.8 % at pH 8. 
Using PE, the highest adsorbed amount was found for pH 2 with a frequency shift of 218 Hz. At pH 
10, the frequency shift was 169 Hz and thus significantly lower (p < 0.001). Adsorbed amounts at pH 
4, 6 and 8 lay in-between these values with frequency shifts between 212 and 195 Hz. For pH 
values > 6, adsorption to PE was in the range of 7.4 to 8.9 mg/m2 and was thus slightly less than 
adsorption to EVA. Adsorbed layer thicknesses were between 5.5 and 7.1 nm. The overall desorption 
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efficiency of SDS on PE was reduced in comparison to EVA. Desorption was lowest for pH 8 (68.9 %), 
and highest for pH 4 (78.4 %). 
10.3.2 Adsorption Kinetics 
(a) (b) 
Figure III-30: Representative ΔΓ vs. Δf plots for formulations (2 mg/mL IgG, 20 mM histidine, 100 mM IS) with 
different pH values for (a) EVA and (b) PE. 
Kinetics during adsorption can be monitored with ΔΓ vs. Δf plots. Figure III-30 shows representative 
plots for the time frame from IgG injection into the measuring cell until signal equilibration. 
Depending on the pH value of the formulation, one, two, or three phases with different slopes can be 
defined. For both surfaces, these observations are comparable. For pH 2, the ΔΓ vs. Δf plot consists of 
only one phase showing a linear and rather steep increase. For pH 10, two phases can be identified. 
An initial, steep increase is followed by a plateau phase, which starts after a frequency shift of 
approximately 100 Hz. For pH values of 4, 6, and 8, three segments can be distinguished. Initially, the 
slope is close to zero. After a short, steep increase, the graph then approaches a plateau after a 
frequency shift of around 175 Hz. In all cases, this plateau phase was reached within two minutes 
after IgG introduction to the measuring cell. The overall times until equilibrium are depicted in Figure 
III-31. At pH 2, signals equilibrated within 20 minutes. For all other pH values, equilibration took 
more than 40 minutes. For the EVA surface, equilibration time was longest at pH 10 with 80 minutes. 
For PE, the maximum equilibration time of 70 minutes was found at pH 6. 
Reversibility (Figure III-32) was defined as the percentage of IgG that was desorbed upon rinsing with 
blank buffer. For the EVA surface, reversibility was in the range of 3 to 10 % for all tested pH values. 
For the PE surface, lowest reversibility values of 1 and 4 % were found at pH 2 and 10, respectively. 
At pH 8, reversibility was 17 % and therefore maximal. 
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(a)  (b)  
Figure III-31: Time until equilibrium for formulations (2 mg/mL IgG, 20 mM histidine, 100 mM IS) with 
different pH values on (a) EVA and (b) PE coatings.  
(a)  (b)  
Figure III-32: Percentage of reversibly bound IgG (2 mg/mL IgG, 20 mM histidine, 100 mM IS) in dependency 
of formulation pH for (a) EVA and (b) PE. 
10.3.3 Viscoelastic Properties of the Adsorbed IgG Layer 
The quotient of damping and frequency shift after buffer rinsing is an indicator for the viscoelastic 
behavior of the irreversibly adsorbed protein layer (Figure III-33). ΔΓ/Δf values of zero describe the 
completely elastic behavior of a rigidly adsorbed layer. The maximum value of 0.75 to 0.8 was 
obtained when introducing liquid into the flow cell and characterizes a completely viscous behavior. 
Water as well as buffer components do not adsorb to the QCM chip, the observed changes in 
damping and frequency can thus be attributed to a change in viscosity only. The lower the ΔΓ/Δf 
value, the more rigid is the adsorbed layer. For most pH values, a rather small ΔΓ/Δf quotient was 
calculated. For EVA, a minimum value of 0.02 was determined at pH 6, whereas for PE, this value was 
lowest at pH 8 and 10 (ΔΓ/Δf = 0.03). At pH 2, this value was significantly increased (0.11 for EVA and 
0.12 for PE) and points towards a more viscoelastic behavior of the formed IgG layer. 
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Figure III-33: ΔΓ/Δf ratios (n=3, *:n=2) of adsorbed IgG layers on (a) EVA and (b) PE for formulations (2 mg/mL 
IgG, 20 mM histidine, 100 mM IS) with different pH values as well as for water and various blank histidine 
buffers (n=39 for water / n=42 for buffer on EVA, n=23 for water and buffer on PE). 
10.3.4 Influence of pH on IgG Size Distribution 
In order to address the observed differences in viscoelastic behavior of IgG layers formed at pH 2, the 
hydrodynamic diameter of freshly filtrated IgG samples of different pH values was determined by DLS 
(Figure III-34). For pH 6 and 10, Z-average values were 11.03 ± 0.01 nm and 10.97 ± 0.12 nm, 
respectively. An increased Z-average of 14.34 ± 0.09 nm was measured at pH 2. PdI values were 
0.072 ± 0.008 for pH 2, 0.038 ± 0.005 for pH 6 and 0.046 ± 0.005 for pH 10.  
 
Figure III-34: DLS size distributions of IgG incubation solutions (2 mg/mL IgG, 20 mM histidine, 100 mM IS) of 
different pH values. 
 
10.4 Influence of Ionic Strength on IgG Adsorption 
In the following section, the influence of varying the ionic strength (IS) on IgG adsorption was 
addressed. In all cases, IgG was formulated at 2 mg/mL in 20 mM histidine buffer pH 6.0. Ionic 
strength was adjusted via the addition of sodium chloride. Assuming that zwitterions do not 
contribute to the overall ionic strength of a solution, ionic strength of formulations without 
additional sodium chloride is supposed to be approximately 10 mM.  
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10.4.1 Adsorbed Amount 
In Figure III-35, frequency shifts upon IgG adsorption and corresponding adsorbed amounts are 
shown for different ionic strength values. For EVA, the adsorbed amount increased significantly upon 
addition of sodium chloride ad 100 mM ionic strength (p < 0.001). With higher ionic strength, there 
was no further change in the adsorbed amount. The amount of IgG adsorbed to PE was also slightly 
increased upon addition of salt, but the effect was not significant. 
(a)  (b)  
Figure III-35: Frequency shifts upon IgG adsorption (2 mg/mL IgG, 20 mM histidine, pH 6.0) in dependency of 
ionic strength for (a) EVA and (b) PE. 
10.4.2 Adsorption Kinetics and Viscoelastic Properties 
The influence of ionic strength on the adsorption kinetics is shown in Figure III-36. For EVA, all three 
graphs essentially overlap and reveal the three-phasic behavior described above. Upon adsorption of 
the formulation with 300 mM ionic strength to PE, a biphasic behavior comparable to the one at pH 
10 is observed. Kinetics of IgG adsorption to PE was comparable for the formulations with 10 mM 
and 100 mM ionic strength. 
(a)  (b)  
Figure III-36: Representative ΔΓ vs. Δf plots for formulations (2 mg/mL IgG, 20 mM histidine, pH 6.0) with 
different ionic strength for (a) EVA and (b) PE. 
With increasing ionic strength, equilibration times on both surfaces increased stepwise from around 
40 minutes up to 80 minutes (Figure III-37). Reversibility of adsorption was lowest for the 
formulation with lowest ionic strength (Figure III-38). On EVA, IgG formulated at 100 mM ionic 
strength adsorbed with highest reversibility of 10 %. On PE, reversibility was highest at 300 mM ionic 
CHAPTER III 
 
70 
no NaCl
added
+ NaCl 
ad 100 mM IS
+ NaCl 
ad 300 mM IS
0
5
10
15
20
 
re
ve
rs
ib
ly 
bo
u
n
d 
[%
]
no NaCl
added
+ NaCl 
ad 100 mM IS
+ NaCl 
ad 300 mM IS
0
5
10
15
20
re
ve
rs
ib
ly 
bo
u
n
d 
[%
]
no NaCl
added
+ NaCl 
ad 100 mM IS
+ NaCl 
ad 300 mM IS
0
10
20
30
40
50
60
70
80
90
tim
e
 
u
n
til
 
e
qu
ilib
riu
m
 
[m
in
]
no NaCl
added
+ NaCl 
ad 100 mM IS
+ NaCl 
ad 300 mM IS
0
10
20
30
40
50
60
70
80
90
tim
e
 
u
n
til
 
e
qu
ilib
riu
m
 
[m
in
]
water buffer no NaCl
added
+ NaCl ad
100 mM IS
+ NaCl ad
300 mM IS
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
∆Γ
/∆
f
*
blank with IgG
water buffer no NaCl
added
+ NaCl ad
100 mM IS
+ NaCl ad
300 mM IS
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
 
∆Γ
/∆
f
blank with IgG
strength with 12 %, but overall variability in the results did not lead to any significant effects. All IgG 
layers formed were rather rigid, as indicated by the low ΔΓ/Δf ratios in the range of 0.01 to 0.05 
(Figure III-39). 
(a)  (b)  
Figure III-37: Time until equilibrium for formulations (2 mg/mL IgG, 20 mM histidine, pH 6.0) with different 
ionic strength for (a) EVA and (b) PE. 
(a)  (b)  
Figure III-38: Percentage of reversibly bound IgG for formulations (2 mg/mL IgG, 20 mM histidine, pH 6.0) 
with different ionic strength for (a) EVA and (b) PE. 
(a)  (b)  
Figure III-39: ΔΓ/Δf ratios (n=3, *:n=2) of adsorbed IgG layers on (a) EVA and (b) PE for formulations (2 mg/mL 
IgG, 20 mM histidine, pH 6.0) with different ionic strength as well as for water and various blank histidine 
buffers (n=39 for water / n=42 for buffer on EVA, n=23 for water and buffer on PE). 
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10.5 Influence of Non-Ionic Surfactants on IgG Adsorption to EVA surfaces 
10.5.1 Influence of Three Different Surfactants on Adsorption 
The influence of the three non-ionic surfactants polysorbate 20 (PS 20), polysorbate 80 (PS 80) and 
poloxamer 188 (Pol 188) on IgG adsorption was tested with QCM runs applying different incubation 
schemes (see Table III-12). Sequential incubation of EVA surfaces with surfactant and IgG (and the 
other way around) as well as concomitant incubation with both components was performed. 
Frequency changes as an indicator for changes in the adsorbed mass were recorded for every single 
incubation step (Figure III-40).  
Adsorption of PS 20 resulted in a frequency shift of 109 Hz after 92 minutes equilibration time. 
Subsequent incubation with IgG led to a minor frequency shift of only 11 Hz and fast equilibration 
within 6 minutes. Similar to previous experiments, adsorption of IgG on the freshly prepared EVA 
surface was completed within 42 minutes and induced a frequency shift of 179 Hz. The following 
incubation step with PS 20 took 23 minutes until equilibration and led to an additional frequency 
shift of 69 Hz. Upon concomitant incubation, the overall frequency shift was only 82 Hz and thus less 
than for the individual components. Moreover, QCM signals equilibrated very quickly within only 
17 minutes. 
For PS 80, similar observations were made although adsorption of the surfactant itself resulted in 
higher frequency shifts of around 200 Hz and longer equilibration times of up to 120 minutes. 
Therefore, the overall reduction in adsorbed mass upon co-incubation was even more obvious. 
Equilibration during incubation with the surfactant after precedent IgG adsorption took 93 minutes 
and thus significantly longer than for PS 20. 
Adsorption of Pol 188 shifted the resonant frequency to a similar extent as PS 20, but occurred much 
faster (within 6 minutes). When incubating pre-adsorbed IgG with Pol 188, a comparable small 
frequency shift of 27 Hz was recorded after only 4 minutes equilibration time. The frequency shift as 
well as the equilibration time induced by co-incubation was in the same range as for Pol 188 
adsorption alone. 
Reversibility values for surfactant adsorption and co-adsorption with IgG are given in Table III-17. The 
amount of reversibly adsorbed mass is obviously increased in co-incubation mode. Reversibility is 
calculated from frequency changes between incubation solution and blank buffer and thus 
contributions from viscosity differences between those two media have to be considered. Viscosities 
of IgG / surfactant mixtures were consistently lower than viscosities of the pure surfactant solutions 
(Table III-17). Hence, viscosity effects did not account for the strong increase in reversibility upon co-
adsorption. 
Table III-17: Adsorption reversibility (n=2) and viscosities of incubation solutions containing surfactant only 
and surfactant plus IgG (2 mg/mL IgG, 0.02 % surfactant, 20 mM histidine, pH 6.0, no NaCl added). 
Surfactant 
Reversibility [%] upon adsorption of Viscosity [mPa·s] of 
surfactant solution surfactant + IgG surfactant solution  surfactant + IgG 
PS 20 7.7 ± 0.5 28.6 ± 5.4 1.333 1.125 
PS 80 2.2 ± 6.0 26.7 ± 0.2 1.466 1.398 
Pol 188 18.1 ± 6.7 25.6 ± 1.9 1.287 1.139 
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Figure III-40: Frequency change and time until equilibrium for subsequent and concomitant incubation of 
EVA-coated QCM chips with surfactant and IgG (2 mg/mL IgG, 0.02 % surfactant, 20 mM histidine, pH 6.0, no 
NaCl added). Frequency changes for single incubation steps are displayed in differently shaded bars. 
Frequency changes for subsequent adsorption steps are shown in stacked mode. Results are displayed for 
(a+b) PS 20, (c+d) PS 80, and (e+f) Pol 188 (n=2). 
 
The damping shifts obtained for separate as well as co-incubation of surfactants and IgG are shown 
in Figure III-41. IgG adsorption resulted in rather small damping shifts. For PS 20 almost no damping 
shift occurred. For the other two surfactants, PS 80 and Pol 188, adsorption led to high damping 
shifts with considerable variability. For IgG / PS mixtures, damping shifts could not be evaluated due 
to signal drifts. For the IgG / Pol 188 mixture, damping was shifted by 8 Hz due to adsorption. 
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Figure III-41: (a) Damping shifts induced by adsorption of surfactants only. Arrows indicate the introduction 
of surfactant solution (“s”) and blank buffer (“b”) to the measuring cell. (b) Damping shifts during adsorption 
of IgG, surfactants, and IgG / surfactant mixtures (2 mg/mL IgG, 0.02 % surfactant, 20 mM histidine, pH 6.0, 
no NaCl added). *Negative values due to drifts in damping signal. 
10.5.2 HP-SEC Determination of the Amount of Adsorbed IgG 
QCM is able to detect minimal changes in mass due to adsorption, but cannot tell the mass 
contributions by different adsorbing species. Therefore, the different incubation schemes were 
applied to Flexboy® bag pieces and the amount of adsorbed protein was determined via desorption 
with SDS and subsequent HP-SEC quantification as described in Chapter II. The results are depicted in 
Figure III-42. For incubation mode #1 (surfactant followed by IgG), IgG amounts close to the IgG 
control were found. Only with Pol 188, the adsorbed IgG amount was significantly reduced (p < 0.01). 
Using incubation mode #2 (IgG followed by surfactant), markedly less adsorbed IgG was found in 
presence of both polysorbate types. For Pol 188, incubation mode #2 resulted in comparable 
adsorbed amounts of protein as incubation mode #1. After co-incubation of IgG and surfactant 
(incubation mode #3), the level of desorbed IgG was below the detection limit (= signal from lowest 
standard concentration of 0.1 µg/mL in calibration curve). 
 
 
Figure III-42: Influence of surfactants (0.02 %) on the adsorbed amount of IgG on Flexboy® bag pieces after 
applying different incubation modes. IgG control: Incubation with IgG (2 mg/mL IgG, 20 mM histidine, pH 6.0, 
no NaCl added) only. x: < LOQ of 0.76 mg/m2.  
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10.5.3 Influence of PS 80 Concentration 
The influence of PS 80 concentration on adsorption was assessed with PS 80 concentrations of 
0.001 %, 0.02 %, and 0.2 %. For comparison, frequency shifts, reversibility values, equilibration times, 
and ΔΓ/Δf ratios for adsorption of IgG or surfactant only are also included in Figure III-43.  
(a) (b) 
(c) (d) 
Figure III-43: Influence of PS 80 concentration on IgG adsorption upon co-incubation (2 mg/mL IgG, 20 mM 
histidine, pH 6.0, no NaCl added). (a) Frequency shifts, (b) reversibility, (c) equilibration time, and (d) rigidity 
in the form of ΔΓ/Δf ratios (n=2). *Negative values due to drifts in damping signal. 
As already mentioned above, the frequency shift and equilibration time upon co-incubating with IgG 
and surfactant at a concentration of 0.02 % were clearly reduced in comparison to incubation with 
the two components individually. A PS 80 concentration of 0.001 % resulted in frequency shifts, 
equilibration time, and reversibility close to that of the IgG solution without added surfactant. The 
higher PS 80 concentration of 0.2 % also reduced mass adsorption significantly. Reversibility was 
observed to be highest for the mixtures with PS 80 concentrations of 0.02 and 0.2 %.  
10.6 Verification of QCM Results with HP-SEC Quantification 
With the help of the Sauerbrey equation, adsorbed amounts can be calculated from measured 
frequency shifts. In order to verify this assumption, adsorbed amounts obtained from such 
calculations were compared to the amount of IgG that was found after SDS desorption from the QCM 
chip. This was tested for pH 2, pH 6, and pH 10 with 100 mM ionic strength and EVA-coated QCM 
chips. Figure III-44 shows that both methods led to comparable results. 
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Figure III-44: Results for IgG amounts adsorbed on EVA-coated QCM chips (2 mg/mL IgG, 20 mM histidine, 
100 mM IS) obtained from QCM frequency shifts (white bars, n=3) and via IgG desorption from the QCM chip 
and subsequent HP-SEC quantification (grey bars, n=1). 
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11 DISCUSSION 
11.1 Implementation of QCM Measurements for Adsorption Studies with 
Single-Use Bag Polymer Surfaces 
QCM crystals can be modified with many different kinds of materials and thus implemented as 
sensors in various applications [26,27]. PE and EVA are typical contact layer materials of single-use 
bioprocess bags [39]. Simple spin-coating of QCM chips with PE or EVA solutions allowed for the 
production of homogeneous polymer layers. Although the coating thickness varied significantly from 
experiment to experiment, complete chip surface coverage could be assumed in any case. 
Independent of the employed QCM chip as well as the achieved coating thickness, reproducible 
frequency shifts for IgG adsorption were obtained. A QCM model for studying protein adsorption to 
the bioprocess materials PE and EVA was thus successfully established. 
11.2 Quantification of Protein Adsorption with QCM 
The QCM frequency shifts upon incubation with IgG provide a direct measurement of the amount of 
adsorbed protein. Assuming a rigid IgG layer, the Sauerbrey equation was applied for calculating the 
adsorbed amount per unit area from the frequency shift provided in Hertz. The influence of pH and 
ionic strength on protein adsorption to both polymer surfaces was rather small. For the EVA coating, 
the adsorption maximum with approx. 10 mg/m2 was found at pH 8, which is close to the protein’s 
IEP. Adsorption maxima are often claimed to be found at the IEP due to the protein’s overall neutral 
charge at this pH value. Thus reduced lateral repulsion forces between adsorbed protein molecules 
enable denser packing of molecules on the surface [11]. At pH 2, adsorption to EVA was slightly 
reduced to 8.9 mg/m2. At this pH value, both protein molecules and polymer layer are positively 
charged. At pH 10 the adsorbed amount of 9.6 mg/m2 was close to the adsorption maximum despite 
likewise electrostatically repulsive forces between the now both negatively charged interaction 
partners. On the PE surface, the adsorbed amount decreased slightly but steadily with increasing pH 
value. Once again, this trend could not be explained with the expected electrostatic interactions 
between adsorbing protein and polymer surface. As a result of the polymer’s zero point of charge at 
around 3.5, maximal electrostatic attraction and thus maximal adsorbed amount would have been 
anticipated between pH 4 and 8 in both cases. Oom et al. did not find the expected strong decrease 
in mAb adsorption to silicon dioxide and polystyrene-coated QCM chips at lower pH values. At pH 6, 
the amounts adsorbed to PS without any added surfactants were found to be 7.1 mg/m2 and 
12.5 mg/m2 for two antibodies with lower and higher hydrophobicity, respectively [40]. Our results 
for IgG adsorption to PE and EVA surfaces were in a similar range and thus significantly higher than 
the maximum adsorbed amount of 5.5 mg/m2 expected for monolayer adsorption [41]. Calculated 
IgG layer thicknesses of 5.5 to 7.5 nm exclude a completely flat-on orientation of adsorbed 
antibodies when assuming typical IgG dimensions of 10 x 14 x 5 nm [42]. Instead, an end-on 
orientation with incomplete surface coverage in the range of 0.547 as given by the jamming limit of 
the random sequential adsorption model [43] might be assumed. An incomplete layer of randomly 
distributed IgG molecules that extent into the bulk solution by 10 nm in end-on orientation would 
give an apparent thickness of 5.5 nm for a homogeneous, evenly distributed layer. Alternatively, the 
formation of more than one layer of IgG has to be taken into account. Wiseman and Frank discuss 
adlayer formation at IgG bulk concentrations above 100 µg/mL [44]. 
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The influence of ionic strength on the amount of adsorbed IgG can be explained by the charge 
shielding effect of salt ions. With increasing ionic strength, lateral repulsive forces between individual 
IgG molecules are increasingly shielded. This allows a denser packing of protein molecules on the 
adsorbent. This effect was observed for both polymer surfaces, but more pronounced with the more 
hydrophilic EVA coating. An optimum in charge shielding was already achieved at an ionic strength of 
100 mM as the adsorbed amount of IgG was not further increased at ionic strength values of 
300 mM. Dixit et al. studied adsorption of an Fc-fusion protein on silicone oil-coated QCM sensors 
and found that an increased ionic strength of 150 mM was sufficient to neutralize any charge effects. 
The observed pH dependency at 10 mM ionic strength was thus leveled off and adsorbed amounts in 
the pH range from 3 to 9 all were around 4-5 mg/m2 [31]. Interestingly, in a QCM study by Höök et al. 
the ferritin amount adsorbed on a methyl-thiolated gold surface strongly increased with increasing 
ionic strength, despite the hydrophobic character of the QCM chip coating. However, above a salt 
concentration of 50 mM adsorbed amounts remained relatively constant. Similar observations with 
pure gold surfaces led to the conclusion that the differences obtained with varying ionic strength are 
dominated by protein-protein rather than protein-surface interactions. Apart from a denser packing 
of protein molecules due to a reduction of repulsive forces upon salt addition, cluster formation in 
the bulk and subsequent adsorption of these pre-formed clusters is discussed [38]. 
The application of the Sauerbrey equation for a quantitative determination of protein adsorption is 
limited to rigidly adsorbed layers only. In the case of a viscoelastic layer, viscous coupling to the 
surrounding fluid reduces the totally measured frequency shift. The Sauerbrey equation thus 
underestimates the adsorbed mass – this is often referred to as the ‘missing mass effect’ [45]. The 
more complex Voigt model accounts for these viscoelastic contributions and includes density, 
viscosity, and shear elasticity of the adsorbed layer in its equations [46]. However, as these values 
are commonly not known for protein layers, they have to be estimated and / or fitted by measuring 
frequency shifts at various overtones [47,48]. For example, density is assumed to be between 1.0 and 
1.35 mg/m3, depending on the water content of the adsorbed layer [40]. However, this assumption 
introduces uncertainties that might be comparable to the error encountered with the Sauerbrey 
approximation. In many cases, the Sauerbrey equation was found to result in adsorbed amounts that 
were close to values calculated with the Voigt model. Oom et al. state a difference of only 2-5 % 
between calculations with the Sauerbrey and the Voigt model for mAb adsorption to various surfaces 
like polystyrene and teflon [40]. Likewise, Kim and coworkers report very good agreement between 
both calculation methods for β-lactoglobulin adsorption to polyethersulfone surfaces for protein 
concentrations up to 10 mg/mL. Only at higher concentrations of 20 mg/mL, the Voigt mass was 
about 50 % higher than the Sauerbrey mass due to an observed increase in dissipation [48]. Dixit et 
al. also justified calculations with the Sauerbrey equation by assuming rigidly adsorbed Fc-fusion 
protein layers on silicone oil-coated surfaces [31]. Applying the Sauerbrey equation for close 
approximations to real adsorbed masses was thus also considered valid for the present study. 
During the quantitative interpretation of QCM data, another aspect has to be considered. The QCM 
frequency shift is not specific for the mass of adsorbed protein, but likewise includes contributions 
from entrapped or adsorbed water and salt molecules [49,50]. According to Lubarsky et al., the 
amount of water within the adsorbed protein film may be up to 90 %, depending on the protein and 
the type of surface under investigation [47,49]. Caruso et al. measured 2.3 times more adsorbed 
mass in the liquid phase than after drying when studying ferritin adsorption to gold surfaces. For IgG, 
a factor of 1.8 is reported [51]. However, mass contribution from associated water molecules 
strongly depends on surface coverage. At high surface coverage, the contribution from surrounding 
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water to frequency changes is postulated to be disproportionately low [24]. This might also apply for 
the present study since adsorption experiments were conducted at rather high IgG incubation 
concentrations and thus saturation conditions (see Chapter II). Additionally, studies by Ouberai et al. 
indicate a generally decreased hydration of ‘soft’ proteins when adsorbed on hydrophobic surfaces 
[52]. This might hold true for the combination of the ‘soft’ protein IgG and nonpolar polymer surfaces 
like EVA and PE as well. Cross-validation of the adsorbed amounts calculated with the Sauerbrey 
equation was performed by desorbing IgG from the EVA-coated QCM chip and analyzing the IgG 
content in the desorption medium. HP-SEC quantification data confirmed the QCM results and once 
again confirms the applicability of the Sauerbrey assumption for the present study. The amount of 
water incorporated in the adsorbed IgG layers did not seem to significantly affect the adsorbed mass 
measured with QCM. 
11.3 Insights into Adsorption Kinetics 
Adsorption kinetics are commonly analyzed in the form of ΔΓ/ΔR/ΔD vs. Δf plots [38,48,53–57]. For 
pH values of 4, 6, and 8, a three-stage adsorption process on both studied surfaces was observed. In 
such a plot, a slope close to zero represents the formation of rigid and densely adsorbed layers, 
whereas a steeper slope indicates that a soft and water-rich film is formed [56]. The first phase 
during adsorption was characterized by a slope of zero and thus the formation of a rigid IgG layer. 
The steep increase during the second phase is indicative of the attachment of loosely bound protein. 
This loosely bound fraction might adsorb to unoccupied areas in-between already attached 
molecules or as a second layer on top of the first one [40,57]. Possibly, a change in antibody 
orientation from rigidly attached, flat-on oriented antibodies towards more loosely bound, end-on 
oriented molecules is induced by increasing surface coverage [44]. During the subsequent plateau 
phase, rigidification of the previously formed layer as it becomes more closely packed is anticipated 
[38]. Alternatively, the formation of an additional, rigid layer might be the reason for this third phase 
[55]. The slope of the initial adsorption phase seems to be dominated by the prevailing electrostatic 
forces between protein and surface: At pH 6, both interaction partners were oppositely charged and 
thus electrostatically attracted each other. At this pH value, the initial phase with zero slope was 
most pronounced. At pH 4 and 8, either the surface or the protein were close to their ZPC (approx. 
3.5) or IEP (approx. 8.5), respectively. Therefore, electrostatic attraction was diminished and the 
initial phase was shorter and / or the slope was slightly higher than for adsorption at pH 6. At pH 2 
and 10, both protein and surface bear charge of the same sign. Electrostatic repulsive forces resulted 
in an initial steep adsorption phase indicative for the formation of soft IgG films. At pH 10 
subsequent rigidification occurred, whereas at pH 2 hardly any plateau phase was observed. 
Rigidification was the most dominant step during equilibration and this phase was typically reached 
within the first minutes. Equilibration times for formulations with pH 2 were the shortest, whereas 
the pronounced rigidification phase for pH 10 on the EVA surface led to prolonged adsorption times. 
It is assumed that rigidification is also achieved via structural rearrangements [58].  
Variations in ionic strength at pH 6 hardly affected adsorption kinetics for IgG adsorption to EVA. ΔΓ 
vs. Δf plots for the formulation with 300 mM ionic strength revealed a slightly higher initial slope and 
a less sharp transition between the first and second adsorption phase, possibly due to a shielding of 
attractive forces between protein and surface. However, choosing an ionic strength of 300 mM for 
IgG adsorption to the less charged PE surface was sufficient to eliminate effects from electrostatic 
attraction during the first adsorption phase. Adsorption was thus reduced to a biphasic process with 
a steep initial slope, comparable to the plots for formulations with pH 10. At the same time, 
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equilibration times extended with increasing ionic strength. According to the described observations 
for ΔΓ vs. Δf plots, this effect was more pronounced with the PE surface. Although the effect of ionic 
strength on the adsorbed amount on both surfaces was limited, a clear influence on adsorption 
kinetics and especially equilibration times was thus determined. A hampering of adsorption at higher 
ionic strength for oppositely charged surfaces as in the case of pH 6 was expected [11].  
Doliška et al. also report a three-phasic process for fibrinogen adsorption to polyethylene 
terephthalate surfaces, but in their studies slopes of the first and third phase were steeper than 
during the second phase [56]. For the adsorption of protein A to Au and Ti surfaces, Marxer et al. 
describe two phases in corresponding ΔD vs. Δf plots. The authors ascribe each phase to the 
formation of a separate protein layer. Comparable to our studies, fast initial adsorption events were 
followed by the formation of more rigid adlayers [55]. Similarly, from their studies on β-lactoglobulin 
adsorption to PES surfaces Kim et al. conclude that after an initial, rapid stage, conformational 
changes might occur in the following plateau phase [48]. Wiseman and Frank interpreted their QCM 
data for mAb adsorption on a hydrophobic model surface as a two-step process: Initially, antibodies 
attach rigidly to the surface in a flat-on orientation, but with increasing surface coverage mAb 
rearrange into a vertical, end-on orientation with looser mechanical coupling to the surface [44]. 
In this context, the three-stage cooperativity model deduced by Luo and Andrade from their studies 
on protein adsorption to hydroxyapatite shall be discussed [59]. In most cases, Hill plots from 
isotherm data of four proteins (lysozyme, BSA, lactoferrin, and transferrin) resulted in S-shaped 
graphs. The three obtained slopes refer to the cooperativity of adsorption at that specific stage. 
Values > 1 indicate positive cooperativity, whereas values < 1 represent negative cooperativity. 
Cooperativity values for the three different phases typically ranked as follows: 3 >1 > 2. Interestingly, 
Hill plots of isotherm adsorption data from Chapter II follow these observations (Figure III-45).  
(a) (b) 
Figure III-45: Hill plots of IgG adsorption (concentrations from 0 to 1 mg/mL, pH 5.4, in 20 mM histidine 
buffer without further additives) for (a) Flexboy® (EVA) and (b) Flexel® (ULDPE) bag. Data is taken from 
Chapter II. 
When relating increasing equilibration concentrations with increasing surface coverage and thus 
increasing frequency shifts during QCM measurements, the interpretation of protein adsorption as 
described by Luo and Andrade can be applied to the three stages observed in ΔΓ vs. Δf plots. The 
initial phase is thus characterized by strong cooperativity between protein molecules and the surface 
due to electrostatic attraction. This is followed by a rather short transition phase with low and even 
negative cooperativity and thus loose attachment of protein molecules. Finally, the third stage 
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indicates very high cooperativity due to lateral interactions between individual protein molecules 
and finally results in the formation of a densely adsorbed layer. 
Nevertheless, a certain fraction of protein molecules can still be rather loosely and thus reversibly 
associated with the adsorbed layer. Reversibility in most cases was found to be below 10 %. 
Exceptions of rather high reversibility values were obtained for IgG adsorption on PE of up to 17 % at 
pH 8 and 100 mM ionic strength and of around 12 % at pH 6 and 300 mM ionic strength. At both 
formulation conditions and especially in combination with the completely nonpolar PE surface, 
electrostatic interactions are reduced since pH 8 is close to the protein’s IEP and high ionic strength 
leads to the discussed charge shielding effect. The lack of electrostatic attraction to the surface might 
be the reason for this increase in adsorption reversibility. Reversibility in general is inversely related 
to the ability of the protein molecules to adapt to the surface [52] and can thus be expected to be 
low for ‘soft’ proteins like IgG [8,11]. Reversibility values of around 10 % were also found in other 
studies. Felsovalyi et al. observed reversibility of up to 8.5 % for lysozyme adsorption on silica [60] 
and Dixit et al. state reversibility values of less than 10 % for Fc-fusion proteins on silicone oil 
surfaces [31]. Kim et al. measured up to 15 % reversibility for β-lactoglobulin adsorbed to PES at 
20 mg/mL with a tendency for increased reversibility at higher protein concentrations. Reversibility is 
calculated from frequency shifts between IgG solution and blank buffer and can thus be biased due 
to viscosity differences of the two media. In consequence, the already rather low reversibility values 
might still be slightly overestimated.  
11.4 Viscoelastic Properties of Adsorbed IgG Layers 
Due to the above described rigidification process during IgG adsorption and ΔΓ/Δf values of less than 
0.1, protein layers obtained for pH values ≥ 4 were assumed to be rigid in nature. The critical ΔΓ/Δf 
value of 0.1 for rigid layers is a more concrete interpretation of the requirement ΔΓ << Δf by 
Reviakine and coworkers [24]. Depending on the parameter utilized and the applied QCM system, 
various limits can be found in literature. Muramatsu et al. defined the reliable range for the 
Sauerbrey equation for values up to ΔR/Δf = 0.01 [53], and Doliška et al. applied a threshold of 
ΔD/Δf < 0.1 x 10-6 Hz-1 [56]. 
IgG layers formed at pH 2 were significantly softer than most other layers. This is deduced from ΔΓ/Δf 
values of > 0.1 and the rather short plateau phase observed in ΔΓ vs. Δf plots. Oom et al. also 
describe an increased softness of IgG layers when adsorbed at lower pH values. Increased hydration 
and a possibly more unfolded structure are claimed to be the raison for this behavior [40]. However, 
from DLS results at pH 2 the prevalence of IgG dimers instead of monomers is concluded and thus a 
completely different adsorption mechanism has to be assumed. The tendency of IgG molecules to 
form dimers and trimers at acidic pH and in the presence of salt was extensively studied by Arosio et 
al. [61,62]. Reported hydrodynamic radii for IgG monomer and dimer of 6 nm and 7.3 nm, 
respectively, correlate well with Z-average values of 11 nm at pH 6 / 10 and 14.3 nm at pH 2 obtained 
for IgG formulations in the present study. Other than IgG monomers, most likely these IgG dimers 
attach to the surface at an acidic pH of 2. It is anticipated that dimers cannot interact with the 
surface to the same extent as the monomer species. Each IgG molecule already interacts with a 
second molecule within the formed dimer; therefore hardly any further interactions with the 
adsorbent can be established. In this context, especially exposed hydrophobic patches that would be 
the most important surface interaction sites might be already covered by the second IgG molecule. 
Moreover, the adsorbing dimer species forms a thicker, but less dense packed layer due to its 
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increased size. In consequence, more water can be entrapped between adsorbed dimers. Together 
with the lacking rigidification step, this results in an overall softer IgG layer. 
11.5 Influence of Surfactants on IgG Adsorption 
Nonionic surfactants like polysorbate 20 (PS 20), polysorbate 80 (PS 80), and poloxamer 188 (Pol 188) 
are commonly used formulation excipients that can stabilize protein drugs via a reduction of 
interfacial destabilization events [63,64]. Like proteins, surfactants are amphiphatic molecules with 
relatively large hydrophobic moieties and thus are supposed to readily adsorb to interfaces. In the 
following section, the adsorption behavior of surfactants alone as well as in combination with the 
model IgG on EVA surfaces is discussed. 
11.5.1 Adsorption Behavior of Surfactants 
The highest adsorbed amount of 8.4 mg/m2 was measured for PS 80 which corresponds to a layer 
thickness of 7.9 nm. Adsorbed amounts for PS 20 and Pol 188 were in a comparable range with 
4.8 mg/m2 (4.3 nm) and 5.2 mg/m2 (4.9 nm), respectively (see Figure III-40 after step 1 of incubation 
mode #1). As indicated by a lower HLB value and the longer hydrocarbon chain, PS 80 is more 
hydrophobic than the other two surfactants (see Table III-18) which might be the reason for the 
higher adsorbed amounts. Molecular weights of PS 20 and 80 are comparable, thus for PS 80 a more 
dense packing of the surfactant molecules with a decreased footprint on the EVA surface can be 
assumed. In consequence, the surfactant molecules are more extended towards the bulk solution, 
giving rise to a higher adsorption layer thickness and also to more pronounced damping shifts during 
adsorption. In contrast to the rather soft PS 80 layer, PS 20 layers were found to be rigidly attached 
to the surface, as damping shifts were close to zero and even below the values obtained for IgG 
layers. Adsorbed Pol 188 was found to result in layers with rather high viscoelasticity, too.  
Adsorption times for PS 80 were approx. 2 hours and thus remarkable long. Together with the 
observed overshooting effect in the damping signal, this might point towards the occurrence of 
structural reorganizations during surface filling [63]. The equilibrium time for Pol 188 was less than 
10 minutes and thus approx. ten times faster than adsorption equilibration for PS 20 and PS 80. This 
might be due to the relatively few poloxamer molecules that actually adsorbed on the surface. 
Although total adsorbed amounts were comparable to PS 20, six times more PS 20 molecules 
adsorbed per unit area in comparison to Pol 188 due to the large difference in molecular weight. 
Adsorption of fewer molecules might simply be completed in a shorter period of time. The reduced 
amount of adsorbing molecules might arise from the bulky structure of individual poloxamer 
molecules together with the lack of reorientation, from a reduced affinity for the hydrophobic 
surface based on the higher hydrophilicity of poloxamer, or from the limited availability of adsorbing 
molecules. Equal incubation concentrations for all surfactants were chosen in the form of mass 
concentrations (w/V) rather than molar concentrations. For Pol 188, this could have resulted in non-
saturation conditions. Although there is no consensus about the true CMC of Pol 188 [65], a 
concentration of 0.02 % (w/V) is supposed to be below this value. 
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Table III-18: Properties of employed surfactants. 
Surfactant type and chemical structure CMC HLB 
PS 20 
 
59 µMa / 
0.007 % 16.7
a
 
MW = 1228 g/mol 
PS 80 
 
12 µMa / 
0.0016 % 15
a
 
MW = 1310 g/mol 
Pol 188 
 40 µMc / 
0.03 % > 24
b
 
MW = 8400 g/mol 
a from Merck Millipore product information, available online at http://www.merckmillipore.com, accessed January 5, 2015. 
b from BASF product information, available online at http://worldaccount.basf.com, accessed January 5, 2015. 
c from Sigma-Aldrich product information, available online at http://www.sigmaaldrich.com, accessed January 5, 2015. 
Not all results are consistent with observations described in literature. The specific surface under 
investigation as well as the quality, concentration, and formulation of the surfactant might have a 
significant impact on the adsorption behavior. For PS 20 (0.06 mM) adsorbed on PS, Shen et al. 
measured a layer thickness of only 1.4 nm using SPR. They also observed a dense PS 20 layer, which 
is anticipated to be the result of a fast initial adsorption phase followed by a slower reorganization 
step at high surface coverage [66]. Dixit et al. studied adsorption of surfactants to a silicone oil 
surface using QCM and found significantly less adsorbed protein. Pol 188 (0.035 %) adsorbed to the 
highest extent with 3.8 mg/m2, PS 20 and PS 80 (both at 0.02 %) adsorbed with only 2.2 mg/m2 and 
2.5 mg/m2, respectively. Comparable increases in resistance and thus similar viscoelasticity for all 
surfactant layers are stated [67]. 
11.5.2 Sequential Adsorption and Co-Adsorption of IgG and Surfactants 
From the negligible frequency shift during IgG incubation after pre-incubation with surfactant, the 
existence of a protein-resistant surfactant layer on the chip surface might be assumed. However, the 
true composition of the adsorbed layer after the second incubation step cannot be concluded from 
frequency shifts alone. When IgG incubation is followed by surfactant adsorption, the additional 
frequency shifts point towards surfactant attachment on top of or in-between the IgG layer. Dixit et 
al. also describe this process and attribute the smaller frequency shift upon subsequent Pol 188 
incubation to the inability of the larger poloxamer molecules to permeate all the available vacancies 
in the pre-existing protein layer [67]. Additionally, at least partial replacement of IgG molecules on 
the surface by surfactant molecules is also expected. For complete IgG replacement, final frequency 
shifts comparable to frequency shifts obtained for pure surfactant adsorption would have been 
expected.  
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Interestingly, for polysorbate / IgG co-incubation, frequency shifts were less than for adsorption of 
the individual compounds, thus neither a complete surfactant nor a saturated IgG layer was formed. 
The remarkable increase in adsorption reversibility that could not be ascribed to viscosity effects 
might point towards the formation and reversible attachment of a mix of protein and surfactant 
molecules [40,64]. Binding of polysorbates to IgG was shown to be negligible [68,69] and also other 
authors deny the formation of protein-polysorbate complexes [70]. Instead, the smaller, faster 
diffusing surfactant molecules are likely to pre-occupy the hydrophobic surface [67], but might not 
be able to reorganize into a dense layer due to subsequently arriving IgG molecules. In return, IgG 
molecules possibly cannot spread and rigidly attach on the surface due to the presence of surfactants 
and thus reversibility is increased. The reduced equilibration times for polysorbate / IgG mixtures 
may thus be explained by the generally reduced amount of adsorbed mass and the lacking 
reorganization process of polysorbate molecules or by an acceleration of surfactant adsorption by 
the protein as described by Lee et al. [64]. In their review, these authors claim that proteins may 
reduce the major entropic barrier for surfactant movement from micelles to the interface. 
Alternatively, the enthalpy of activation might be reduced by a destabilized surfactant self-
association. Corresponding experimental data gives evidence that this theory seems to hold true for 
polysorbate but not poloxamer adsorption to the air-water interface [71]. For Pol 188 / IgG co-
adsorption, frequency shifts and equilibration times were similar to the values obtained for 
poloxamer adsorption alone. This indicates that the layer formed during co-incubation was mainly 
composed of Pol 188 and that the presence of protein did not influence the poloxamer adsorption 
rate. Dixit et al. were able to deduce the relative composition of layers formed during co-incubation 
from the extent of damping shifts [67,72]. From our data on damping shifts, no clear conclusion can 
be drawn about the presence of IgG and / or surfactant in co-adsorbed layers. Only the damping shift 
for Pol 188 / IgG co-incubation could be evaluated. Since this value was between the damping shifts 
received for adsorption of pure IgG and pure surfactant, also a mixed layer might have been formed. 
Quantification of the final amount of IgG on the EVA surface via desorption and HP-SEC analysis after 
the above described sequential and co-adsorption steps brings us to partially revise the theory about 
the formation of a protein-resistant surfactant coating. IgG molecules were able to replace most of 
the adsorbed surfactant molecules since adsorbed IgG amounts after incubation mode #1 were close 
to the IgG control value. Pre-adsorbed IgG molecules were only partly replaced by surfactants in a 
subsequent incubation step. In this context, polysorbate 20 was most effective and replaced about 
50 % of adsorbed IgG, whereas Pol 188 desorbed only 20 %. For co-incubated samples, adsorbed IgG 
amounts were below the detection limit. However, due to the rather high detection limit up to 20 % 
of IgG found in the control might still be present on the surface after co-incubation. 
Replacement of pre-adsorbed proteins by surfactants is reported in several studies [73–76]. 
Desorption from the surface can be either mediated by the formation of surfactant-protein 
complexes and subsequent solubilization or by comparably stronger surfactant-surface interactions. 
The extent of protein displacement was found to depend on the properties of the protein, the 
surfactant, and the surface. In this context, rather low effectivity is attributed to nonionic surfactants 
[64]. Replacement of pre-adsorbed surfactant by proteins, however, was less expected. Many 
authors report the formation of a protein-resistant surfactant layer that effectively inhibits 
subsequent protein adsorption [66,67,76,77]. Only for very hydrophilic surfaces different 
observations were made. Joshi and McGuire found that pre-coating silica surfaces with PS 80 did not 
reduce lysozyme adsorption [76]. Also, Kim et al. report displacement of Pol 188 as well as PS 20 and 
80 from silica-titania surfaces during subsequent lysozyme and GCSF incubation. The ability of pre-
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adsorbed surfactant to inhibit protein adsorption thus strongly depends on the affinity of the 
surfactant and the protein for the specific surface. The affinity of the tested surfactants to the EVA 
surface under investigations was apparently not sufficient for efficient protein adsorption reduction 
when applied successively. Only during co-incubation, surfactants were able to effectively reduce 
protein adsorption. 
11.5.3 Importance of Surfactant Concentration 
Varying the PS 80 concentration demonstrated that a surfactant concentration above the CMC is 
needed for effectively inhibiting protein adsorption during co-incubation. The adsorption profile for 
the IgG formulation with a PS 80 concentration of 0.001 % strongly resembled the one for the IgG 
formulation without surfactant. An increased PS 80 concentration of 0.02 or 0.2 % led to clearly 
reduced frequency shifts and higher reversibility, probably due to the above discussed adsorption 
mechanism during co-incubation. Similar observations are described in literature. Zhang and Ferrari 
found that albumin adsorption reduction to silicon surfaces by PS 20 was most effective at 
concentrations close to the CMC [78]. Joshi and McGuire describe an increase in reduction of 
lysozyme adsorption to silica with increasing PS 80 concentrations of up to 80 ppm (≈ 0.008 % (w/V)) 
[76]. In contrast, Mollmann et al. showed that insulin displacement from a hydrophobic silane-
modified quartz was effective for PS 80 concentrations from 0.001 % upwards [75]. Likewise, Kapp et 
al. report that already a PS 80 concentration of half the CMC was effective in reducing mAb 
adsorption to hydrophobically modified surfaces, but a concentration of two times CMC was 
necessary to achieve a reduction in mAb adsorption of up to 90 % [77]. 
11.6 Comparison of Results Obtained with Real Bag Surfaces and Casted 
Polymer Films 
In the previous chapter, IgG adsorption to real bag surfaces was measured by desorbing IgG with SDS 
and subsequently analyzing the IgG content via HP-SEC with fluorescence detection. Table III-19 
comparatively lists the adsorbed amounts obtained with this method for QCM chips with the casted 
EVA surface and for real Flexboy® bag pieces. It is obvious that for the model surface three to four 
times more adsorbed protein mass was found than for the real bag surface. However, trends with 
regards to the observed pH dependency of adsorption were similar. 
Table III-19: Adsorbed amounts [mg/m2] obtained with the desorption / HP-SEC method for EVA-coated QCM 
chips and the real bag surface (results from Chapter II) for IgG formulations (2 mg/mL IgG, 20 mM histidine, 
100 mM IS) of different pH values. 
pH From desorption of  EVA-coated QCM chip (n=1) 
From desorption of  
Flexboy® bag piece (n=3) Deviation by factor 
2 8.7 2.3 ± 0.2 3.8 
6 12.3 4.6 ± 0.7 2.7 
10 10.4 2.9 ± 0.1 3.6 
 
The adsorbed protein amounts obtained with the real bag pieces were in the range of monolayer 
coverage. In contrast, results from QCM chips pointed towards the formation of IgG multilayers. The 
observed differences trace back to the disparity between the real bag surface and the model surface. 
The model surface was produced via polymer dissolution in an organic solvent und subsequent spin-
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coating. Real bag surfaces are manufactured by extruding melted polymer granules. The contact with 
organic solvents during the preparation of QCM model surfaces might have a significant impact on 
film properties. A thorough control of surface characteristics like contact angles, surface free energy, 
and residual solvent content during future studies is thus highly recommended for future studies. 
Moreover, surface morphology of both films as analyzed via 3D laser scanning microscopy revealed 
distinct differences. This divergence in surface roughness can also affect the extent of protein 
adsorption considerably [79,80].  
12 SUMMARY AND OUTLOOK 
During the course of this study, spin-coated polymer surfaces were employed as model surfaces for 
single-use bioprocess bags during QCM adsorption studies. It was thus possible to gain insights into 
the adsorption mechanism of therapeutic proteins on process materials like EVA and PE. Frequency 
shifts from QCM experiment were translated into adsorbed mass per unit area by applying the 
Sauerbrey equation. This approach was found to be valid since the model IgG adsorbed rigidly to the 
sensor surface and contributions from water associated with the adsorbed layer seemed to be 
negligible. Adsorbed IgG amounts were in the range of 7 to 10 mg/m2, which clearly exceeds 
monolayer coverage. The influence of pH on the adsorbed amounts was rather small. Increasing 
adsorbed masses and equilibration times with increasing ionic strength could be attributed to the 
charge shielding effect of salt ions. For most formulations a three-stage adsorption process was 
identified in the corresponding ΔΓ vs. Δf plots. During the first phase, rigid attachment was most 
likely governed by electrostatic attractive forces between protein and surface. The second phase was 
characterized by rather loose adsorption of additional molecules, possibly in a second layer. Finally, 
positive cooperativity in the form of lateral interactions between protein molecules is supposed to be 
responsible for rigidification of the adsorbed layer in the third phase. Consequently, most final IgG 
layers revealed a low ΔΓ/Δf ratio, which indicates low viscoelasticity. An exception to that 
observation was IgG layer formation at pH 2. In this case, a completely different adsorption 
mechanism, namely adsorption of IgG dimers that hardly undergo conformational changes on the 
surface, is anticipated. The influence of the three nonionic surfactants PS 20, PS 80, and Pol 188 on 
IgG adsorption was studied in sequential and co-adsorption mode. The three surfactants clearly 
varied in adsorption behavior, with more pronounced differences between the polysorbate types 
and poloxamer. However, all three surfactants were effective in reducing adsorption only during co-
incubation. For PS 80, it was exemplarily shown that a surfactant concentration above the CMC 
seems to be necessary for significantly affecting protein adsorption. A comparison of adsorption data 
from the previous chapter (HP-SEC quantification after protein desorption from real bag surfaces) 
with the results obtained from QCM chip desorption revealed deviations in the adsorbed amounts by 
a factor of 3 to 4. This divergence is traced back to differences in polarity and roughness of the QCM 
model surface and the real bag film. However, the combination of real bag films with QCM as an 
orthogonal method was found to be useful, e.g. for the elucidation of the adsorption layer 
composition in the presence of surfactants. Cross-checking the reliability of quantitative QCM results 
with an additional, independent method like AFM [47,48,51,81], SPR [49,51,81,82], TIRF [77], dual 
polarization interferometry [52], OWLS [50], or ellipsometry [49] is recommended. In conclusion, 
QCM studies with model surfaces helped to gain a deeper understanding of the adsorption process 
but cannot replace adsorption studies with real surfaces encountered during drug product 
manufacturing.  
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13 ABBREVIATIONS 
A  active electrode area 
AFM  atomic force microscopy 
ATR-IR  attenuated total reflection infrared 
C  crystal sensitivity constant 
CMC  critical micelle concentration 
D  dissipation 
DLS  dynamic light scattering 
EVA  ethylene vinyl acetate 
f  frequency 
HCl  hydrochlorid acid 
HLB  hydrophilic-lipophilic balance 
HP-SEC  high performance size exclusion chromatography 
ID  inner diameter 
IgG  immunoglobulin G 
IRAS  infrared reflection adsorption spectroscopy 
IS  ionic strength 
mAb  monoclonal antibody 
MW  mean value 
NaCl  sodium chloride 
NaOH  sodium hydroxide 
OWLS  optical waveguide lightmode spectroscopy 
PDI  polydispersity index 
PE  polyethylene 
PES  polyethersulfone 
Pol  Poloxamer 
PS  polystyrene 
QCM  quartz crystal microbalance 
R  resistance 
rpm  revolutions per minute 
RSD  relative standard deviation 
s  standard deviation 
SDS  sodium dodecyl sulfate 
SPR  surface plasmon resonance 
THF  tetrahydrofurane 
TIRF  internal reflection fluorescence 
ULDPE  ultra-low density polyethylene 
VA  vinyl acetate 
Γ  damping 
Δm  mass 
μ:  shear modulus of quartz  
ρ:  density of quartz  
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CHAPTER IV 
 
PARTICLE SHEDDING FROM SILICONE TUBING UPON 
PERISTALTIC PUMPING 
 
ABSTRACT 
In a typical manufacturing setup for biopharmaceutical drug products, the fill and dosing pump is 
placed after the final sterile filtration unit in order to ensure adequate dispensing accuracy and avoid 
backpressure peaks. Given the sensitivity of protein molecules, peristaltic pumps are often preferred 
over piston pumps. However, particles may be shed from the silicone tubing employed. In this study, 
particle shedding and a potential turbidity increase during peristaltic pumping of water and buffer 
were investigated using three types of commercially available silicone tubing used in pharmaceutical 
fill & finish. In the recirculates, mainly particles of around 200 nm size next to a very small fraction of 
particles in the lower micrometer size range were found. Using 3D laser scanning microscopy, surface 
roughness of the inner tubing surface was found to be a determining factor for particle shedding 
from silicone tubing. As the propensity towards particle shedding varied between tubing types and 
also cannot be concluded from manufacturer’s specifications, individual testing with the presented 
methods is recommended during tubing qualification. Choosing low abrasive tubing can help to 
further minimize the very low particle counts to be expected in pharmaceutical drug products. 
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1 INTRODUCTION 
The design of a suitable drug product (DP) manufacturing process is essential for biopharmaceutical 
DP quality. Due to the sensitivity of protein molecules, decisions should be taken with care [1,2]. For 
fill & finish processes, several types of pumps are generally employed, including rotary piston pumps, 
rolling diaphragm pumps, peristaltic pumps, and time-pressure fillers. Given the fact that pumping to 
dispense into units occurs after the sterile filter in order to avoid backpressure peaks and to ensure 
adequate dispensing accuracy, generated particles may directly end up in the final drug product units 
[1,3,4]. The European and US pharmacopeia require parenteral drug products to be 
essentially/practically free from visible particles. Additionally, subvisible particle counts have to be 
below harmonized thresholds (not more than (NMT) 6000 particles ≥ 10 µm and NMT 600 particles 
≥ 25 µm per container) [5]. Therefore, drug products are carefully monitored for visible as well as 
subvisible particles, also in frame of continuous discussions about immunogenicity caused by protein 
particles [1,6–9]. Non-proteinaceous particles might pose a risk to patients due to capillary occlusion, 
although controlled studies on this subject are not available [10]. 
To date, several studies indicate that the use of rotary piston pumps might increase the risk of 
particle formation in protein-based DP solution [1,3,6]. Upon filling, the protein possibly acts as 
lubricant and is exposed to significant forces [1]. In consequence, the formation of protein particles is 
frequently encountered. Moreover, stainless steel particles can be shed from the pump head [6]. In 
contrast, stress on the proteins exercised upon filling with peristaltic pumps has been shown to be 
minimal [2,11,12] and the use of peristaltic pumps has not led to a significant increase in particle 
counts and turbidity [3]. Another main benefit of filling with a peristaltic pump is the fact that the DP 
solution only comes into contact with the inner surface of the disposable tubing. This greatly 
diminishes the risk for cross-contaminations [13] and the need for cleaning validation of these 
components. Downsides of peristaltic pumps include the lower dosing accuracy in comparison with 
piston pumps. 
For fill & finish operations with a peristaltic pump, platinum-cured silicone tubing is the material of 
choice as it releases less leachables than peroxide-cured silicone or tubing made from other 
plasticizer containing materials [14]. Concerns about extractables and leachables from these 
materials are generally low, given that additives for silicone tubing usually only involve fillers like 
fumed silica but not plasticizers. Moreover, silicone tubing exhibits excellent long-term durability, 
can be sterilized, is highly flexible, and therefore, is well-suited for usage in peristaltic pumps [15]. 
Nevertheless, potential drawbacks might result from enhanced particle spallation from the tubing 
material due to the mechanical stress exerted within the peristaltic pump. Presently, particle 
shedding and tubing wear have mainly been investigated in the context of medical use [16–23], as 
silicone tubing is employed i.e. during haemodialysis and in cardiopulmonary bypass operations [24]. 
Silicone tubing was shown to be more prone for particle shedding as compared to tubing made from 
polyvinyl chloride and polytetrafluoroethylene composites [25]. Despite these findings, silicone 
tubing remains the standard material for operation in peristaltic pumps due to the above mentioned 
advantages. 
A study that characterizes particle shedding from different kinds of silicone tubing used during 
biopharmaceutical drug product manufacturing is still lacking. We close this gap by presenting a 
comprehensive data set on the amount of shed particles, particle characteristics, and tubing wear of 
three different commercially available silicone tubing types. Influences of tubing pre-treatment, 
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pumping time, recirculation medium (WfI and a surfactant-containing placebo solution), and possible 
batch-to-batch variations were considered. Furthermore, the influences of tubing inner diameter 
(ID), pump head type, and an additional post-curing step during tubing production on particle 
shedding were investigated. Surface characterization with 3D laser scanning microscopy of all tested 
tubing types was employed to identify the root cause for the observed differences in particle 
shedding. In addition, the impact of pumping cycles on the mechanical properties of the different 
tubing sets was studied. As experiments were performed under recirculating conditions, particle 
counts of this study were extrapolated to production conditions during fill & finish of a 
biopharmaceutical DP. Studying the influence of shed particles on the stability of a 
biopharmaceutical DP or interactions with protein was beyond the scope of this study, but is 
addressed in a follow-up study (see Chapter V).  
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2 MATERIALS AND METHODS 
2.1 Materials 
Water for injection (WfI) was produced via distillation (Muldestor Modell SE, Wagner + Munz, 
München, Germany) from deionized water. Placebo pH 6.0 containing 10 mM L-histidine 
monohydrochlorid monohydrate and 10 mM L-histidine (Ajinomoto Europe S.A.S, Louvain-la-Neuve, 
Belgium), 200 mM sucrose (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) and 0.02 % 
polysorbate 20 (Croda GmbH, Nettetal, Germany) was prepared with highly purified water 
(purification system arium pro with Sartopore 2 150 0.2 μm filter capsule from Sartorius AG, 
Göttingen, Germany). After filtration (0.2 µm, cellulose acetate, Sartorius) the buffer was stored at 
2 - 8°C until further use. 
Three different types of commercially available silicone tubing (A, B, and C) were tested (see Table 
IV-20). Tubing sets employed in recirculation experiments consisted of two 30 cm long pieces for 
location within the pump head connected to 100 cm long tubing pieces via polypropylene Y-
connectors (Kartell, purchased from VWR International GmbH, Darmstadt, Germany). Sets were used 
either untreated, washed (washing cycles with highly purified water of 80°C, drying with filtered air 
at 110°C), washed and sterilized (30 minutes at 126°C and 2 bar) or CIP/SIP/DIP treated (washing 
cycles with highly purified water of 80°C, sterilization for 30 minutes at 131°C and 3 bar, drying with 
sterile nitrogen at room temperature). This material processing was performed in analogy to 
production conditions and parameters. Unless otherwise stated, tubing was used as received from 
the manufacturer (=untreated). 
Table IV-20: Tubing specifications as given by the manufacturers. 
Tubing Type Tubing A Tubing B Tubing C 
Type pt-cured pt-cured,  post-cured pt-cured 
ID (mm) 6.0 1.6 6.0 1.6 6.4 1.6 
Wall thickness (mm) 2.1 1.6 2.1 1.6 1.6 1.6 
Hardness (Shore A) 55 - 65 60 ± 5 / 57 - 65* 50 (15 sec) 
Specific gravity 1.09 - 1.15 1.12 - 1.16 1.14 
Tear B / tear strength / tear resistance (ppi) ≥ 150 85 - 171 185 
Ultimate tensile strength (psi) ≥ 900 943 - 1885 1293 
Elongation at break (%) ≥ 300 300 - 650 719 
* Specifications for second generation tubing B  
2.2 Methods 
2.2.1 Online-Turbidity Monitoring 
Pumping cycles were performed under a laminar flow cabinet to avoid external particle 
contamination. Tubing sets (6 mm ID) were flushed with 4 L of highly purified water and 1 L of WfI 
prior to the recirculation experiment using a laboratory vacuum pump (LABOPORT, KNF Neuberger 
GmbH, Freiburg, Germany). Flush volumes were based on initial experiments (data not shown). The 
low-pressure flow-through cuvette set (HACH LANGE GmbH, Düsseldorf, Germany) as well as the 
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outer surfaces of the ends of the tubing set were rinsed with highly purified water and WfI until the 
rinsing fluid was visually free from particles. Online-turbidity monitoring was performed with 250 mL 
of WfI or placebo in recirculation over 24 h with the setup shown in Figure IV-46. The operation 
parameters of the Flexicon PD12 peristaltic pump (Watson-Marlow Flexicon, Ringsted, Denmark) 
were based on previous experiments (data not shown) and set as follows: dispensing mode, 180 rpm, 
acceleration of 60, starting filling volume of 5.0 mL. As occlusion pressure is known to have an impact 
on particle shedding [16,17,19], this parameter was kept at factory settings resulting in an occlusion 
pressure of 1.1 bar (tubing A) or 1.3 bar (tubing B and C) upon operation in air (accuracy class 2.5 
manometer from WIKA Alexander Wiegand SE & Co. KG, Klingenberg, Germany). For the smaller 
tubing ID of 1.6 mm the pressure was approx. 3 bar. In continuous mode, these settings resulted in a 
flow rate of 23 mL/s for 6.0 mm ID and 2 mL/s for 1.6 mm ID. Online-turbidity monitoring was carried 
out with a HACH 2100AN turbidimeter connected to a computer using HachLink 2000 V.2.9 alpha 
software. The operation mode of the turbidimeter included activated ratio function, auto range 
function and signal averaging (n=15). Data points were collected every 60 seconds. Turbidimeter 
functionality was confirmed with turbidity standards (< 0.15 NTU stray light standard, 0-2 / 0-20 / 0-
200 / 0-2000 NTU Gelex Secondary Standards from HACH; max. deviation of ± 5 % in comparison to 
precedent measurement) prior to every experiment. Different pre-treatments of each tubing type 
were investigated with n=2. 
For tubing with 1.6 mm ID the starting filling volume was 50 mL and was adjusted during the course 
of the experiment. For pre-rinsing, 0.5 L of highly purified water and 0.5 L of WfI were pumped 
through the tubing set with the Flexicon pump in continuous operation mode. 
 
 
Figure IV-46: Experimental setup for online-turbidity monitoring experiments. A – recirculation reservoir 
containing 250 mL of WfI or placebo, B – peristaltic pump, C – reservoir levelling off volume and pressure 
variations, D – turbidimeter with flow-through cuvette, E – computer for data acquisition, F – flow path in 
case of mismatch between pumped volume and volume flowing through turbidimeter due to hydrostatic 
pressure. Black solid line: tubing set under investigation, black dashed line: Tygon® R-3603 tubing as part of 
HACH flow-through cuvette set. 
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2.2.2 Determination of Pump Rate 
A stop watch and a measuring cylinder (250 mL for 6.0 mm ID, 50 mL for 1.6 mm ID) were used to 
determine the pump rate of each tubing set over approx. 10 seconds before and after the 24 h 
pumping cycle (n=5). 
2.2.3 Dynamic light scattering (DLS) 
Particle characterization in the nanometer range was performed by dynamic light scattering using 
the Ζetasizer Nano-ZS (Malvern Instruments Ltd., Herrenberg, Germany). The undiluted, neither 
filtered nor centrifuged samples were measured in disposable Plastibrand semi-micro PMMA 
cuvettes (Brand GmbH, Wertheim, Germany) at a backward scatter of 173° after 20 seconds 
equilibration time at 25°C and with water as dispersant (viscosity of 0.8872 cP). Positioning, 
attenuation selection and measurement duration as well as number of sub runs for the three 
performed measurements per sample were optimized automatically for each run by the Ζetasizer 
Software 6.32. Z-average and polydispersity index (PdI) were calculated applying the ‘General 
purpose (normal resolution)’ analysis model.  
The ζ-potential of the particles was measured with the same instrument. An aliquot of 800 µL of the 
final recirculate was analyzed in disposable folded capillary cells (Malvern) with three measurements 
of 10 to 30 sub runs each at a voltage of 50 V. ζ-potentials were derived from electrophoretic 
mobility data applying the monomodal analysis model and Smoluchowski theory.  
In order to analyze the ζ-potential over a range of pH values, ζ-potential measurements with the 
Ζetasizer Nano ZS were performed as described above and combined with pH titration performed by 
a connected MPT-2 autotitrator (Malvern). 9.0 mL of WfI recirculate were filled into a polypropylene 
sample tube (Sarstedt AG & Co., Nümbrecht, Germany) equipped with a stirring bar. 0.1 M NaOH and 
HCl were employed for titration from pH 10 to 2 in pH steps of 0.5 with a target pH tolerance of 0.1. 
Pump speed was set to 80% and stirrer speed was 30%. The sample was recirculated between repeat 
measurements (n=3). 
2.2.4 Light Obscuration (LO) 
The final recirculate was analyzed for particles in the micrometer range by light obscuration (in 
analogy to USP 788 and Ph Eur 2.9.19 requirements) with a SVSS-C instrument (PAMAS, Partikelmess- 
und Analysesysteme GmbH, Rutesheim, Germany) within three days after the pumping cycle. After a 
pre-run volume of 0.5 mL, each sample was analyzed in triplicates of 0.3 mL at a filling and emptying 
rate of 10 mL/min. Size channels from 1 to 60 µm were auto-scaled logarithmically. Before each run, 
the system was rinsed with at least 5 mL of highly purified water. Data was collected using PAMAS 
PMA Program V 2.1.2.0. 
2.2.5 Analysis of Particle Morphology 
Using the micro-flow imaging (MFI) system DPA4100 from Brightwell Technologies Inc. (Ottawa, 
Canada) equipped with a high-resolution 100 μl flow cell and the MFI™ View Application Software, 
particle morphology was investigated. Pre-run volumes of 0.3 mL and sample volumes of 0.65 mL 
were drawn through the flow cell by a peristaltic pump at a flow rate of 0.1 mL/min. Prior to each 
sample run, the system was rinsed with highly purified water to provide a clean baseline and to 
optimize illumination. 
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Additionally, particle morphology was visualized using a FlowCAM VS-I instrument (Fluid Imaging 
Technologies, Yarmouth, Maine, USA) equipped with a 20x objective and a FC 50 FlowCell. The 
system was controlled by Visual Spreadsheet software v3.1.10. Prior to each run, the system was 
rinsed with 1 mL highly purified water at a flow rate of 0.5 mL/min. After a pre-run volume of 0.5 mL, 
0.5 mL of the undiluted sample was analyzed at a flow rate of 0.07 mL/min in the AutoImage Mode 
at a camera rate of 20 frames per second. 
2.2.6 Fourier-Transform-Infrared-Spectroscopy (FTIR) 
10 mL of WfI recirculate from tubing C were centrifuged (Megafuge 1.0R, Thermo Scientific) for 
60 min at 4000 rpm, the supernatant was decanted and the pellet was air-dried. 500 µl of n-heptane 
(Sigma-Aldrich) were added. After two days at RT the pellet had turned transparent and the 
supernatant was analyzed by FTIR. A Bruker Tensor 27 FTIR spectrometer (Bruker Optics, Ettlingen, 
Germany) with a BIO ATR II measuring cell was used. The detector was cooled with liquid nitrogen 
and the beam path was purged with nitrogen. Each spectrum was recorded in 64 scans between 400 
to 4000 cm-1 with a resolution of 4 cm-1 and a corresponding blank spectrum was subtracted. 
Moreover, water and atmospheric compensation as well as vector normalization were performed 
with the Opus software version 6.5. 
2.2.7 Nanoparticle Tracking Analysis (NTA) 
For NTA measurements shortened pumping cycles of only 2 h (2880 fillings à 5.0 mL) with a reduced 
recirculation volume of 70 mL of WfI or placebo were carried out. Pumping cycle time was decreased 
in order to enable prompt characterization of all samples within one analysis run. Turbidity of the 
final recirculates was measured with a Lange Nephla turbidimeter in triplicates in pre-rinsed glass 
cuvettes with flat bottom. Scattered light of a λ = 860 nm laser is detected at an angle of 90° and the 
result is given in FNU (Formazine nephelometric units). This turbidimeter requires a sample volume 
of only 1.5 mL and was therefore preferred in this experiment. Nanoparticle tracking analysis was 
performed with a NanoSight LM20 system with PL 20/0 objective using NTA2.2 software (NanoSight 
Ltd., Salisbury, UK). The measuring cell was cleaned with particle-free water (filtered through a 
0.02 µm filter, Anotop 2, Whatman) and flushed with 1 mL of sample prior to analysis (n=3). Shutter 
(ca. 700) and gain (ca. 300) as well as focus were adjusted manually for each sample. Capture 
duration was set to 60 seconds and measurements were performed at RT. WfI recirculates from 
tubing A were diluted 1:10 with particle-free water prior to analysis, all other recirculates were not 
diluted. Analysis was performed with background extraction, a minimum track length of 10 and a 
minimum expected particle size of 100 nm. Detection threshold (ca. 5) and blur (mostly 9x9) were 
adjusted manually for each video. 
2.2.8 Scanning Electron Microscopy (SEM) 
Tubing wear was visualized with scanning electron microscopy using a Jeol JSM-6500F instrument 
(Jeol Ltd., Tokyo, Japan) with Inca Software (Oxford instruments, Oxfordshire, UK). Tubing pieces 
were fixed with conductive silver on aluminum stubs (both from Plano GmbH, Wetzlar, Germany) 
and were sputtered with carbon. SEM micrographs were collected at a magnification of 90x and an 
accelerating voltage of 5.0 kV.   
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Figure IV-47: Evaluation of three roughness standards (HALLE Präzisions-Kalibriernormale GmbH) for the 
appropriate selection of cutoff values. Cutoff value combinations (= measuring conditions 1 to 5) for λc and λs 
were chosen according to DIN EN ISO 4288:1998 and DIN EN ISO 3274:1998. Cutoff values λc in mm / λs in µm 
for the five different measuring conditions are 1) 0.08 / 2.5, 2) 0.25 / 2.5, 3) 0.8 / 2.5, 4) 2.5 / 8, 5) 8 / 25. Red 
lines indicate the mean as well as maximum and minimum values stated by the DKD calibration. 
2.2.9 3D Laser Scanning Microscopy 
Surface roughness of inner tubing walls was visualized using the 3D laser scanning microscope 
Keyence VK-X210 with a CF Plan 20x objective (Keyence GmbH, Neu-Isenburg, Germany). Using a 
scalpel, tubing pieces were cut into thin strips and placed under the microscope with horizontal flow 
direction. For every sample micrographs were captured with VK Viewer software in ‘Easy Mode’ at 
eight different sections. For used tubing all of these analyzed areas had been located inside the pump 
head during pumping cycles. The roughness parameters arithmetic mean roughness Ra and maximum 
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height Rz were calculated according to the JIS standard B0601:2001 in the multi-line roughness mode 
with VK Analyzer Plus software version 3.3.0.0 from an average of 2xn+1 horizontal lines with n=30 
and 10 (5 for ID of 1.6 mm) skipped lines in-between. Tubing curvature was corrected via the ‘correct 
tilt – sec curved surf. (auto)’ function. Appropriate cutoff values for λc (high-pass filtering) and λs 
(low-pass filtering) were evaluated using a KNT 4058/03 set of three roughness standards from 
HALLE Präzisions-Kalibriernormale GmbH (Edemissen, Germany). Cutoff values of λc = 2.5 mm and 
λs = 8 µm were applied since these settings provided the best results for the roughness standards 
(see Figure IV-47). 
2.2.10 Evaluation of a Second Type of Pump Head 
Sets of 1.6 mm ID tubing were employed in 2 h pumping cycles with 20 mL of WfI or placebo as 
recirculate without online-turbidity monitoring. The different geometries of the two investigated 
pump heads from Flexicon and Optima (Optima pharma GmbH, Schwäbisch Hall, Germany) are 
shown in Figure IV-48. In order to mimic the pump settings chosen for the default Flexicon pump, the 
parameters for the Optima pump were adjusted as follows: 1.5 sec filling time, 1.0 sec cycle time, 
and start / end filling ramp of 30 %. The filling volume was set to 1.65 mL in order to achieve a filling 
speed of 180 rpm. In order to achieve comparable recirculates, pumping cycles with 0.7 mL filling 
volume were performed with the Flexicon pump. All other parameters for the Flexicon pump were 
set as described above (2.2.1). Settings on both pump types corresponded to 24 fillings per minute 
and a total filling number of 2880. Sample turbidity was analyzed with the Dr. Lange Nephla 
turbidimeter (n=2) with a 90° turn of the glass cuvette between measurements. 
(a) 
(b)  
Figure IV-48: Employed pump heads. (a) Flexicon PD12I pump head, (b) Optima pump head. 
2.2.11 Simulated Post-Curing Process 
Post-curing of tubing sets was simulated by 4 h incubation at 200°C in a drying cabinet (Binder 
GmbH, Tuttlingen, Germany). 
2.2.12 Determination of Mechanical Properties  
The mechanical strength of the tubing material was analyzed with a Texture Analyser (TA.XT plus, 
Stable Micro Systems, Godalming, UK). As test probe, a cylinder with a diameter of 12.7 mm was 
used. The indentation force at an indentation depth of 5 mm for 6 mm ID / 1 mm for 1.6 mm ID 
tubing was measured (n=3 for areas outside the pump head, n=5 for areas within the pump head). 
Pre-test speed was set to 1.0 mm/s and test speed was 2.0 mm/s. 
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2.2.13 Thermogravimetric Analysis (TGA) 
20 to 30 mg of cut tubing pieces (ID 6.0 mm) were placed on an aluminum crucible of the TGA 
instrument (TGA 2950 CE, TA Instruments GmbH, Alzenau, Germany). The temperature program 
included an equilibration step at 30°C, followed by an increase in temperature up to 200°C with 
10°C/min. The mass loss during a holding time of 240 minutes at 200°C was evaluated. Subsequently, 
the temperature was further increased to 300°C with 10°C/min. Since the aluminum crucible showed 
a minor weight increase during the equilibration step at 200°C, measurement results were corrected 
for this blank value. 
2.2.14 Statistics 
Measurement results are reported as mean values with standard deviation (SD). F-tests (equality of 
variances) were conducted with p=0.95. Significance testing was performed via the t-test function in 
Microsoft Excel 2010. Significance levels are indicated by asterisks: p < 0.05 (*), p < 0.01 (**), and 
p < 0.001 (***). 
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3 RESULTS 
3.1 Online-Turbidity Monitoring 
In order to study the extent of particle shedding from silicone tubing, the setup described in Figure 
IV-46 was employed. During the course of the experiment, the recirculate repeatedly passed the 
peristaltic pump with the tubing under investigation as well as the flow-through cuvette inside the 
turbidimeter. 
(a)  (b) 
  
(c) 
 
(d)  
(e) 
 
(f) 
 
Figure IV-49: Online-turbidity monitoring graphs from 24 h pumping cycles with (a) different tubing A, B and 
C, (b) differently treated sets of tubing A, (c) different batches of tubing A and B, all with WfI in recirculation. 
Online turbidity monitoring graphs obtained for pumping of placebo in comparison to WfI are shown in (d-f). 
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Figure IV-49a shows the obtained turbidity profiles for 24 h pumping cycles with WfI in recirculation. 
Solutions that were recirculated with tubing A and C showed highly increased turbidity endpoint 
values of up to 18 NTU. After a steep increase during the first hours, the profiles flattened or even 
reached a plateau during the second half of the experiment. In contrast, recirculates of tubing B 
showed only a minor and almost linear increase over the test period and turbidity endpoints reached 
a maximum of 1.6 NTU. Turbidity graphs from pumping cycles with tubing A showed considerable 
variation concerning the starting slope of the curve, the onset of the plateau and the turbidity 
endpoints. As shown in Figure IV-49b, differences could not be ascribed to the pre-treatment of the 
tubing sets, which included several washing and sterilization procedures. Moreover, for tubing A and 
B a second batch of untreated tubing was tested. Considering the overall variations between 
different runs, turbidity increase (see Figure IV-49c), LO particle counts, and DLS particle 
characteristics (data not shown) of the WfI recirculate did not significantly differ between the two 
batches. During online-turbidity monitoring experiments with a surfactant-containing placebo buffer 
steep increases and sudden drops in turbidity were observed, especially with tubing B and C (see 
Figure IV-49d-f). In these experiments, air bubbles visibly accumulated in the flow-through cuvette. 
The formation of these air bubbles and their sudden release from the cuvette wall caused these 
excursions. For tubing A and B, turbidity endpoints of the air bubble free placebo recirculates were 
consistently lower than the ones obtained with WfI. With tubing B, comparably low turbidity 
endpoints were measured upon recirculation of placebo and WfI. 
3.2 Particle Characterization 
Recirculates were qualitatively analyzed for particles in the nanometer range using DLS. For WFI, Z-
average values of around 200 nm were obtained, independent of tubing type and tubing pre-
treatment (Figure IV-50a). The narrow size distribution was reflected by a rather low polydispersity 
index (PdI) below 0.2. The size distribution was mostly monomodal, only in a few cases a second 
rather small micrometer particle fraction was observed (Figure IV-50c). This second fraction in DLS 
occurred randomly. NTA measurements also suggested a monomodal size distribution in the 
nanometer range with a peak at approximately 180 nm.  
In recirculated placebo solution, Z-average and PdI values were higher (Figure IV-50b) due to a 
multimodal size distribution (Figure IV-50d). Apart from the shed particle fraction, additional peaks at 
around 1 nm and 10 nm were detected, arising from the high sucrose concentration [26] and the 
existence of polysorbate micelles in the placebo buffer. The particle fraction in the micrometer range 
occurred more frequently in placebo recirculates. As the shed particle fraction was observed to be 
smaller for tubing B, Z-average and PdI values for tubing B recirculates were more heavily impacted 
by the additional peaks present in placebo. With NTA, only the particle fraction with a diameter of a 
few hundred nanometers was detected, since the measurable size range of this technique is between 
30 and 1000 nm [5,27]. 
In conclusion, the nanometer particle fraction was the most predominant particle fraction in all 
samples. Table IV-21 shows turbidity values and corresponding NTA counts for nanometer-sized 
particles for recirculates from tubing A and B. In analogy to turbidity values, NTA counts were less for 
recirculates from tubing B (2.0 to 2.4 x 108 particles / mL in WfI) than from tubing A 
(5 x 109 particles / mL in WfI). For tubing A recirculates, NTA counts were slightly decreased when 
using placebo (3 x 109 particles / mL). For tubing B recirculates, only a minor difference between WfI 
and placebo particle counts (around 1.7 x 108 particles / mL in placebo) was noted. It needs to be 
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mentioned that NTA particle counts have to be interpreted in a more semi-quantitative way due to 
the significant imprecision inherent to this technique [27]. 
 
(a) (b) 
(c) (d) 
Figure IV-50: Results from DLS and NTA analysis. PdI and Z-average of (a) WfI and (b) placebo recirculates 
after 24 h pumping cycles. Different pre-treatments were tested with WfI as recirculate (a), for placebo 
studies (b) untreated tubing sets were employed. Values are depicted as replicates (n=2) for every pre-
treatment. The lower panel shows representative particle size distributions as analyzed by DLS (peak 
maximum (Z-average)) and NTA (mode (mean) value) for (c) a WfI recirculate of tubing A and (d) a placebo 
recirculate of tubing B after 2 h pumping cycles. 
Table IV-21: NTA particle counts and measured turbidity endpoints after 2 h pumping cycles. 
Sample description Turbidity [FNU] NTA particle count [x 106 / mL] 
Blank WfI 0.2 ± 0.0   5 ± 2 
Placebo 0.2 ± 0.0 132 ± 27 
Tubing A WfI #1 5.5 ± 0.1 4953 ± 176 
#2 5.7 ± 0.0 4703 ± 449 
Placebo #1 2.6 ± 0.0 2647 ± 566 
#2 2.7 ± 0.0 2877 ± 337 
Tubing B WfI #1 0.4 ± 0.0 201 ± 28 
#2 0.3 ± 0.0 237 ± 40 
Placebo #1 0.2 ± 0.0 169 ± 45 
#2 0.3 ± 0.0 176 ± 15 
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Table IV-22 depicts subvisible particle counts ≥ 2, ≥ 5, ≥ 10, and ≥ 25 µm from light obscuration (LO) 
measurements. Particle counts for recirculated WfI were between 300 and 1,000 particles ≥ 2 µm per 
mL with few exceptions. No clear influence of tubing type or pre-treatment on LO particle counts was 
observed. Particle counts in recirculated placebo ranged from around 1,300 particles ≥ 2 µm per mL 
for tubing A up to nearly 7,000 particles ≥ 2 µm per mL for tubing B. This difference in subvisible 
particle counts between WfI and placebo is in accordance with the more frequent appearance of the 
second species of larger particles in DLS measurements of placebo recirculates. Only few subvisible 
particles ≥ 10 µm (NMT 51 particles / mL for WfI and NMT 258 particles / mL for placebo) and 
≥ 25 µm (NMT 13 particles / mL for WfI and NMT 34 particles / mL for placebo) were found. The 
recirculated solutions did not contain particulates that were macroscopically visible to the naked eye. 
 
Table IV-22: Particle counts of recirculated WfI and placebo after 24 h pumping cycles as obtained from light 
obscuration data (tubing ID of 6 mm). 
Tubing 
type 
Recirculating 
solution 
Tubing pre-
treatment 
 Particle counts / mL 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm 
A WfI untreated  #1 1104 267 19 0 
#2 954 226 18 0 
washed #1 1332 322 51 13 
#2 919 248 26 0 
sterilized #1 2427 392 39 1 
#2 830 216 14 0 
CIP/SIP/DIP #1 264 49 6 1 
#2 2199 338 28 0 
Placebo washed #1 1354 124 32 3 
sterilized #2 2106 422 109 17 
B WfI untreated  #1 467 138 17 1 
#2 358 92 18 2 
washed #1 684 150 18 1 
#2 841 206 24 6 
sterilized #1 617 144 24 2 
#2 500 129 26 2 
Placebo washed #1 5681 431 69 16 
sterilized #2 6823 1538 258 8 
C WfI Washed #1 644 168 22 6 
#2 457 81 21 9 
sterilized #1 791 209 19 1 
#2 952 183 37 10 
placebo untreated 
 
#1 2681 414 113 14 
#2 2469 512 192 34 
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The ζ-potential of shed particles was found to be around -30 mV in WfI and around -3 mV in placebo 
(Table IV-23). These values indicate a rather low colloidal stability of shed particles. This is well in line 
with the observation that subvisible particle counts ≥ 1 µm in WfI increased substantially between 
day 5 and 14 upon quiescent storage of fresh recirculates (see Figure IV-51a). The attenuated ζ-
potential in placebo most likely enhanced particle agglomeration. This most probably led to the 
frequently higher numbers of micrometer-sized particles in recirculated placebo (see Table IV-22), 
which coincides with decreased turbidity and NTA counts in placebo as compared to WFI (see Table 
IV-21). However, characteristics of the nanometer-sized particles in WfI did not change over storage 
time (see Figure IV-51b). 
Table IV-23: Ζeta-potential (mV) of particles in recirculated solutions from 2 h pumping cycles. 
Tubing type Recirculated WfI Recirculated placebo 
A -34.5 ± 0.9 -4.6 ± 0.6 
 -29.8 ± 1.5 -4.4 ± 0.4 
B -28.1 ± 1.2 -3.3 ± 1.2 
 -26.0 ± 1.0 -1.7 ± 1.2 
 
 
(a) (b) 
Figure IV-51: Evolution of particle characteristics of a WfI recirculate of tubing A upon storage at 2-8°C. (a) 
Differential particle counts ≥ 1 µm as determined with LO analysis. (b) Z-Average (bars) and PdI values (black 
squares) obtained from DLS analysis. 
 
Recirculated solution from tubing A (n=6, received from differently pre-treated tubing sets) were 
additionally investigated for particle morphology with MFI. Representative scatter plots and particle 
images for one sample are exemplarily shown in Figure IV-52a-c. The object intensity mean value of 
786.0 ± 5.2 pointed to translucent particles. The maximal object intensity mean value was 
automatically set to 870 due to contrast adjustment and relates to the saturated background. The 
average aspect ratio of 0.82 ± 0.02 indicated rather spherical particles. As the employed MFI system 
has limitation in image resolution,[28] the FlowCAM instrument VS-I was additionally used for 
morphological characterization. The FlowCAM pictures confirmed the spherical morphology (Figure 
IV-52d). For particles ≥ 2 µm a bright center within a dark edge area becomes noticeable, which is 
typical for transparent particles. 
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Figure IV-52: Particle morphology. (a) Object intensity mean and (b) aspect ratio as calculated from MFI 
analysis of a 24 h WfI recirculate from tubing A. (c) Representative MFI pictures of analyzed particles with 
varying equivalent circular diameter (ECD given in µm). (d) FlowCAM pictures of particles with varying 
equivalent spherical diameter (ESD given in µm). 
Shed particles revealed the chemical characteristics of polydimethylsiloxane material [29]. The FT-IR 
spectrum of the dissolved fraction of shed particles (Figure IV-53a) showed a peak at 1260 cm-1 
arising from symmetric deformation vibrations of methyl groups, and peaks at 1097 and 1018 cm-1 
which can be attributed to Si-O-Si valence stretching vibrations. The small peak at 1412 cm-1 points 
towards asymmetric deformation vibrations of the methyl group [30,31]. A broadening of the peak at 
around 1100 cm-1 in comparison to the corresponding silicone oil peak is typical for a strongly cross-
linked silicone polymer [32]. Figure IV-53b shows the ζ-potential of particles in WfI in dependence of 
the pH value. Interestingly, the variation of the ζ-potential with pH follows exactly the same 
distribution as described by Gu and Li for silicone oil droplets in water [33]: at acidic pH, the ζ-
potential was around 20 mV, whereas at basic pH it was approximately -80 mV. The zero point of 
charge was located near pH 5. 
 
(a) (b)  
Figure IV-53: (a) FT-IR spectra of shed particles dissolved in n-heptane. (b) ζ-potential of particles suspended 
in water as a function of pH value. 
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3.3 Tubing Wear 
Investigation of tubing wear led to the conclusion that the particles found in the recirculated solution 
must indeed originate from the tubing itself, more precisely from the part of the tubing that was 
located inside the pump head during pumping cycles. In Figure IV-54, scanning electron micrographs 
are shown for tubing A, B and C before and after pumping cycles with WfI. The inner surface of 
unused tubing showed platelet-like structures for all three tubing types. After the 24 h pumping 
cycles, the morphology remained unchanged for tubing parts outside the pump head. In contrast, 
tubing parts that were located inside the pump head exhibited a smoothened morphology without 
any platelet-like structures. At the exit from the pump head, particle deposition was visible with WfI 
as a recirculate. These depositions most likely reflect clusters of shed subvisible and/or submicron 
particles or may represent larger visible particles that did not even reach the recirculation reservoir 
after generation in the pump head. Cluster formation is suggested due to the stickiness of the 
particles that was observed during different sample preparation procedures. For example, recirculate 
filtration eventually led to clogged filter membranes covered by a smooth, continuous layer. 
Likewise, recirculate centrifugation resulted in a compact pellet that was not re-dispersible.  
 
 
Figure IV-54: Characterization of tubing wear on tubing inner surfaces with SEM after 24 h pumping cycles 
with WfI. Arrows indicate flow direction during pumping. The depicted area per micrograph is 1067 µm x 
1333 µm. 
Furthermore, tubing surface morphology was visualized using a 3D laser scanning microscope. Other 
than with SEM, where surfaces of unused pieces of all three tubing types appeared similar, 3D laser 
scanning microscopy elucidated distinct differences in surface roughness of tubing A, B and C (Figure 
IV-55). For tubing A and C the inner tubing surface was smoothened after 2 h and this effect was 
even more pronounced after 24 h of pumping. Pumping cycles with tubing B resulted on the one 
hand in a rather smooth surface (Figure IV-55iii+iv) and on the other hand in regions with plaques 
(Figure IV-55i+ii). Most likely, this plaque formation was a consequence of the above described 
tendency for particle depositioning. Apart from smoothened tubing surfaces, 3D laser scanning 
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micrographs revealed an increased number of indentations for tubing A and C upon recirculation of 
placebo. Recirculation of placebo with tubing B resulted in a smooth surface without any 
indentations or plaques. The existence of plaques or indentations was determined via profile analysis 
in the microscope software (see Figure IV-56). 
 
 
Figure IV-55: Characterization of surface morphology of tubing inner surfaces in dependence on pumping 
time with 3D laser scanning microscopy. For microscopy tubing pieces were oriented horizontally with 
direction of flow from left to right. The depicted area per micrograph is 534 µm x 712 µm. 
 
(a) 
 
(b) 
 
(c)  
  
Figure IV-56: Exemplified profiles of micrographs from Figure IV-55 showing the existence of plaques or 
indentations. (a) Tubing A, 24 h placebo – (b) tubing B, 24 h WfI – (c) tubing C, 24 h placebo. 
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Surface roughness of the three tested tubing types was evaluated via the calculation of Ra and Rz 
values. With the help of roughness standards, the correct settings for the cut-off values were 
determined prior to roughness evaluation (see Figure IV-47). The cut-off values as recommended by 
DIN standards [34,35] were not applicable in this case due to the limited scanning area of 712 µm x 
534 µm. Figure IV-57 depicts the R values for tubing A, B and C over pumping time obtained from 
areas that were located within the pump head during the applied pumping cycle. R values of unused 
tubing substantiated the visual impression from the micrographs shown in Figure IV-55. Unused 
tubing A exhibited the highest surface roughness with a Ra value of 3.95 ± 0.41 µm and a Rz value of 
29.7 ± 3.8 µm. In comparison, values for tubing B with 0.41 ± 0.05 µm for Ra and 3.0 ± 0.2 µm for Rz 
were significantly lower and confirmed the smoother appearance in the micrographs. Tubing C 
revealed a rather moderate surface roughness as indicated by a Ra value of 1.15 ± 0.08 µm and a 
value of 8.7 ± 1.3 µm for Rz. With increasing pumping time, Ra and Rz values of all tubing types 
approached a similar end value of about 0.6 µm and 5 µm, respectively. Moreover, the increased 
relative standard deviations for R values after 2 and 24 h pumping reflected the observed 
heterogeneity in the form of indentations and plaques on the tubing surface. For example, the 
relative standard deviation for Ra of tubing A increased from initially 10 % up to 50 % after 24 h.  
 
(a) 
 
(b) 
 
Figure IV-57: (a) Ra and (b) Rz values calculated from 3D laser scanning microscopy of untreated tubing 
surfaces (0 h) and after 2 and 24 h pumping cycles with WfI. 
3.4 Influence of Tubing ID 
Particle shedding from tubing with an ID of 1.6 mm was studied in analogy to the 6 mm ID tubing but 
with WfI as recirculate only. Figure IV-58a shows the turbidity profiles for the three different tubing 
types A, B, and C obtained during online monitoring of 24 h pumping cycles. Final turbidity values of 
tubing A recirculates varied between 2.6 and 5.9 NTU, recirculates from tubing B showed end values 
of around 2 NTU, and using tubing C led to turbidity end values of 6 to 7.4 NTU. The two different 
starting profiles obtained for tubing A were due to the different tubing batches that were used for 
the preparation of the tubing sets (see paragraph 3.5). Intermittences of the turbidity profiles were 
due to errors during data transfer to the computer. Influences of the tubing pre-treatment on the 
turbidity profiles as well as the particle characteristics were not observed for any tubing type. DLS 
analysis for all recirculates led to Z-average values between 160 and 200 nm with a PdI between 0.1 
and 0.2 (Figure IV-58b). Particle counts in the micrometer range as obtained by LO analysis (see Table 
IV-24) did not differ significantly for all samples and were less than 1000 particles ≥ 2 µm/mL with 
few exceptions only. Rather limited amounts of subvisible particles ≥ 10 µm (NMT 135 particles / mL) 
and ≥ 25 µm (NMT 42 particles / mL) were found. 
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Figure IV-58: Characterization of particle shedding from tubing with an ID of 1.6 mm. (a) Online-turbidity 
monitoring over 24 h pumping cycles, (b) results from particle characterization of recirculates with DLS. 
 
Table IV-24: Particle counts (LO analysis) of 24 h WfI recirculates from tubing with an ID of 1.6 mm. 
Tubing 
type 
Tubing pre-
treatment 
 Particle counts / mL 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm 
A untreated  #1 490 141 17 1 
#2 457 153 22 3 
washed #1 3333 859 130 13 
#2 9888 1836 135 1 
sterilized #1 430 120 27 1 
#2 1139 242 24 0 
B untreated  #1 290 76 13 1 
#2 373 92 22 3 
washed #1 998 183 36 4 
#2 714 151 22 6 
sterilized #1 406 112 21 0 
#2 502 118 9 0 
C washed #1 466 152 62 42 
sterilized #1 503 132 24 2 
#2 393 86 17 1 
 
Initially, the tubing surface morphology of the three tubing types differed substantially (Figure IV-59). 
All three surfaces exhibited regular variations in surface height. These height differences were most 
pronounced on the surface of tubing A, whereas tubing B showed more frequent but less distinct 
height changes. This is reflected in the corresponding roughness values (Figure IV-60), which were 
highest for tubing A (Ra = 3.31 ± 0.52 µm, Rz = 21.4 ± 3.3 µm), lowest for tubing B 
(Ra = 0.55 ± 0.04 µm, Rz = 3.8 ± 0.3 µm), and in-between for tubing C (Ra = 1.52 ± 0.29 µm, 
Rz = 10.1 ± 2.0 µm). After 2 h of pumping, surface roughness values of tubing A already decreased 
slightly, whereas roughness values of tubing B was unchanged. After 24 h, 3D laser scanning 
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microscopy revealed very smooth surfaces but especially for tubing A and B also areas with distinct 
irregularities in the form of plaques and indentations. The observed heterogeneities gave rise to Ra 
and Rz values of around 1-2 µm and 7-10 µm, respectively, that significantly varied depending on the 
investigated spot on the tubing surface (RSDs of up to 97 % for tubing B). In comparison to the initial 
surface roughness, mean Ra and Rz values after 24 h pumping time were thus decreased for tubing A, 
increased for tubing B, and rather unchanged for tubing C. 
 
Figure IV-59: Morphology of surface roughness (tubing ID of 1.6 mm) initially and after 24 h pumping cycles 
with WfI, analyzed with 3D laser scanning microscopy. 
(a)  (b) 
Figure IV-60: Evolution of surface roughness values (a) Ra and (b) Rz of tubing with an ID of 1.6 mm over 
pumping time using WfI as recirculate. 
3.5 Influence of Tubing Batch 
In order to account for batch-to-batch differences, at least a second batch of tubing A (6.0 and 
1.6 mm ID) and B (6.0 mm) was analyzed via online-turbidity monitoring (Figure IV-61). Moreover, 
the recirculates were characterized for particles in the nano- and micrometer range and the decrease 
in flow rate was determined (Table IV-25). Although the corresponding data for tubing A with ID 
1.6 mm was already presented in section 3.4, it is included again for better comparison. 
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Figure IV-61: Online-turbidity monitoring of different batches of (a) tubing A with 6.0 mm ID, (b) tubing B 
with 6.0 mm ID, and (c) tubing A with 1.6 mm ID. Please note the differences in scale of the y-axis. 
For the second batch of tubing A (6.0 mm ID), slightly lower turbidity end values than for the first 
batch were obtained (Figure IV-61a). Considering the overall quite high variability between different 
runs with the same tubing type (see Figure IV-49b), this effect is rather small. The same conclusion 
applies for the marginal differences in particles counts ≥ 2 µm. DLS results and flow rate decreases 
were comparable for both tubing batches (see Table IV-25). All three batches of tubing B (6.0 mm ID) 
led to turbidity end values below 1.2 NTU (see Figure IV-61b). Turbidity profiles for batch #2 and #3 
were very similar and ended at around 0.7 NTU. Particle characteristics in the nano- and micrometer 
range as well as flow rate changes after pumping were comparable for all three tested batches. It 
needs to be mentioned that the manufacturer of tubing B announced a production change while this 
study was performed. Batch #3 is part of this new generation of tubing B made with the same raw 
materials and extrusion equipment, but with a more optimized mixing ratio of its compounds. This 
change does not seem to have altered the anyway low propensity of tubing B to shed particles. 
However, the modified composition led to 35 % higher indentation forces for this batch (see Figure 
IV-62). Flow rate decreases for all 6 mm ID tubings investigated ranged between 1.7 and 6.1 % (see 
details in section 3.6). 
The turbidity profiles for different batches of tubing A with an ID of 1.6 mm revealed distinct 
differences, especially with regards to the initial slope. Batch #1 tubing sets showed a steady, but 
limited increase in turbidity over pumping time, whereas sets from batch #2 led to a rather steep 
turbidity increase initially with a plateau phase afterwards (see Figure IV-61c). Z-Average and PdI 
values for particles obtained from batch #2 tended to be lower than from batch #1. No significant 
effect of the used batch on particle counts ≥ 2 µm could be deduced. Hardly any changes in flow 
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rates before and after the pumping cycle were measured for batch #2, whereas for batch #1 flow 
rates decreased by 3 % on average. Initial pump rates for batch #2 were 7 % higher than for batch #1 
(see section 3.6). The indentation force for batch #2 was 22 % lower than for batch #1 (Figure IV-62).  
Table IV-25: Comparison of particle characteristics of recirculates as well as flow rate variations obtained 
from different tubing batches. 
Tubing 
type  batch run 
Particle counts 
≥ 2 µm/mL (LO)  
DLS Decrease in 
flow rate [%] Z-Average [nm] PdI 
A  1 #1 1104 ± 55 201.3 ± 1.4 0.122 ± 0.009 -2.2 
6 mm ID  #2 954 ± 62 195.0 ± 1.0 0.193 ± 0.009 -1.7 
 2 #1 763 ± 23 197.3 ± 0.8 0.108 ± 0.019 -2.2 
  #2 787 ± 90 191.5 ± 0.5 0.100 ± 0.019 -3.5 
B 1 #1 467 ± 67 193.0 ± 2.5 0.128 ± 0.017 -4.5 
6 mm ID  #2 358 ± 46 193.8 ± 4.9 0.142 ± 0.025 -5.3 
 2 #1 1046 ± 51 196.2 ± 5.5 0.199 ± 0.028 -4.9 
  #2 361 ± 17 198.9 ± 7.2 0.181 ± 0.046 -6.1 
 3 #1 308 ± 31 198.0 ± 3.2 0.228 ± 0.046 -4.0 
  #2 188 ± 28 194.3 ± 5.3 0.159 ± 0.030 -3.8 
A 1 #1 490 ± 51 195.0 ± 3.8 0.162 ± 0.005 -2.9 
1.6 mm ID  #2 3333 ± 75 201.2  4.8 0.160 ± 0.009 -2.5 
  #3 9888 ± 282* 200.0 ± 3.5 0.200 ± 0.023 -3.4 
 2 #1 457 ± 40 162.9 ± 1.2 0.115 ± 0.009 ±0.0 
  #2 430 ± 20 171.3 ± 2.1 0.109 ± 0.007 -1.9 
  #3 1139 ± 54 180.9 ± 4.9 0.118 ± 0.008 ±0.0 
*Flow via flow path F as shown in Figure IV-46 was observed towards the end of this run. It is assumed that flow via flow path F correlates 
with the increased slope in the turbidity profile Figure IV-61 starting at approx. 16 h pumping time and likewise might have resulted in 
comparably high particle counts. 
 
 
Figure IV-62: Indentation forces for different tubing batches. 
Initial surface roughness values of several batches of tubing A and B (ID of 6.0 mm) were comparable 
within one tubing type, however were differing by a factor of 10 on average between tubing A and B 
(Figure IV-63). The evolution of surface roughness over time was confirmed for a second batch of 
tubing A and B, as well as for tubing sets from pumping cycles with placebo (Figure IV-64). 
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Figure IV-63: Surface roughness values Ra and Rz of different batches of tubing A (a+b) and B (c+d) (6.0 mm). 
 
(a) (b) 
(c) 
 
(d) 
Figure IV-64: Evolution of surface roughness over time in dependency of batch and recirculating medium for 
tubing A (a+b) and B (c+d) (6.0 mm ID). 
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3.6 Effect of Pumping on Mechanical Properties of Tubing 
Pump rates of tubing sets were determined prior and after pumping cycles (Figure IV-65) as a 
measure for the deformation of the tubing lumen due to the mechanical stress exerted by the 
peristaltic pump. 
(a) (b) 
Figure IV-65: Pump rates before and after pumping cycles for tubing with (a) 6 mm and (b) 1.6 mm ID. 
All tubing sets apart from tubing C (6 mm ID) showed a clear decrease in pump rate after the 
pumping cycle. In contrast to this, for 1.6 mm ID tubing, this decrease in percent as listed in Table IV-
26 was highest for tubing C, followed by tubing B and lowest for tubing A. Big differences in initial 
pump rate and decrease were seen between the two batches of tubing A with 1.6 mm ID (see also 
section 3.5). 
Table IV-26: Change (%) in pump rates after 24 h pumping cycles with WfI, calculated as mean values with 
standard deviations from the pump rates shown in Figure IV-65. 
Tubing type 6 mm ID 1.6 mm ID 
A -1.8 ± 0.9 -2.9 ± 0.5 / -0.6 ± 1.1* 
B -4.5 ± 0.9 -7.0 ± 0.5 
C +1.0 ± 1.2 -8.5 ± 2.6 
*: Pump rate deviations for the two different batches used 
Indentation forces were recorded as a second measure for the mechanical stress that the rollers 
within the pump head exert on the tubing (Figure IV-66). For all tubing types and IDs, indentation 
forces were clearly reduced after the pumping cycles on areas located within the pump head. 
Reductions in indentation forces were between 22 to 27 % for tubing with an ID of 6 mm (A: -23.5 %, 
B: -27.3 %, C: -21.8 %), and even up to 40 % for the smaller tubing ID of 1.6 mm (A: -39.8 %, B:  
-31.6 %, C: -34.3 %). Already after 2 h of pumping, indentation forces for all tubing types were 
decreased by approx. 20 %. 
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Figure IV-66: Indentation forces measured for tubing sets with an ID of (a) 6 mm and (b) 1.6 mm, before and 
after 24 h pumping cycles with WfI. 
3.7 Influence of Pump Head 
The influence of a different pump on particle shedding from tubing A and B with an ID of 1.6 mm was 
studied via 2 h recirculation experiments employing WfI and placebo buffer as recirculation media. 
This comparative study included turbidity, DLS and LO analysis of the obtained recirculates. 
Moreover, particle depositioning at the exit from the pump head as already described in Figure IV-54 
was evaluated via visual and microscopic inspection. 
(a) (b)  
Figure IV-67: Comparison of the two pump heads Flexicon and Optima in terms of (a) turbidity and (b) DLS 
characteristics of the obtained recirculates. (*PdI not shown, multimodal size distribution due to additional 
micelles and sucrose peak resulted in highly increased values that are not meaningful in this context.) 
Turbidity values confirmed previously described trends since turbidity values of recirculates from 
tubing A were generally higher than those from tubing B and also generally higher when pumping 
WfI instead of placebo (Figure IV-67a). Upon recirculation of WfI with the Optima pump, the turbidity 
increase was by a factor of 2.7 / 2 (tubing A / B) higher compared to the turbidity increase resulting 
with the Flexicon pump. Turbidity values of placebo recirculates were similar. No differences in the 
size distribution of shed nanoparticles could be deduced (Figure IV-67b). Particle counts in the 
micrometer range were higher for Optima than for Flexicon recirculates (Table IV-27). 
Correspondingly, particle depositioning on the inner tubing surface was more often observed upon 
operation in the Optima pump, especially with WfI as recirculate (Table IV-28).  
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Table IV-27: Particle counts from LO analysis of recirculates produced with two different pump heads. 
Pump 
head 
Tubing 
type 
Recirculating 
solution 
 Particle counts / mL 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm 
Optima A WfI #1 12322 1287 242 29 
#2 8606 1489 232 33 
Placebo #1 6358 1520 408 134 
#2 6174 1379 367 119 
B WfI #1 6140 1030 136 23 
#2 3940 881 171 40 
Placebo #1 3564 584 211 101 
#2 3416 536 213 112 
Flexicon A WfI #1 4560 968 192 23 
#2 4119 702 126 16 
Placebo #1 1988 540 122 42 
#2 2278 594 156 47 
B WfI #1 1099 244 40 3 
#2 704 182 16 1 
Placebo #1 2823 631 159 37 
#2 1906 1046 409 128 
 
Table IV-28: Evaluation of particle deposition on the inner tubing surface after the pumping cycle. 
Tubing type Recirculating solution  Optima Flexicon 
A WfI #1 ++ – 
  #2 ++ – 
 Placebo #1 – – 
  #2 – –/+ 
B WfI #1 +/– – 
  #2 + – 
 Placebo #1 – – 
  #2 – – 
– :  no particle depositions visible 
+/– :  particle deposition observed in only one of two flanks 
+ :  minor particle deposition observed in both flanks 
++ : major particle deposition observed in both flanks 
A smoothened inner surface after pumping was observed for all studied tubing sets (Figure IV-68). 
Surfaces of tubing B generally appeared smoother, but apart from that tubing morphologies were 
comparable and independent of the used pump head. This observation is reflected in the 
corresponding roughness values (Figure IV-69). Mean R values of tubing B were slightly less reduced 
when using the Optima pump for recirculation. However, due to the rather high standard variations 
resulting from surface heterogeneity, this effect was not significant. 
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Figure IV-68: 3D laser scanning micrographs of the inner tubing surface on areas located inside the pump 
head during pumping cycles (2 h). 
(a)  (b) 
Figure IV-69: Roughness values (a) Ra and (b) Rz of the inner tubing surfaces shown in Figure IV-68 in 
comparison to initial surface roughness before pumping. 
As a measure for the mechanical stress that the different pump heads exerted on the tubing, 
mechanical stiffness in percent was determined as the relative indentation force on areas that were 
located within the pump head in comparison to areas outside the pump head (Figure IV-70). The 
mechanical stiffness of all samples was decreased by at least 20 % after 2 h of pumping. Only for 
tubing A with WFI as recirculating medium, significant differences (p < 0.05) were found for the 
impact of the two pump heads on the mechanical properties of the tubing material. 
 
Figure IV-70: Remaining mechanical stiffness of the different tubing sets after the 2 h pumping cycle. 
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3.8 Influence of Post-Curing 
Only the manufacturing process of tubing B includes a post-curing step. Therefore, the impact of 
such a post-curing step was further investigated with tubing of 6.0 mm ID, especially with regards to 
particle shedding. The manufacturer of tubing B claims that post-curing for 4 h at 200°C with high air 
throughput ensures a reduced amount of volatile residues and optimized physical properties by 
completing crosslinking. Post-curing was simulated in a heating oven without the possibility for 
continuous air throughput. The performance of post-cured tubing sets in terms of particle shedding, 
mass loss during heating, as well as mechanical properties was compared to tubing sets that did not 
receive this additional treatment. 
 
Figure IV-71: Turbidity monitoring graphs of recirculation experiments with placebo buffer and two 
differently treated sets of tubing A (6.0 mm ID). 
Online-turbidity monitoring demonstrated slightly higher turbidity values for the post-cured tubing 
set (Figure IV-71). However, these differences seem to be well within the overall variability in 
turbidity profiles obtained for tubing A (see Figure IV-49d). Depending on the tubing type, TGA 
analysis revealed mass losses during equilibration for 4 h at 200°C of 0.1 to 0.6 %. Mass losses were 
minimally reduced after the applied post-curing treatment and the obtainable mass losses seemed to 
recover with prolonged storage time. For data interpretation, the precision of the TGA instrument of 
0.1 % needs to be considered. Indentation forces increased by less than 1 N and were thus largely 
unaffected by the simulated post-curing step. 
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4 DISCUSSION 
Online-monitoring of turbidity with recirculating WfI turned out to be highly valuable for 
characterizing the extent of particle shedding from silicone tubing upon peristaltic pumping. With 
surfactant-containing placebo solution, the obtained online-turbidity monitoring graphs were less 
valuable due to excursions caused by the entrapment of air bubbles within the measuring cell. The 
observed slight variability in turbidity profiles between different runs with the same tubing type may 
be due to variations in the manual mounting of the tubing sets within the pump head and in particle 
deposition at the pump head end. Washing cycles as well as sterilization of the tubing material at 
temperatures up to 131°C, as applied during typical CIP/SIP/DIP cycles, did not impact the extent of 
particle shedding. This is well in line with the fact that silicones are thermally stable due to a 
shielding of the polar backbone by methyl groups and therefore can be operated at temperatures up 
to 215°C [14]. High temperatures may instead enhance the extraction of low molecular weight 
species [36]. However, the determination of extractable levels was not within the scope of this study. 
 
Shedding mainly resulted in particles of around 200 nm in size. With both DLS and NTA, a narrow 
monomodal size distribution was identified in recirculated WfI (PdI of about 0.2). Particle 
characteristics were independent of tubing type and pre-treatment. The number of nanometer-sized 
particles as assessed with NTA varied between different tubing types. WfI recirculated with tubing A 
contained about 20 to 25 times more nanometer-sized particles than WfI recirculated with tubing B. 
Additional excipient peaks in DLS measurements of recirculated placebo solutions lead to higher 
variability in Z-average and PdI values. These parameters are therefore considered as less meaningful 
for the interpretation of particle characteristics in recirculated placebo. The main particle fraction of 
200 nm was also observed in recirculated placebo. It is anticipated that particle shedding will result in 
similar particle characteristics when using e.g. protein solution.  
It is assumed that this nanometer-sized particle fraction was the primary form of particle spallation 
from silicone tubing and that these particles formed the obtained micrometer-sized particles. This 
hypothesis of agglomeration and subsequent fusion of shed nanoparticles is supported by the 
observed particle stickiness and the increase in particle counts of around 1 µm after several days of 
quiescent storage of fresh recirculates (see Figure IV-51). The change in particle size distribution due 
to colloidal instability seemed to be more pronounced in placebo buffer. The effect corresponds to 
the less negative ζ-potential of the particles in buffer compared to WfI. Accordingly, the numbers of 
micrometer-sized particles in recirculated placebo tended to be higher than particle counts in 
recirculated WfI. The morphology of the micrometer-sized particles as assessed with MFI strongly 
resembled those of silicone oil droplets apart from slightly brighter edges [9,37,38]. FT-IR 
characterization of the particles after redissolution in heptane demonstrated spectral features that 
are typical for silicone polymer materials, and also the pH-dependent ζ-potential profile in WfI 
indicated that the particles consist of polydimethylsiloxane. For clarification, it needs to be pointed 
out that the particles consisted of silicone elastomer and not silicone oil, a fact that is simply 
deducible from the rather high relative density of the particles.  
Barron et al. reported that the majority of shed particles in their studies was smaller than 16 µm in 
diameter [19] and in line with their findings, we also observed only few particles larger than 10 µm. 
Therefore, it is unlikely that the pharmacopeial requirements for subvisible particle counts ≥ 10 µm 
and ≥ 25 µm could be compromised by particle shedding from silicone tubing [5]. However, it is 
nevertheless desirable to keep any particulates in the final product to a minimum. Overall, particles 
shed from silicone tubing upon operation in a peristaltic pump should be considered as one possible 
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source of particle contamination, although to a rather limited extent. For the interpretation of our 
data, it has to be kept in mind that particle counts presented here resulted from recirculation 
experiments. Hence, the number of shed particles accumulated in a limited volume of recirculation 
medium. From our particle count data after 2 h pumping time, we estimated the number of particles 
deriving from the particle shedding and to be expected in a final DP. This extrapolation translated 
into a very low particle burden for both the micrometer and nanometer range for the final DP (Table 
IV-29) close to blank level. For several reasons, this calculation is only an approximation. Firstly, NTA 
counts are a rather semi-quantitative estimate of nanometer-size particle numbers. Secondly, a more 
diluted particle suspension as obtained after filling without recirculation might lower the possibility 
for particle agglomeration and the formation of micrometer-sized particles. 
Still, in order to obtain a DP with optimal quality, unwanted particle contamination should be 
avoided and choosing low abrasive tubing contributes to this ubiquitous pharmaceutical claim.  
Table IV-29: Expected particles to be found in a filled product due to tubing shedding during production 
conditions calculated from the 2 h recirculation experiments. 
 Number of (shed) particles 
 < 1 µm in 106 particles / mL (NTA) ≥ 2 µm / mL (LO) 
 recirculating conditionsa 
production 
conditionsb 
recirculating 
conditionsa 
production 
conditionsb 
Tubing A / WfI 4953 ±    176 24 ±    0.9 719 ±    59 3 ±    0 
Tubing A / placebo 2646 ±    566 12 ±    2.8 340 ±    34 1 ±    0 
Tubing B / WfI 201 ±    28 1 ±    0.1 277 ±    38 1 ±    0 
Tubing B / placebo 169 ±    45 0.2 ±    0.3 652 ±    22 3 ±    0 
a Experimental data was not corrected for blank values. Blank values measured with NTA / LO in particles per mL were 5 ± 2 × 106 / 3 ± 0 
for WfI and 132 ± 27 × 106 / 107 ± 13 for placebo. 
b During experiments, 70 mL of recirculation medium was employed with a total of 2880 fills of 5 mL each. This resulted in a pumped 
volume of 14,400 L meaning that every milliliter of the recirculate passed the pump 206 times. The particle counts obtained from 
experimental conditions as stated in the table were divided by this factor after blank value subtraction in order to give the stated number 
of additional particles to be expected in the filled drug product. 
 
Wear of the inner surface of tubing after pumping cycles was noticed in earlier studies with medical 
background. Kim and Yoon found grooves with SEM and phase contrast microscopy [22]. Kurusz also 
described grooves located at the points of maximum flexure within the tubing material [21]. Such 
grooves seem to be a natural consequence of the occlusion pressure applied by the pump head and 
were visible inside all tubing sets of this study as well. On the inner surface of unused tubing, Dewan 
et al. noted adherent particles that were not seen after use of the tubing within a pump [20]. In our 
case, the tubings were free of pre-existing particle contamination. Instead, spallation and 
smoothening of the surface as reported by Kurusz [21] drives particle formation during pumping. The 
ongoing particle shedding was proven by the alteration in morphology of the inner tubing walls after 
pumping as depicted with SEM and 3D laser scanning microscopy.  
Distinct differences in surface morphology were found to be responsible for the different extent of 
particle shedding from the three analyzed tubing types. In SEM micrographs, all unused tubing 
revealed a similar platelet-like structure, which might be a result of the extrusion process during 
tubing production. In contrast, 3D laser scanning microscopy clearly depicted the diversity of the 
three tubing types in terms of surface texture, thus making this analytical tool an exquisite method 
for tubing surface characterization. Factors with possible influence on surface texture are extrusion 
equipment and the composition and features of the extrusion mixture. Surface characteristics cannot 
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be concluded from the specifications given by the manufacturers who only provide mechanical 
features like hardness / Shore A, specific gravity, Tear B / tear strength / tear resistance, ultimate 
tensile strength, and elongation at break. Therefore, analysis of the surface morphology of tubing by 
the customer can be a helpful additional characterization technique, especially when new tubings are 
considered, evaluated, and qualified for DP manufacturing. Surface roughness was found to be 
specific for each tubing type and rather independent of the investigated batches. 
With the applied 3D laser scanning microscopy, surface morphology could not only be visualized but 
also put in numbers via the roughness parameters Ra and Rz. The obtained values were lowest for 
tubing B and correlated with the lowest extent of particle spallation. It is therefore concluded that 
the number of shed particles can be minimized by choosing tubing with low R values. Although 
surface morphology of tubing B changed over pumping time, R values shifted only marginally. The 
minimally increased R values after 2 and 24 h if WFI was pumped were due to the observed plaque 
formation via particle deposition. Upon pumping of placebo, such depositions did not occur and R 
values remained constant (see Figure IV-64c+d). It is assumed that the contained surfactant helped 
to keep shed particles suspended. In contrast, the higher surface roughness values of unused tubing 
A and C decreased with increasing pumping time. After 24 hours, roughness values of all three tested 
tubing types approached the same low Ra and Rz values of approximately 0.6 µm and 5 µm, 
respectively. Similarly, during pumping cycles with online monitoring, turbidity graphs for tubing A 
and C flattened after several hours and approached a plateau. This indicates that particle shedding 
due to surface ablation is more pronounced at the start of pumping and diminishes once a certain 
smoothness of the surface is achieved. 
In conclusion, 3D laser scanning microscopy was found to be a valuable and effective tool for surface 
roughness determination of tubing material. This is the first study that successfully implemented this 
surface characterization method with regards to biopharmaceutical DP processing materials. The 
correct cut-off values for the evaluation of the roughness parameters Ra and Rz can be obtained via 
roughness standards. 
 
For smaller tubing with an ID of 1.6 mm, previous observations in terms of particle characteristics in 
the recirculates as well as the rank order of initial tubing surface roughness were confirmed. 
However, endpoint turbidity values were slightly increased for tubing C in comparison to tubing A, 
and the overall higher increase in turbidity compared to tubing B was less pronounced than with 
tubing of 6 mm ID. Generally, endpoint turbidity values of recirculates obtained from tubing with an 
ID of 1.6 mm were lower than those from 6 mm ID tubing. A reduced extent of particle shedding 
seems to be a logical consequence of the smaller inner tubing surface that is available for particle 
spallation. After 24 h pumping cycles, surface roughness likewise tended to decrease. Not only 
smooth areas but also pronounced heterogeneities, especially for tubing B, were microscopically 
visible on the inner tubing surface. Roughness values after 24 h of pumping were thus slightly higher 
and more diverse than for the 6 mm ID tubing. Thus smaller tubing appears to be more susceptible to 
the mechanical stress exerted by the pump. After 24 h, not only surface erosion but possibly also 
destructive events already started leading to more frequent heterogeneities on the tubing surface. 
 
For tubing with an ID of 6 mm, different batches resulted in a comparable extent of particle 
shedding. In contrast, the two different batches of tubing A with an ID of 1.6 mm led to distinct 
variations in turbidity profile, indentation force, and also flow rate reduction. The stiffer batch #1 led 
to a minor, but steady turbidity increase over time and the lower flow rate of 2.05 mL/min was 
decreased by 2.8 % on average after the pumping cycle. Indentation forces for batch #2 were lower, 
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turbidity profiles were characterized by a steep initial increase with a subsequent plateau, and the 
higher flow rate of 2.2 mg/mL remained unchanged after pumping. According to Colas et al., batch to 
batch variations appear greater with smaller tubing IDs since smaller defects in the polymer material 
seem to be more critical here [14].  
Differences in indentation forces were also observed for batch #3 of tubing B with 6.0 mm ID, but 
this did not have a measurable effect on particle shedding. The announced production change 
regarding the relative composition of the extrusion mixture might encompass an increase in the 
amount of used fillers like silicon dioxide. This compound leads to higher mechanical strength via 
interactions with the silicone elastomer molecules [29]. 
All in all, the mechanical properties of tubings were not found to be the determining factor for 
particle shedding. Tubing with both high and low propensity towards particle spallation showed 
comparable mechanical properties initially (A vs. B) as well as rather identical decreases in stiffness 
after the pumping cycle. Flow rates after pumping were decreased by 2 to 8 % in most cases due to a 
flattening of the tubing lumen [14]. Such decreases are to be expected and compensated by 
automatic adjustments of pump settings over the course of the filling process. The lumen 
deformation and the loss in stiffness demonstrate the strong mechanical stress that the tubing 
experiences within the pump head. Therefore, silicone tubing is limited in its operation time. 
However, typically forming part of a disposable concept, the silicone tubing is replaced after each 
and every filling process anyway. 
 
When it comes to the mechanical stress that is exerted on the tubing material, the choice of a 
suitable pump head is of upmost importance. Indeed, operating tubing A and B with the Optima 
pump led to higher turbidity values of WFI recirculates, increased numbers of micrometer-sized 
particles, and a more frequent occurrence of particle depositions in the tubing lumen. Surface 
roughness as well as mechanical stiffness of tubing sets after the pumping cycle was comparable for 
both tested pumps. For different pump heads, the use of a different kind of tubing might thus be 
recommended. 
 
Initially, it was anticipated that the post-curing step that is included in the manufacturing of tubing B 
might be responsible for the differences in particle shedding. Post-curing refers to a 4 h curing step at 
200°C with high air throughput which is applied after tubing extrusion. The performed TGA analysis 
resembles the testing for volatile matter of silicone tubing as described by the European 
Pharmacopeia [39]. Up to 2 % of volatile matter is accepted for platinum-cured silicone tubing, only 
0.5 % is acceptable for peroxide-cured tubing. Platinum-cured silicone polymer is produced in the 
presence of cyclic siloxanes as process aids. These volatile compounds are claimed to remain in the 
tubing with concentrations of 0.5 to 2 % (w/w), if post-curing is not performed. However, even 
before the simulated post-curing step mass loss for none of the tested samples was above 0.6 %. 
Mass losses were slightly reduced after post-curing, but tended to recover upon storage. 
Consequently, post-curing was not found to have a sustainable lasting effect on mass loss. Likewise, 
the claimed increase in mechanical strength after a post-curing step could not be confirmed. Post-
curing might affect physical properties only if applied directly after the tubing production process. An 
impact on particle shedding was not observed in our study, but post-curing indeed might improve 
tubing quality with regards to extractables and leachables. Particle shedding, however, seems to be 
predominantly influenced by the surface roughness of the tubing. 
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5 SUMMARY AND CONCLUSION 
Particle shedding from silicone tubing upon operation in a peristaltic pump during DP processing 
cannot be completely avoided but can be minimized. The amount of shed (nano)particles to be 
expected during production conditions was calculated to be below any detection limit. Nevertheless, 
when choosing tubing with low surface roughness values – as this parameter was found to correlate 
with particle shedding – particle shedding can further be minimized.  
The use of a new surface analytical technique like surface roughness measurements with 3D laser 
scanning microscopy can be employed to assess the particle shedding propensity of tubing types with 
otherwise comparable material characteristics. Pumping cycle experiments, e.g. with online-turbidity 
monitoring, can be a useful tool to directly evaluate particle shedding and to support evaluation of 
tubing for biopharmaceutical DP manufacturing. The possible impact of external particle 
contaminations from tubing shedding on protein stability in the final drug product is addressed in the 
next chapter. 
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6 ABBREVIATIONS 
 
CIP/SIP/DIP cleaning-in-place / sterilization-in-place / drying-in-place 
DKD  Deutscher Kalibrierdienst 
DLS  dynamic light scattering 
DP  drug product 
ECD  equivalent circular diameter 
ESD  equivalent spherical diameter 
FNU  Formazine nephelometric units 
ID  inner diameter 
JIS  Japan Industrial Standard 
λc  cutoff wavelength for high-pass filtering 
λs cutoff wavelength for low-pass filtering 
LO  light obscuration 
MFI  micro-flow imaging 
NMT  not more than 
NTA  nanparticle tracking analysis 
NTU  nephelometric turbidity unit 
PdI  polydispersity index 
Ra  arithmetic mean roughness 
rpm  revolutions per minute 
RSD  relative standard deviation 
RT  room temperature 
Rz  maximum height 
SD  standard deviation 
SEM  scanning electron microscopy 
TGA  thermogravimetric analysis 
WfI  water for injection 
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CHAPTER V 
 
INFLUENCE OF PARTICLE SHEDDING FROM 
SILICONE TUBING ON ANTIBODY STABILITY 
 
ABSTRACT 
Rotary piston pumps but also peristaltic pumps that are commonly employed during fill & finish 
operations of a biopharmaceutical drug may shed particles into the final product. It was the aim of 
this study to elucidate the potential influence of silicone particles shed from peristaltic pump tubing 
on the stability of a drug product. Therefore, two formulated antibodies were spiked with two 
realistic, but worst-case levels of particles and a 6-month accelerated stability study at 2-8°, 25°, and 
40°C was conducted. Both mAbs revealed instabilities in terms of protein aggregation and 
fragmentation in SEC analysis. These instabilities were independent of the presence and the amount 
of spiked-in particles. Monitoring of turbidity, subvisible, and visible particles did not uncover any 
additional mAb particle formation. An increase in MFI particle counts for one the mAb formulations 
containing shed particles could be attributed to the limited colloidal stability of shed particles in this 
composition as indicated by a similar increase in placebo. In conclusion, shed silicone particles from 
peristaltic pump tubing are assumed to not impair DP stability. 
 
 
 
 
 
 
 
 
 
 
 
The following chapter is intended for publication. 
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1 INTRODUCTION 
The use of peristaltic pumps in fill & finish operations of a biopharmaceutical drug product (DP) 
complies with the emerging disposables concept. Furthermore, this type of pump is often preferred 
over rotary piston pumps, especially for the filling of shear-sensitive therapeutic proteins [1]. It was 
shown that the formation of proteinaceous particles is enhanced in rotary piston pumps [2]. 
Additionally, rotary piston pumps may shed stainless-steel particles that also end up in the final 
product [3]. However, previous studies revealed that silicone tubing operated in a peristaltic pump 
may also lead to particle shedding, although to a rather limited extent [4]. 
Several studies indicate that (external) particle contamination might induce protein instability by 
acting as aggregation seed and / or adsorption interface [5]. Bee et al. [6] tested the influence of 
micro- and nanoparticles made from various potential processing materials like glass, iron(III)oxide, 
silica, alumina, titania, cellulose, and stainless steel on the aggregation behavior of a monoclonal 
antibody (IgG1) and found that the addition of stainless steel microparticles caused mAb aggregation. 
However, the number of spiked-in particles was about 106 times higher than expected for an actual 
product. Tyagi and coworkers [3] focused on the influence of stainless steel nanoparticles shed from 
rotary piston pumps on the stability of an IgG and propose that these particles serve as 
heterogeneous nuclei for the formation of protein microparticles. But not only pumps can be a 
source for shed particles. In a study by Liu et al. [7], filters were identified as processing units that 
can introduce foreign micro- and nanoparticles to a DP solution. Increased particle formation during 
agitation of keratinocyte growth factor 2 solutions after filtration with polyether sulfone membranes 
was observed. More often, the impact of silicone oil droplets on the stability of therapeutic proteins 
was investigated. Silicone oil droplets in a formulation can originate from siliconized stoppers or 
syringe barrels. In this context, Thirumangalathu et al. [8] conducted an “accelerated degradation” 
study by adding 1.5 % (w/V) silicone oil to a model antibody with subsequent isothermal storage. 
Only upon agitation with at least 350 rpm, mAb aggregation was observed. Aggregation could be 
completely inhibited by the presence of 0.1 % (w/V) polysorbate 20. Similarly, Jones et al. [9] 
observed silicone oil induced aggregation of four proteins with various molecular weights and 
isoelectric points in the presence of 0.5 % (w/V) silicone oil under gentle horizontal shaking in a 
multi-well plate. Distinct conformational changes or alterations in the thermal stability of the 
proteins were not detected. In contrast, Britt et al. [10] found a significantly perturbed tertiary 
structure for three model antibodies when adsorbed to silicone oil droplets. However, aggregation or 
precipitation of the antibodies was not observed. Correspondingly, Li et al. [11] did not see abatacept 
aggregation in the presence of silicone oil when stored at RT. Only at 40°C a slight increase in 
aggregate levels occurred, which could be prevented by adding polysorbate 80.  
Depending on the chosen experimental setup including storage mode (agitated, non-agitated), 
storage temperature, type of particles spiked-in as well as their spiking level and of course the 
chosen model protein, instabilities in the presence of added particles might occur. The possible 
influence of particles shed from silicone tubing during peristaltic pumping on the stability of two IgGs 
was assessed in this study. After particle preparation via placebo buffer recirculation, particles were 
characterized and spiked to the mAb formulations at worst-case, but realistic spiking levels. A 6-
months stability study with quiescent storage at 2-8°, 25°, and 40°C was conducted and protein 
aggregates, turbidity, as well as visible and subvisible particles were monitored. The mAb 
formulations used in this study were representative for standard protein formulations used in clinical 
trials and on the market, including stabilizers such as sugar and surfactants.  
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
Histidine, histidine-hydrochloride monohydrate as well as methionine were purchased from 
Ajinomoto (Louvain-la-Neuve, Belgium), sucrose and trehalose were from Ferro Pfanstiehl 
(Waukegan, IL, USA). Polysorbate 20 was obtained from Croda GmbH (Nettetal, Germany), 
Poloxamer 188 was received from BASF (Ludwigshafen, Germany). HP-SEC buffer compounds 
included KH2PO4 (Sigma-Aldrich, St. Louis, MO, USA), KH2PO4 and KCl (both from Acros Organics, 
Thermo Fisher Scientific, Geel, Belgium). 
2.1.2 Silicone Tubing 
The employed platinum-cured silicone tubing with an ID of 6.0 mm is commercially available (type A 
as described in previous chapters). Tubing sets were prepared and rinsed as described earlier [4] and 
subsequently autoclaved at 121°C and 2 bar for 15 minutes. 
2.1.3 Model Antibodies 
The monoclonal IgG1 antibody solutions mAb1 at 25 mg/mL and mAb2 at 150 mg/mL were filtered 
using 0.22 µm Sterivex™-GV filters in combination with a Sterivex™-HV 0.45 µm pre-filter unit 
(Millipore, Billerica, Massachusetts, USA) prior to use. mAb1 was formulated in 20 mM histidine 
buffer at pH 5.5 with 240 mM sucrose, 10 mM methionine, and 0.02 % PS 20. The mAb2 formulation 
contained 20 mM histidine buffer pH 5.5 with 200 mM trehalose and 0.04 % Poloxamer 188. Placebo 
buffers were prepared using deionised water and sterile filtrated using Stericups (0.22 µm PVDF, 
Millipore). 
2.1.4 Packaging Material 
Samples were stored in 6 mL colorless glass vials (Schott AG, Mainz, Germany). Filled vials were 
closed with teflon-coated serum stoppers (Daikyo Seiko, Ltd., Tokyo, Japan) and crimped using 
aluminum caps with PP-cap (Helvoet Pharma Deutschland GmbH, Karlsbad, Germany). 
2.2 Methods 
2.2.1 Preparation of Recirculates 
Recirculates containing particles shed from peristaltic silicone tubing were prepared as described 
earlier [4]. Autoclaved tubing sets were operated in a Flexicon PD 12 peristaltic pump. 100 mL of the 
respective placebo buffer were recirculated for 2 h in dispense mode (2800 fillings à 5 mL). Every 
aliquot of placebo buffer thus passed the pump 140 times (concentration factor = 2800·5 mL / 
100 mL = 140) and recirculates represent a 140x concentrated particle suspension in comparison to 
non-recirculating conditions during actual filling. 
2.2.2 Sample Preparation and Stability Study 
Sample preparation was performed under a laminar flow cabinet. Both mAbs were spiked with the 
corresponding recirculates at two spiking levels (140:1 and 280:1). The “high” spiking level of 140:1 
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represents a 1x concentrated particle suspension obtained by diluting the 140x concentrated 
recirculate. This particle level is expected for drug product units that are filled during the first hours 
of the filling cycle. An earlier study revealed a flattening of turbidity monitoring graphs with 
increasing recirculation time (after approx. 8 hours) indicating that with time of use less additional 
particles are worn away from the tubing [4]. Therefore, the “low” spiking level of 280:1 was chosen 
due to the reduced extent of particle shedding expected for these later time points during the filling 
process. The concentration of shed particles in the “high” spiking level samples was thus twice as 
high as for the “low” spiking level samples. Control solutions included antibody formulations spiked 
with placebo buffer (140:1, ‘IgG blank’) and placebos spiked with recirculate (140:1, ‘Particle blank’). 
All solutions were prepared in glass beakers and homogenized via gentle rotation for 30 seconds. 
Aliquots of 2.4 mL were filled into 6R glass vials using 25 mL Eppendorf biopur Combitips (Eppendorf 
AG, Hamburg, Germany) and stored upright at 2-8°C, 25°C, and 40°C for up to 6 months without 
applying agitation. 
2.2.3 Visual Inspection 
Visual inspection was carried out under a polarized light inspection device (Optima pharma GmbH, 
Schwäbisch Hall, Germany) as well as with the semi-automatic inspection device Seidenader V90-T 
(Seidenader Maschinenbau GmbH, Markt Schwaben, Germany) with automated container spin at 
20 % rotation speed.  
2.2.4 Turbidity 
Under a laminar flow cabinet, 2 mL sample aliquots were transferred into round glass cuvettes. 
Turbidity in FTU was measured using a HACH 2100AN turbidimeter (HACH LANGE GmbH, Düsseldorf, 
Germany). 
2.2.5 Subvisible Particle Analysis 
Subvisible particle analysis was performed via light obscuration (LO) with a HIAC/Royco Model 9703+ 
particle counter (Beckman Coulter Life Sciences, Brea, CA, USA). Particle counts for three aliquots of 
0.4 mL were determined. Results are given as average values from run two and three. 
Additionally, subvisible particles were characterized using micro-flow imaging (MFI) with a DPA4200 
Flow Microscope from Brightwell Technologies Inc. (Ottawa, Canada). Illumination optimization was 
performed with particle-free water or filtered mAb formulation (0.22 µm Millex®-GV, Millipore) in 
the case of particle blank samples or samples containing mAb, respectively. The purge volume was 
0.20 mL and the analyzed sample volume was set to 0.60 mL at a flow rate of 0.17 mL/min (set point 
3). Two vials per sample were pooled and analyzed in triplicates. Results are given as mean values 
with standard deviations. Only particles > 5 µm in size were considered for morphological evaluation. 
Performance of both instruments was checked with commercially available 5 µm particle size and 
count standards (Thermo Fisher Scientific Inc., Waltham, MA, USA) prior to every use. 
2.2.6 High Performance Size Exclusion Chromatography (HP-SEC) 
The relative amount of monomer, aggregates, and fragments was determined with HP-SEC with a 
TSKgel G3000SWXL column (Tosoh Bioscience GmbH, Stuttgart, Germany) operated in a Waters 2695 
Alliance Separations Module (Waters Corporation, Milford, MA, USA) with UV detection at 280 nm. 
Samples were diluted to a protein concentration of 10.0 mg/mL using the corresponding placebo 
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buffer. The mobile phase consisted of 200 mM potassium phosphate buffer pH 7.0 with 250 mM 
potassium chloride. Injection volume was 15 µL and flow rate was set to 0.5 mL/min. The 
autosampler was cooled to 5°C, whereas the column oven temperature was 25°C. 
2.2.7 Dynamic Light Scattering (DLS) 
Particle characterization in the nanometer range was performed by dynamic light scattering using 
the Ζetasizer Nano-ZS (Malvern Instruments Ltd., Herrenberg, Germany). The undiluted, neither 
filtered nor centrifuged samples were measured in disposable Plastibrand semi-micro PMMA 
cuvettes (Brand GmbH, Wertheim, Germany) at a backward scatter of 173° after 20 seconds 
equilibration time at 25°C and with water as dispersant (viscosity of 0.8872 mPa·s). Positioning, 
attenuation selection and measurement duration as well as number of sub runs for the three 
performed measurements per sample were optimized automatically for each run by the Ζetasizer 
Software 6.32. Z-average and polydispersity index (PdI) were calculated applying the ‘General 
purpose (normal resolution)’ analysis model.  
2.2.8 Nanoparticle Tracking Analysis (NTA) 
Nanoparticle tracking analysis was performed with a NanoSight LM20 system with a 488 nm laser 
and NS200 camera type using NTA software version 2.3 (NanoSight Ltd., Salisbury, UK). The 
measuring cell was cleaned with particle-free water (filtered through a 0.02 µm filter, Anotop 2, 
Whatman) and flushed with 1 mL of sample prior to analysis (n=3). Shutter (ca. 900 for formulation 1, 
ca. 500 for formulation 2) and gain (ca. 260 for formulation 1, ca. 330 for formulation 2) as well as 
focus were adjusted manually for each recirculate and the same settings were applied to the 
corresponding placebo blanks. Capture duration was set to 60 seconds and measurements were 
performed at RT. Analysis of undiluted samples was performed with background extraction, a 
minimum track length of 10 and an automatically set minimum expected particle size. Detection 
threshold was set to 10 and blur was chosen to be 5x5 after manual optimization. 
2.2.9 Leachable Analysis via GC-MS 
After stir bar sorptive extraction (“Twister”, Gerstel GmbH & Co. KG, Mülheim an der Ruhr, Germany) 
for 60 minutes at 800 rpm, leachables analysis after thermal desorption (Gerstel TDS 3) was carried 
out on an Agilent 6890 gas chromatograph equipped with a DB-1MS column (J&W Scientific, Folsom, 
CA, USA). An Agilent 5975 mass spectrometer was used as detector (Agilent Technologies GmbH, 
Boeblingen, Germany). For quantification purposes, the two reference substances tetrahydrofurfuryl 
methacrylate and di-pentyl-phthalate were used as internal standards. 
2.2.10 3D Laser Scanning Microscopy 
Surface roughness of inner tubing walls was visualized using the 3D laser scanning microscope 
Keyence VK-X210 with a CF Plan 20x objective (Keyence GmbH, Neu-Isenburg, Germany). With a 
scalpel, tubing pieces were cut into thin strips and placed under the microscope with horizontal flow 
direction. For every sample, micrographs were captured with VK Viewer software in ‘Easy Mode’ at 
eight different sections. All of the analyzed areas of used tubing had been located inside the pump 
head during the pumping cycle. The roughness parameters arithmetic mean roughness Ra and 
maximum height Rz were calculated according to the JIS standard B0601:2001 in the multi-line 
roughness mode with VK Analyzer Plus software version 3.3.0.0 from an average of 2xn+1 horizontal 
lines with n=30 and 10 skipped lines in-between. Tubing curvature was corrected via the ‘correct tilt 
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– sec curved surf. (auto)’ function. Cutoff values of λc  = 2.5 mm and λs = 8 µm were applied. 
Roughness values are stated as mean values (n=8) with standard deviations. 
3 RESULTS 
3.1 Recirculate Characterization 
3.1.1 Particle Characterization 
Using LO and MFI, the number of particles in the micrometer range of the recirculates was analyzed 
(Table V-30). The particle counts ≥ 2 µm obtained with LO were below 100 for both recirculates and 
blanks. For placebo 1 no significant increase in the number of micrometer-sized particles after 
recirculation was observed. A trend to a slight increase of the number of particles in the 2 to 10 µm 
range after recirculation could be identified for placebo 2. Clearly more particles could be identified 
with MFI. After recirculation, a ten- and fivefold increase in particle counts ≥ 1 µm was measured for 
placebo 1 and 2, respectively. The increase of the number of particles became less pronounced with 
larger size. MFI pictures did not reveal a well-defined morphology of the particles (Figure V-72). 
Rather blurry pictures were obtained due to the small size of the particles; a spherical and rather 
transparent morphology can be anticipated. 
Table V-30: Subvisible particle counts per mL of recirculates and corresponding blanks. 
Method Size range 
Placebo 1 Placebo 2 
Recirculate Blank Recirculate Blank 
LO (#/mL) ≥ 2 µm 82 ± 31 61 ± 68 55 ± 12 10 ± 11 
 ≥ 5 µm 14 ± 0 14 ± 18 9 ± 3 2 ± 2 
 ≥ 10 µm 3 ± 2 1 ± 2 0 ± 1 0 ± 1 
 ≥ 25 µm 0 ± 0 0 ± 0 0 ± 0 0 ± 1 
MFI (#/mL) ≥ 1 µm 2456 ± 672 243 ± 102 2751 ± 383 567 ± 132 
 ≥ 2 µm 484 ± 224 69 ± 27 297 ± 66 104 ± 12 
 ≥ 5 µm 93 ± 52 12 ± 6 30 ± 14 19 ± 7 
 ≥ 10 µm 23 ± 23 1 ± 1 4 ± 3 7 ± 2 
 ≥ 25 µm 3 ± 3 0 ± 0 0 ± 0 0 ± 0 
 
(a) (b) 
Figure V-72: Morphology of particles in recirculates of (a) placebo 1 and (b) placebo 2. Zoom: 700%. 
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Table V-31: Turbidity, DLS and NTA characteristics of recirculates and corresponding blanks. 
Method / Parameter 
Placebo 1 Placebo 2 
Recirculate Blank Recirculate Blank 
Turbidity (FNU) 1.13 ± 0.05 0.112 ± 0.038 0.631 ± 0.013 0.097 ± 0.007 
DLS Z-Average (nm) 302.2 ± 19.4 63.9 ± 84.3 245.0 ± 30.8 58.5 ± 54.3 
 PdI 0.563 ± 0.031 0.303 ± 0.102 0.645 ± 0.203 0.546 ± 0.310 
NTA Counts/mL 9.41 ± 0.37 E8 0.80 ± 0.06 E8 8.74 ± 0.27 E8 3.60 ± 0.06 E8 
 
Representative 
image from 
analyzed video 
    
 Mean (nm) 235 ± 5.2 134 ± 5.5 205 ± 6.3 135 ± 2.9 
 Mode (nm) 183 ± 9.0 114 ± 6.7 165 ± 9.4 117 ± 6.0 
 
(a) (b) 
(c) (d) 
Figure V-73: Particle size distributions of recirculates and corresponding blanks obtained with DLS (a+b) and 
NTA (c+d). 
Turbidity values as an indicator for the amount of shed particles after recirculation were increased by 
a factor of 10 and 6.5 for placebo 1 and 2, respectively (Table V-31). Evaluation of DLS data via Z-
average and PdI values added limited value to the characterization of the recirculates due to 
excipient peaks that were already present in the corresponding placebos [12,13]. From the size 
distribution graphs (Figure V-73a+b), the appearance of a distinct peak at around 300 to 500 nm 
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became obvious after recirculation. Likewise, NTA size distribution graphs revealed an increased peak 
at around 200 nm after recirculation (Figure V-73c+d) and also particle counts in the nanometer 
range were strongly increased in comparison to the particle counts for the placebo blanks (Table V-
31). Final NTA particle counts of both recirculates were comparable, however, the increase in particle 
counts in comparison to the blanks was more pronounced for placebo 1 (12-fold) than for placebo 2 
(2.4-fold). 
3.1.2 Leachables Analysis 
Since leachables also might have a negative effect on the stability of the two antibodies, the amount 
of possibly present leachables in the recirculates was measured using GC-MS. In both recirculates 
only one compound, namely 1,2-diacetin, was found at a concentration of 0.06 ppm, close to the 
reporting threshold of 0.05 ppm. At a leachable concentration of 0.05 ppm, the daily uptake would 
have to be more than 30 mL in order to exceed the maximally allowed default value of 1.5 µg per day 
(derived from the ICH M7 Guideline [14]). Due to the applied spiking procedure, the actual leachable 
level in the samples designed for stability testing was further reduced by a factor of 140 or even 280. 
3.1.3 Surface Roughness of Tubing 
Tubing surface roughness was evaluated as a proof for the ongoing shedding of particles from the 
inner tubing wall. After pumping, tubing morphology appeared smoother than initially and the 
roughness values Ra and Rz were decreased (Table V-32). 
Table V-32: Evaluation of surface roughness of used tubing sets before and after the pumping cycle. 
Parameter Initial After pumping of placebo 1 
After pumping of 
placebo 2 
Morphology 
   
Ra [µm] 3.88 ± 0.33 3.31 ± 0.44 3.36 ± 0.45 
Rz [µm] 28.3 ± 4.5 20.0 ± 3.0 19.1 ± 2.2 
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3.2 Stability Data 
The above described recirculates were spiked to the antibody formulations at two different levels. As 
control, the ‘IgG blank’ samples contained mAb solution spiked with placebo blank, whereas the 
‘Particle blank’ samples represented a 1:140 dilution of recirculates with the corresponding placebo 
blank. 
3.2.1 Monomer Content 
                mAb1             mAb2 
2-8° 
(a)  (b)  
25° 
(c)  (d)  
40° 
(e)  (f)  
Figure V-74: HP-SEC stability data on monomer (=main peak, including not separated LMW1 fraction in the 
case of mAb2), fragment (LMW=low molecular weight species) and aggregate (HMW=high molecular weight 
species) content of mAb1 and mAb2 samples stored at 2-8°, 25° and 40°C. 
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With both mAbs, the main peak area representing monomer markedly decreased over 28 weeks of 
storage at 40°C. Samples of mAb1 elicited only minor instability upon storage at 25°C, whereas at 2-
8°C storage the monomer content did not change. In contrast, mAb2 samples revealed distinct 
decreases in the monomer content already during storage at 2-8° and 25°C. The decrease in 
monomer content was comparable for all samples of each specific mAb and therefore independent 
of the presence and the amount of spiked-in particles. 
Representative SEC chromatograms are shown in Figure V-75. For mAb1, a small shoulder at the 
longer retention time flank of the main peak arose during storage at 25°C and also a second fragment 
peak at 20 minutes retention time evolved. Storage at 40°C led to significantly higher fragment 
peaks. The peak at 13.5 minutes arising from mAb aggregates was only slightly increased after 
storage at 40°C. The main peak content for mAb2 includes the signal from the first fragment peak as 
a shoulder of the monomer peak. Only after 28 weeks at 40°C, this first LMW fraction formed a 
discrete peak. Other than for mAb1, the aggregation peak of mAb2 at around 13 minutes retention 
time substantially increased during storage at 25° and 40°C.  
(a) (b)  
Figure V-75: Representative HP-SEC chromatograms for IgG blank samples of (a) mAb1 and (b) mAb2. 
Corresponding chromatograms for the two spiking levels „high“ and “low” were identical. 
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3.2.2 Turbidity Data  
Turbidity was monitored as an indicator for particle formation (Figure V-76). For mAb1 samples 
(25 mg/mL protein), all turbidity values were around 4 FTU. For the higher concentrated mAb2 
formulations (150 mg/mL) values of around 5 FTU were obtained. Only for mAb2 samples stored at 
40°C a slight tendency towards increasing turbidity values with increasing storage time might be 
anticipated. Turbidity of the ‘particle blank’ samples that did not contain any protein was below 
0.2 FTU in any case. 
 
                mAb1             mAb2 
2-8° 
(a)  (b)  
25° 
(c)  (d)  
40° 
(e)  (f)  
Figure V-76: Turbidity data obtained for mAb1 and mAb2 samples stored at 2-8°, 25° and 40°C. 
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3.2.3 Subvisible Particle Levels 
Particle counts ≥ 2 µm per mL obtained with light obscuration were below 1,000 for mAb1 samples 
and on average below 400 for mAb2 samples. Considering the overall variations in particle counts, 
particle counts were found to stay constant over the maximum storage time of 28 weeks (Table V-33 
and Table V-34 in the Appendix). Clear changes in the LO particle size distributions over storage time 
could not be identified (Figure V-77). 
(a)  (b)  
Figure V-77: Particle size distributions for (a) mAb1 and (b) mAb2 samples obtained with LO analysis. 
Interestingly, MFI analysis revealed a substantial increase in particle counts after 12 weeks storage at 
40°C for all mAb1 samples containing spiked-in silicone particles (Figure V-78a). The highest increase 
was recorded for the ‘Particle blank’ sample that did not contain any IgG. After 12 weeks storage at 
40°C, particle counts for the ‘Particle blank’ were around 25,000 particles/mL and remained at that 
level until the 28 weeks analysis time point. For comparison, analysis of mAb1 placebo after 
12 weeks storage at 40°C resulted in low particle counts ≥ 1 µm of 1252 ± 43 per mL. The MFI particle 
count increases thus have to be attributed to the silicone particles themselves. For all protein 
containing samples, particle counts after 28 weeks were slightly decreased in comparison to the 12 
weeks data. This might be a consequence of the suggested shift in the MFI particle size distribution 
towards larger particles (Figure V-78c).  
Particle counts of mAb2 samples (Figure V-78b) were around 2,000 particles/mL for the IgG blank, 
the particle blank and the “high” spiking level protein sample. The slightly higher particle counts of 
around 4,000 to 6,000 particles per mL for the “low” spiking level samples seem contradictory. In any 
case, MFI particle counts as well as particle size distributions (Figure V-78d) for mAb2 samples were 
comparable at all time points. The particle count for mAb2 placebo stored at 40°C for 12 weeks was 
250 ± 111 particles ≥ 1 µm/mL.  
Since in most cases more than 95 % of all particles detected during MFI analysis were in the range of 
1 to 5 µm, a representative morphological evaluation was hardly achievable. However, for mAb1 
samples containing spiked-in particles mostly spherical and transparent particles were found (Figure 
V-78e). The ‘IgG blank’ of mAb2 contained big and clearly identifiable protein aggregates (Figure V-
78f, upper row). In samples with spiked-in particles also a small fraction of spherical, transparent 
particles was found (Figure V-78f, lower row). 
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Figure V-78: MFI stability data for storage at 40°C. Particle counts, particle size distributions and 
representative MFI pictures (28w) for (a+c+e) mAb1 and (b+d+f) mAb2 samples. The zoom factor for the MFI 
pictures in (e) is 700% and 150% in (f). 
 
3.2.4 Visual Inspection 
All samples were found to be practically free of particles (0 to 4 particles per container) upon visual 
inspection with the polarized light inspection device (Optima lamp). From visual inspection with the 
Seidenader device it was concluded that the number of visible particles did not change over storage 
time and that all samples were essentially free of particles (Table V-35 in the Appendix). 
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4 DISCUSSION 
Peristaltic pumping of two different placebo formulations using silicone tubing resulted in shed 
particles of similar characteristics, which correspond to earlier data [4]. The obtained recirculates 
contained rather few particles in the lower micrometer range. Due to the low resolution of the MFI 
system in this size range, the possibility for a morphological particle evaluation was limited [15,16]. 
The predominantly shed particle fraction appeared at around 200 nm in DLS and NTA analysis. The 
200 nm signal of shed particles overlapped with contributions arising from sugar impurities [13]. 
Nonetheless, from the clearly increased 200 nm peak and higher NTA counts as well as turbidity 
values after recirculation, the generation of shed particles was proved. Likewise, the smoothening of 
the inner tubing surface after recirculation demonstrated the origin of these particles.  
The two spiking levels with 1:140 and 1:280 dilutions of the recirculates were chosen as realistic, but 
nevertheless worst-case scenarios since the employed tubing was found to shed particles to a 
relatively high extent (tubing A in reference [4]). The 1:140 dilution represented an extrapolation to 
realistic fill & finish conditions during which every aliquot of drug product passes the pump only 
once. The higher dilution of 1:280 should mimic situations encountered at later time points during 
filling since particle shedding was found to level off over time [4]. Moreover, it is judged 
representative for particle levels obtained with tubing that is less prone for particle shedding (e.g. 
tubing B in reference [4]). For the “high” spiking level, 16 particles ≥ 1 µm (MFI) and 6.2 x 106 
particles in the nanometer range (NTA) were added to every milliliter of mAb1 formulation. For 
mAb2, the number of added nanometer particles per mL was 3.7 x 106. This is rather an 
approximation due to the limited reliability of particle quantification with NTA [17].  
Not only added particulates can impair the stability and quality of a biopharmaceutical drug product, 
but also leachables can add to this effect [5,18–20]. Only one leachable slightly above the reporting 
threshold of 0.05 ppm was found in the prepared recirculates. Due to the applied spiking procedure, 
the found leachable was further diluted by the sample preparation. The non-hazardous substance 
1,2-diacetin is a glycerol diacetate ester and used as humectant or aroma carrier in the food industry 
[21]. Destabilizing effects arising from this compound were not expected. In general, the use of 
platinum-cured silicone tubing is expected to result in low extractable and leachable levels [22]. 
Nevertheless, Jiang et al. quantified the amount of extractables via total organic carbon (TOC) 
analysis for several disposable assembly components and ranked the TOC amount per extractable 
surface area highest for the tested platinum-cured silicone tubing [23]. The unique leachables profile 
of a specific type of silicone tubing can vary depending on the tubing pre-treatment, tubing lot, 
contact time and mode as well as formulation components [24–27].  
The two mAbs differed in stability, but the presence and the amount of spiked-in silicone particles 
did not affect mAb stability. For mAb1, which was formulated at 25 mg/mL in histidine buffer pH 5.5 
including sucrose, methionine, and polysorbate 20, a marked increase in low molecular weight 
species upon storage at 40°C was observed with SEC analysis. Fragmentation seems to be the main 
route of degradation for mAb1. The increase in aggregates was minimal. Turbidity (4 to 4.5 FTU), 
visible and subvisible particle counts ≥ 2 µm obtained with HIAC (around 500 particles/mL) of all 
mAb1 samples stayed constant at all storage temperatures and over the whole storage period of six 
months. The strong increase in MFI particle counts in samples containing shed silicone particles is 
attributed to the earlier described colloidal instability of these particles [4]. It is anticipated that the 
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colloidal instability of the nanometer-sized particles led to particle fusion. The presence of mAb1 
seemed to influence the colloidal stability since particle count increases were less for the mAb 
containing samples than for the ‘Particle blank’ despite the initially same particle burden. The “low” 
spiking level samples contained less shed particles and therefore showed a less pronounced increase 
in particle counts. Ludwig et al. also describe possible effects of their model protein lysozyme on the 
kinetic stability of silicone oil emulsions finally leading to flocculation [28]. In our case, the formation 
of micrometer-sized particles was reduced instead of increased in the presence of protein. The 
morphology of these micrometer-sized particles resembled at particles found in the recirculates and 
thus supports the particle fusion hypothesis. Intrinsic buffer instabilities as root cause could be ruled 
out since placebo controls did not show any increase in MFI particle counts after 12 weeks storage at 
40°C. No further increase in particle counts between 12 and 28 weeks storage was observed. Most 
likely due to their high transparency, the formed particles were not detectable with LO [29,30]. It is 
commonly known that MFI is more sensitive and typically detects up to 3 to 10 times more particles 
than LO [31,32]. 
For the highly-concentrated mAb2 samples, a strong tendency towards aggregation was observed in 
SEC, but also fragmentation occurred upon storage at 40°C. Although the trend towards increased 
turbidity of samples stored at higher temperature was only minor and should not be overestimated, 
this observation might be traced back to aggregate formation. In any case, turbidity of all mAb2 
samples was below 6 FTU and therefore below the turbidity value for the slightly opalescent 
reference suspension II as stated by the European Pharmacopeia [33]. With MFI, protein aggregates 
could be identified in mAb2 containing samples. Surprisingly, the number of these micrometer-sized 
particles remained constant over storage time. Protein aggregation does not necessarily lead to an 
increase in subvisible particle counts. Depending on the protein and its aggregation mechanism as 
well as the applied stress, aggregation might rest at the HMW species level in SEC or proceed from a 
state with soluble oligomers towards bigger, insoluble aggregates that can be detected as 
particulates [34,35]. There are other cases, however, in which subvisible particles were detected as 
early signs for protein aggregation before any changes in SEC became measureable [36]. An increase 
in particle counts was not observed in the ‘particle blank’ samples either. This might point to a higher 
colloidal stability of the shed silicone particles in the mAb2 formulation buffer. In general, 
formulations with high protein concentrations as in the case of mAb2 are considered to show 
pronounced aggregation even during quiescent storage [37–39]. In any case, the addition of particles 
shed from silicone tubing during peristaltic pumping did not accelerate or alter the aggregation 
behavior of mAb2. 
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5 SUMMARY AND CONCLUSION 
In the present study, two model IgG antibodies were spiked with particles shed from silicone tubing 
during peristaltic pumping. Two realistic particle levels were chosen that actually might be 
encountered in the final DP after fill & finish. In accordance with previous studies, shedding mainly 
resulted in particles of around 200 nm in size with a minor particle fraction in the lower micrometer 
range. During the course of the conducted stability study, both mAbs revealed distinct instabilities in 
terms of protein aggregation and fragmentation in SEC analysis, especially upon storage at 40°C. 
However, these instabilities were independent of the presence and the amount of spiked-in particles. 
The turbidity values as well as the number of subvisible (LO) and visible particles did not change over 
time. For mAb1, an increase in MFI particle counts was observed for all samples containing shed 
silicone particles due to their limited colloidal stability in this formulation. In conclusion, DP 
manufacturers should be aware of the fact that particles shed from silicone tubing can end up in the 
final product when filled with a peristaltic pump, although they are not detectable with standard 
release testing methods like LO. Our results indicate that the expected particle burden is very low 
and does not negatively influence mAb stability. With the presented particle preparation and spiking 
approach, the susceptibility of other biopharmaceuticals for destabilization by shed silicone particles 
can be assessed on a case-by-case study. 
 
 
 
 
 
 
6 ABBREVIATIONS 
DLS  dynamic light scattering 
DP  drug product 
FTU  formazin turbidity unit 
HMW  high molecular weight species 
HP-SEC  high-performance size exclusion chromatography 
IgG  immunoglobuline G 
LMW  low molecular weight species 
LO  light obscuration 
mAb  monoclonal antibody 
MFI  micro-flow imaging 
NTA  nanoparticle tracking analysis 
ppm  parts per million 
Ra  arithmetic mean roughness 
rpm  revolutions per minute 
Rz  maximum height 
w  weeks 
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8 APPENDIX 
 
Table V-33: Particle counts (LO) for mAb1 samples over storage time. 
T 
[°C] Sample 
Storage 
Time 
Particle counts / mL 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm 
- 
IgG blank 
initial 
338 93 15 0 
Particle blank 428 38 9 0 
Spiking “high” 218 55 19 0 
Spiking “Low” 403 94 13 0 
2-8 
IgG blank 
4w 485 113 23 0 
12w 106 26 9 0 
28w 641 118 10 0 
Particle blank 
4w 381 29 3 0 
12w 795 61 5 0 
28w 533 20 1 0 
Spiking “high” 
4w 466 36 4 0 
12w 630 58 8 1 
28w 819 152 14 0 
Spiking “low” 
4w 346 28 4 0 
12w 835 115 14 0 
28w 711 161 31 1 
25 
IgG blank 
2w 303 48 9 1 
4w 539 104 18 0 
12w 320 59 14 0 
28w 373 66 14 0 
Particle blank 
2w 334 16 0 0 
4w 185 23 1 0 
12w 489 53 5 0 
28w 524 10 0 0 
Spiking “high” 
2w 214 38 5 0 
4w 541 86 8 0 
12w 479 59 5 0 
28w 533 49 3 0 
Spiking “low” 
2w 318 51 5 1 
4w 358 61 8 0 
12w 478 65 9 0 
28w 450 74 14 0 
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40 
IgG blank 
1w 304 43 9 1 
2w 180 36 6 0 
4w 446 129 31 0 
12w 471 116 20 0 
28w 491 155 51 3 
Particle blank 
1w 1035 44 9 1 
2w 294 26 8 1 
4w 165 15 0 0 
12w 721 23 0 0 
28w 850 33 5 0 
Spiking “high” 
1w 571 55 6 1 
2w 374 35 5 1 
4w 333 41 4 0 
12w 431 64 6 0 
28w 813 118 18 0 
Spiking “low” 
1w 388 45 5 0 
2w 415 80 13 0 
4w 501 81 5 0 
12w 514 86 13 0 
28w 664 135 43 1 
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Table V-34: Particle counts (LO) for mAb2 samples over storage time. 
T 
[°C] Sample 
Storage 
Time 
Particle counts / mL 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm 
- 
IgG blank 
initial 
231 40 19 1 
Particle blank 55 9 3 0 
Spiking “high” 70 15 8 0 
Spiking “Low” 110 13 6 0 
2-8 
IgG blank 
4w 50 5 1 0 
12w 48 13 4 0 
28w 76 20 8 0 
Particle blank 
4w 51 9 1 0 
12w 55 10 3 0 
28w 55 5 1 0 
Spiking “high” 
4w 33 13 0 0 
12w 45 26 9 0 
28w 95 29 6 0 
Spiking “low” 
4w 190 16 1 0 
12w 201 40 8 0 
28w 184 23 11 1 
25 
IgG blank 
2w 156 24 4 3 
4w 134 11 3 0 
12w 151 23 8 1 
28w 69 9 3 0 
Particle blank 
2w 49 11 0 0 
4w 54 14 1 0 
12w 66 15 3 0 
28w 35 6 1 0 
Spiking “high” 
2w 186 35 1 0 
4w 175 34 3 0 
12w 109 26 1 0 
28w 255 58 6 0 
Spiking “low” 
2w 166 33 8 0 
4w 248 11 0 0 
12w 306 44 14 0 
28w 61 10 4 0 
40 IgG blank 
1w 101 26 3 0 
2w 199 46 9 1 
4w 266 44 10 1 
12w 564 105 33 1 
28w 121 21 9 3 
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Particle blank 
1w 93 19 3 0 
2w 64 11 3 0 
4w 54 9 0 0 
12w 89 16 0 0 
28w 70 6 0 0 
Spiking “high” 
1w 90 40 6 0 
2w 145 38 10 0 
4w 90 9 0 0 
12w 296 76 15 0 
28w 214 66 10 0 
Spiking “low” 
1w 270 23 3 0 
2w 184 45 11 0 
4w 75 13 0 0 
12w 1088 68 11 0 
28w 355 31 3 0 
 
 
 
 
 
Table V-35: Particle counts obtained via visual inspection with the Seidenader device. 
Formulation Sample Initial 
2-8°C 25°C 40°C 
12w 28w 12w 28w 12w 28w 
mAb1 IgG blank 1-5 > 10 1-5 1-5 1-5 1-5 1-5 
 Particle blank 0 > 10 0 0 0 0 1-5 
 Spiking „high“ 1-5 1-5 1-5 0 1-5 0 1-5 
 Spiking „low“ 1-5 1-5 1-5 0 0 1-5 0 
mAb2 IgG blank 1-5 0 1-5 0 0 0 1-5 
 Particle blank 1-5 1-5 1-5 0 1-5 1-5 1-5 
 Spiking „high“ 0 0 0 0 0 0 0 
 Spiking „low“ 0 0 1-5 0 0 0 1-5 
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CHAPTER VI 
 
PRESERVATIVE LOSS FROM SILICONE TUBING 
DURING FILL & FINISH 
 
ABSTRACT 
The high permeability of silicone tubing for gases and volatile substances is widely known and 
described in literature in the context of preservative losses during filling line down times. This study 
focuses on the three most commonly used preservatives in protein drugs, benzyl alcohol, phenol, 
and m-cresol. Concentration losses during static incubation were quantified and interpreted with 
regards to the potential driving forces for the underlying sorption, diffusion, and desorption steps. 
Partitioning from the solution into the silicone polymer was identified as the most decisive 
parameter for the extent of preservative loss. Additionally, the influence of tubing inner diameter, 
starting concentration as well as silicone tubing type was evaluated. Theoretical calculations 
assuming equilibrium between solution and tubing inner surface and one-directional diffusion 
following Fick’s first law were used to approximate experimental data. Since significant losses were 
found already after few minutes, adequate measures must be taken to avoid out of specification 
(OOS) deviations during filling of preservative-containing protein solutions. 
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1 INTRODUCTION 
Silicone tubing is commonly used for fill & finish processes with a peristaltic pump due to its 
advantageous mechanical properties. However, silicone rubber is highly permeable for gases and 
other volatile molecules [1]. As shown by Bahal and Romansky, this characteristic needs to be 
considered during filling of preservative-containing solutions [2,3]. In their studies, different types of 
tubing and preservatives were tested and the concentration decrease of preservative solutions was 
highest when incubated in silicone tubing. Within 24 hours, propylparaben concentrations were 
reduced by 100% and methylparaben solutions showed losses of around 40% [2]. Similar losses of 30 
to 40% were also found for benzoic and sorbic acid as well as for benzyl alcohol. However, sorption 
did not occur with the ionic substance benzalkonium chloride [3].  
Preservatives are used in multi-dose formulations in order to ensure microbial stability. From the 
numbers presented in Table VI-36 it becomes clear that the overall use of preservatives diminished 
over the last decades. For protein-based drugs, the most often employed preservatives include 
benzylalcohol, phenol, and m-cresol. Thiomersal and chlorobutanol can also be found in peptide or 
protein formulations, but less frequently. Examples for preservative-containing protein drug 
formulations are Pegasys® from Roche and Sandostatin® from Novartis [4]. 
Table VI-36: Number and type of marketed parenteral products containing preservatives, adapted from 
Meyer et al. 2007 [4]. 
Preservative 
Product Type  Frequency of Use 
Peptide/Protein Vaccines Small Molecule  1996 2001 2006 
Chlorobutanol x - x  17 13 3 
Methylparaben - - x  50 40 9 
Propylparaben - - x  40 33 9 
Benzyl alcohol x - x  74 69 19 
Phenol x x x  48 30 15 
Thiomersal x x -  46 20 6 
m-Cresol x - -  3 7 11 
Phenoxyethanol - x -  3 4 5 
 
A suitable preservative needs to be chosen carefully during formulation development, since a 
potential effect of the preservative on protein stability cannot be excluded. In this context, Alford et 
al. [5] as well as Zhang and co-workers [6] studied the interactions between benzyl alcohol and 
recombinant human interleukin-1 receptor antagonist. Hutchings et al. [7] found that m-cresol, 
phenol, benzyl alcohol, phenoxyethanol, as well as chlorobutanol can induce protein aggregation by 
enhancing partial protein unfolding. In contrast, a positive effect of phenolic preservatives on the 
self-assembly and thus stability of some insulin analogs was reported [8]. 
In this study, the three most relevant preservatives for protein formulations, namely benzyl alcohol, 
phenol, and m-cresol were investigated for their sorption behavior in silicone tubing with two 
different inner diameters (ID). Previous, unpublished results showed that preservative losses were 
independent of the presence of a protein drug. Hence, preservative formulations in a placebo buffer 
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only were employed for this study. With this approach, simple UV measurements could be 
performed for preservative quantification without any need for further chromatographic separation 
steps. Formulation parameters like concentration and pH were chosen according to Table VI-37. 
Since preservative losses are expected to be especially critical during filling line down times, static 
incubation experiments were performed. It is the aim of this study to quantify losses and also 
generate a deeper understanding of the underlying mechanism and influencing factors. Therefore, 
not only the known molecular characteristics of Table VI-37 were used for the interpretation of the 
obtained data. The three preservatives were additionally characterized for their partitioning, 
diffusion, and evaporation behavior in conjunction with the silicone polymer matrix and a 
mathematical model was established. 
Table VI-37: Molecular structure and properties of the three investigated preservatives. MW: molecular 
weight, logPow: Octanol-water partition coefficient. Typical values for formulation concentration and pH are 
taken from [4]. 
Preservative Structure MW [g/mol] logPow 
Typical 
concentration 
pH 
optimum 
Benzyl alcohol 
 
108.14 1.1 [9] 1 % < 5 
Phenol 
 
94.11 1.46 [10] 0.25 – 5 % < 9 
m-Cresol 
 
108.14 1.96 [11] 0.3 % < 9 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
M-Cresol and benzyl alcohol were purchased from Merck KGaA (Darmstadt, Germany), phenol was 
obtained from AppliChem (Darmstadt, Germany). NaCl, Na2HPO4, and NaH2PO4 were supplied by 
VWR International (Darmstadt, Germany). NaOH (1 M) and HCl (1 M) were obtained from Sigma-
Aldrich (Taufkirchen, Germany). Highly purified water used for buffer preparation was taken from an 
arium® pro DI Ultrapure Water System (Sartoris Stedim Biotech GmbH, Goettingen, Germany) or a 
USF ELGA PURELAB Plus UV/UF purification system (ELGA LabWater, Celle, Germany). Buffer 
filtration was performed with pressurized nitrogen and 0.2 μm cellulose acetate filters (47 mm ø, 
Sartorius Stedim Biotech GmbH). 
2.1.2 Silicone Tubing 
The two employed platinum-cured silicone tubing types from different manufacturers (type A and B) 
with an ID of 6.0 mm and 1.6 mm were purchased from Watson-Marlow / Flexicon (Ringsted, 
Denmark). Wall thicknesses were 2.1 mm and 1.6 mm, respectively. 
2.2 Methods 
2.2.1 Sample Preparation 
The three preservatives were dissolved in 10 mM phosphate buffer containing 145 mM NaCl at the 
pH and concentration stated in Table VI-38.  
Table VI-38: Stock solution formulation and analysis parameters. 
Preservative Concentration pH Sampling volume  
Dilution for 
analysis λmax 
Benzyl alcohol 10 mg/mL (= 1 %) 5 200 µL 1:5 258 nm 
Phenol 5.5 mg/mL (= 0.55 %) 7 50 µL 1:20 270 nm 
m-Cresol 3.15 mg/mL (= 0.315 %) 7 100 µL 1:10 272 nm 
 
2.2.2 Sorption Experiments 
40 cm long pieces of tubing with an ID of 6.0 mm were filled with 10 mL of preservative solution 
(n=3). For tubing with an ID of 1.6 mm, three 20 cm long pieces per analysis time point were filled 
with 300 µL. Ends were clamped and the tubing pieces were incubated at RT for 5, 10, 15, 30, 60, 
120, 240, and 360 minutes. For the 6.0 mm ID tubing, samples were withdrawn from the filled tube 
at every analysis time point. The exact volume of the sampling aliquots is given in Table VI-38. 
1.6 mm tubing pieces were completely emptied for sampling. Sample aliquots were diluted (Table VI-
38) and stored in 2R glass vials (Schott AG, Mainz, Germany) prior to analysis. For phenol and m-
cresol samples that were incubated in 1.6 mm tubing for 4 and 6 hours, the dilution factor was 
reduced to 1:5. 
CHAPTER VI  
 
158 
2.2.3 UV Absorption Measurements 
200 µL of each diluted sample as well as of each standard concentration (Appendix, Table VI-43) and 
the corresponding blank buffer were analyzed in triplicates in a 96-well quartz well plate (Hellma 
Analytics, Müllheim, Germany) for UV absorption with a FLUOstar Omega well-plate reader and 
Omega software version 1.01 (BMG Labtech GmbH, Ortenberg, Germany). A positioning delay of 
0.5 seconds and analysis with 20 flashes per well in ‘Absorbance endpoint’ mode was applied. 
Absorption maxima as stated in Table VI-38 were determined from UV absorption scans in the range 
of 220 to 350 nm. Linear regression fit with the ‘average data based on blank corrected’ raw data 
was performed within the MARS Data Analysis Software version 1.01 (BMG Labtech). 
2.2.4 Determination of the Partition Coefficient k 
Approx. 600 mg of cut silicone tubing pieces were incubated with 2.0 mL of preservative solution in 
stoppered 10R glass vials (Schott AG, Mainz, Germany). Solutions with concentrations of 1, 2, 4, 6, 8, 
and 10 mg/mL preservative were employed (n=3). For every concentration, a blank glass vial 
containing preservative solution without any added silicone tubing pieces was prepared. After 
overnight equilibration, preservative concentrations of the incubation and blank solutions were 
determined after dilution. From the concentration difference between the blank and the incubation 
solutions, the sorbed amount of preservative per unit volume of silicone tubing was calculated 
assuming a specific gravity for silicone tubing of 1.1 as stated by the manufacturer. Preservative 
concentrations in the silicone were plotted against preservative concentrations in solution. Linear 
regression analysis (no error weighting, y-intercept of 0) was performed in Origin 8G (OriginLab 
Corporation, Northampton, MA, USA). The obtained slope represents the partitioning coefficient k. 
2.2.5 Determination of the Diffusivity D 
Permeation tests with jacketed Franz-type diffusion cells (diameter of 15 mm, volume of 12 mL, 
Gauer Glas, Püttlingen, Germany) were conducted at 26°C. A cut-open silicone tubing piece (6.0 mm 
ID, length of 2.5 cm, thickness d of 2.1 mm) was used as membrane. 2.0 mL of a saturated 
preservative solution (BA: 40 mg/mL, phenol: 80 mg/mL, m-cresol: 20 mg/mL) were employed as 
donor medium. The exact volume of the corresponding blank buffer in the acceptor compartment 
was subject to minor variations in the Franz cell geometry and was therefore determined separately 
for each diffusion cell. Sampling was performed every 15 minutes for up to 4 hours. Using a Hamilton 
Gastight 1000 µL syringe with 8 cm long stainless steel cannula (Hamilton Company, Bonaduz, 
Switzerland), approx. 250 µL were withdrawn from the middle of the acceptor compartment. The 
sampling volume was subsequently replaced by blank buffer. Preservative concentration of the 
undiluted samples was measured as described above. For every preservative, two sets of 
experiments with 5 Franz-type diffusion cells each were performed. A plot of absorbance mean value 
versus time was generated and linear regression analysis (no error weighting) for data points 
between 90 and 240 minutes incubation time was performed in Origin 8G. The x-intercept was 
calculated and introduced into the following formula as lag time t: 
? = ?
?
6 × ? 
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2.2.6 Determination of the Evaporation Characteristics 
2 cm long, cut-open and weighted tubing pieces were incubated overnight in stoppered 10R glass 
vials filled with 8 mL of saturated preservative solution (see section 2.2.5). After removal from the 
incubation solution, the tubing piece was dried from the outside with filtered, pressurized air and 
placed on a Mettler Toledo AX205 balance (Mettler Toledo, Greifensee, Switzerland). Mass loss over 
time was automatically monitored via the BalanceLink Software version 3.01. Data acquisition was 
performed every 60 seconds. Data plots show the ratio of actual mass to tubing piece mass (M∞). 
2.2.7 Modelling of Data with Fick’s Law of Diffusion 
Fick’s first law of diffusion describes the amount of substance per unit area and time that diffuses 
from regions of high concentrations to regions of low concentrations assuming a steady state [12]: 
? = 	−? ??−???  
J: Flux [g/(m2·s)] 
D: Diffusivity [m2/s], experimentally determined 
c1: concentration of permeant in the medium surrounding the tubing [mg/cm3] 
c2: concentration of permeant in the tubing lumen [mg/cm3] 
d: distance [m], in this case tubing wall thickness (2.1x10-3 m for tubing ID of 6.0 mm) 
Diffusion was presumed to occur in direction of the concentration gradient across the tubing wall 
only. The concentration c1 on the outside of the tubing wall was set to zero since the lab and 
production environment shows high air exchange rates and can be considered a reservoir of infinite 
volume (=sink conditions). The concentration on the inside of the tubing wall c2 was calculated as 
follows: 
?? = ? × ?????? 
with k being the experimentally determined partition coefficient for the silicone polymer – water 
system and clumen being the measured preservative concentration inside the tubing lumen. 
Theoretical mass loss from one time point tn to the next time point tn+1 arising from diffusion through 
the tubing wall was calculated with the following equation: 
∆?? = ?? × (???? − ??) × ? 
whereas A is the contact area per mL of solution. Based on the inner radius of the tubing lumen of 
r = 3 mm, A is given by the following term: 
? = 2??ℎ 
ℎ = 1	?????  
In total, the theoretical concentration expected for the next analysis time point tn+1 by assuming 
losses due to unhindered steady-state diffusion only is:  
???? = ?? −
∆??
1	?? 
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3 RESULTS 
3.1 Preservative Loss during Static Incubation in Silicone Tubing 
Preservative loss inside the silicone tubing lumen was substantial already during the first minutes of 
the experiments (Figure VI-79). After five minutes incubation time in tubing with an ID of 6.0 mm, 
preservative contents were reduced by approx. 3 % in the case of benzyl alcohol and phenol and by 
10 % in the case of m-cresol. For tubing with the smaller ID of 1.6 mm, 20 to 40 % preservative were 
lost within the first five minutes. Over time, preservative losses levelled off. For the 1.6 mm ID 
tubing, the preservative contents approached zero after six hours. In 6.0 mm ID tubing, the 
preservative contents remaining after six hours were around 63 % for benzyl alcohol (BA), 53 % for 
phenol, and 34 % for m-cresol. The same rank order for preservative loss was observed in 
experiments with 1.6 mm ID tubing. Despite initially overlapping curves, finally less phenol was 
present than BA. There was no difference in the behavior of the silicone tubings from two different 
manufacturers. 
(a)  (b)  
Figure VI-79: Preservative losses in silicone tubing (type A and B) with an ID of (a) 6.0 mm and (b) 1.6 mm. 
 
3.2 Influence of Preservative Concentration 
In the previous paragraph, relative preservative losses were compared at different starting 
concentrations of the preservatives which reflect relevant formulation compositions. In the 
following, the influence of the starting concentration on the relative loss was investigated for benzyl 
alcohol and m-cresol at 5.5 mg/mL. For both investigated tubing sizes, relative preservative losses 
were independent of the actual starting concentration (Figure VI-80). At 5.5 mg/mL, the initial steep 
slope relates to absolute m-cresol losses of 0.10 and 0.41 mg/mL per minute for an ID of 6.0 and 
1.6 mm, respectively (Figure VI-81). For benzyl alcohol and phenol, the initial loss rate was 0.03 and 
0.2 mg·mL-1·min-1, respectively. Towards the end of the 6 h incubation period, loss rates decreased to 
0.001-0.004 mg·mL-1·min-1 in all cases. 
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(a)  (b)  
Figure VI-80: Relative preservative loss in tubing A for two differently concentrated incubation solutions of 
(a) benzyl alcohol and (b) m-cresol. 
(a) (b) 
Figure VI-81: Absolute preservative loss over incubation time in silicone tubing B with an ID of (a) 6.0 mm 
and (b) 1.6 mm. The dotted line represents the maximum loss reflecting starting concentration of 5.5 mg/mL. 
 
3.3 Determination of the Partition Coefficient k 
The affinity of the three preservatives for migration into the tubing material was characterized by 
plotting the preservative concentration in the tubing material against the preservative concentration 
(w/V) in the supernatant (Figure VI-82). The slope of the linear fit reflects the partition coefficient k. 
The coefficient of determination was above 0.98 for all three data sets. For better comparison with 
literature, the logP was calculated (Table VI-39). The rank order of the partition coefficients was 
k(m-cresol) >> k(benzyl alcohol) > k(phenol). This indicates that the solubility of m-cresol in the 
silicone matrix was much higher than for the other two preservatives. 
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(c)  
Figure VI-82: Amount of preservative inside the tubing versus the amount of preservative remaining in 
solution at equilibrium for (a) benzyl alcohol, (b) phenol, and (c) m-cresol. Linear regression analysis was 
performed for the determination of the partition coefficient (Table VI-39). 
Table VI-39: Partition coefficients obtained via linear regression analysis as shown in Figure VI-82. 
Parameter Benzyl alcohol Phenol m-Cresol 
Slope / partition coefficient k 0.44 0.27 0.83 
R2 0.987 0.994 0.998 
Calculated logP (silicone/water) -0.35 -0.57 -0.08 
 
3.4 Determination of the Diffusivity D 
The diffusivity of the three preservatives in the silicone tubing material was determined with a typical 
Franz cell setup. After a lag time of around 50 minutes, the absorbance and thus the amount of 
preservative in the acceptor compartment increased linearly (Figure VI-83). From extrapolation of 
this linear section to the x-intercept, the lag time t was determined and converted into diffusivity 
values (Table VI-40). Benzyl alcohol and m-cresol revealed comparable lag times of around 54 and 56 
minutes and thus similar diffusivity values of 2.3x10-10 and 2.2x10-10 m2/s, respectively. Both 
molecules have an identical molecular weight of 108.14 g/mol. The diffusivity of the smaller molecule 
phenol was calculated to be 3.0x10-10 m2/s and thus approx. 30% higher. 
PRESERVATIVE LOSS FROM SILICONE TUBING DURING FILL & FINISH 
 
163 
0 50 100 150 200 250
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
 experimental data
 Linear fit
co
rr
e
ct
e
d 
a
bs
o
rb
a
n
ce
time [min]
Phenol
0 50 100 150 200 250
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
co
rr
e
ct
e
d 
a
bs
o
rb
a
n
ce
time [min]
 experimental data
 Linear fit
m-Cresol
0 50 100 150 200 250
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
co
rr
e
ct
e
d 
a
bs
o
rb
a
n
ce
time [min]
 experimental data
 Linear fit
Benzyl alcohol
(a)  (b)  
(c)  
Figure VI-83: Plots of absorbance in the acceptor compartment (corrected for dilution effects during 
sampling) versus time for (a) benzyl alcohol, (b) phenol, and (c) m-cresol. Extrapolation of the linear part was 
performed for the determination of lag times t (Table VI-40). 
Table VI-40: Lag time t obtained from linear extrapolation of the graphs shown in Figure VI-83 to the x-axis 
and the corresponding diffusivity values. 
Parameter Benzyl alcohol Phenol m-Cresol 
Lag time t [min] 54.0 40.4 56.4 
Diffusivity D [m2/s] 2.3E-10 3.0E-10 2.2E-10 
 
3.5 Determination of the Evaporation Characteristics 
The propensity of each preservative for evaporation from the tubing surface was characterized by 
monitoring the time-dependent mass reduction of tubing pieces that were pre-incubated with 
preservative (Figure VI-84). Incubation in pure water did not lead to any measureable mass uptake. 
Swelling of the tubing material in water could thus be excluded. The mass uptake was highest for 
phenol, which was simply due to the higher saturation concentration of phenol that was chosen as 
incubation concentration. Next to the exact concentration of the incubation solution, also the 
partition coefficient is decisive for the absolute mass update. The evaporation characteristics are 
reflected by the rate of the mass decrease. As a numerical measure, the evaporation half-value time 
was calculated. This value was lowest for phenol with 186 minutes (mean value from n=2), indicating 
the highest evaporation rate. For benzyl alcohol and m-cresol significantly higher t1/2 evaporation 
values of 296 and 377 minutes, respectively, were obtained. 
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Figure VI-84: Mass loss over time of silicone tubing pieces soaked with preservative (n=2). As a control, 
silicone tubing was incubated in pure water. 
 
3.6 Modelling of Data with Fick’s Law of Diffusion 
Fick’s first law of diffusion is only applicable to steady state problems and thus not valid for the entire 
process of preservative loss. In consequence, Fick’s equation was used to calculate the flux J through 
the silicone tubing wall (ID of 6.0 mm) at each specific analysis time point (Table VI-41). This 
computation is based on the experimental data for comparable starting concentrations of 
5.5 mg/mL. The initial flux was found to be highest for m-cresol. Initial flux values for phenol were 
lowest, but close to those for benzyl alcohol. The flux decreases over time as the concentration 
gradient diminishes. This decrease in flux rate was most pronounced for m-cresol. Flux values after 
an incubation time of 6 h were in a similar range for all three preservatives. For tubing with an ID of 
1.6 mm, flux rates for the starting concentration of 5.5 mg/mL were 1.3 times higher than for tubing 
with an ID of 6.0 mm due to the reduced wall thickness of 1.6 mm (Appendix, Table VI-44). 
With these flux values, the remaining amount of preservative inside the tubing lumen was estimated 
for the next analysis time point. A comparison between the experimental data and the theoretically 
determined concentrations for clumen is shown in Figure VI-85. During the first hour of the experiment, 
experimental values were typically lower than theoretical ones. At some point, the theoretical 
estimation closely matched the experimental data. This was the case at analysis time point t = 60 min 
for benzyl alcohol, and t = 120 min for phenol and m-cresol. In the following, the theoretical values 
underestimated actually measured concentrations significantly. Modeled data for 1.6 mm ID tubing 
matched experimental values at earlier time points and the divergence at later time points was more 
pronounced (Appendix, Figure VI-88). 
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Table VI-41: Calculation of c2 [mg/mL] and J [g/(m2·s)] for each analysis time point and a tubing ID of 6.0 mm, 
based on measured preservative concentrations inside the tubing. Experimentally determined partition 
coefficients k and diffusivities D as presented above were used for the computations. The starting 
concentration inside the tubing lumen was 5.5 mg/mL for all preservatives. 
Analysis time point 
[min] 
Benzyl alcohol Phenol m-Cresol 
c2 J c2 J c2 J 
0 2.47 0.26 1.48 0.21 4.55 0.50 
5 2.41 0.25 1.44 0.21 4.14 0.45 
10 2.35 0.25 1.40 0.20 3.81 0.42 
15 2.31 0.24 1.38 0.20 3.71 0.41 
30 2.21 0.23 1.31 0.19 3.25 0.36 
60 2.09 0.22 1.21 0.17 2.72 0.30 
120 1.91 0.20 1.08 0.15 2.20 0.24 
240 1.72 0.18 0.92 0.13 1.66 0.18 
360 1.60 0.17 0.80 0.11 1.36 0.15 
 
(a)  (b)  
(c)  
Figure VI-85: Comparison of experimental data for the preservative concentration inside the tubing lumen 
(ID of 6.0 mm) with theoretically determined values applying Fick's first law of diffusion. Graphs are shown 
for (a) benzyl alcohol, (b) phenol, and (c) m-cresol. 
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4 DISCUSSION 
The presented data revealed substantial preservative losses inside the lumen of silicone tubing 
during static incubation. Although losses decreased with increasing incubation time, a plateau was 
not reached. This indicates that the preservative molecules do not only adsorb on the inside of the 
silicone tubing or accumulate inside the tubing material, but indeed permeate through the tubing 
wall and evaporate on the outside. The high permeability of silicone elastomer for gases is described 
in the commentary of the European Pharmacopoeia [1]. Colas et al. also stress the higher 
permeability of polydimethylsiloxane (PDMS) for low molecular weight species and non-polar 
substances in comparison to other polymers like polyethylene and polytetrafluoroethylene [13]. 
Wijman and Baker state that polydimethylsiloxane has long been the most permeable polymer 
known [14]. This property can be attributed to the low methyl-to-methyl intermolecular interactions 
between PDMS chains [13], and the high segmental mobility of the Si-O backbone [12,15]. Not only 
the nature of the polymer, but also the polymer molar mass, the extent of crosslinking, and the 
presence and amount of fillers [12,16,17] might affect the permeability. Fillers are supposed to 
reduce the free volume that is available for permeating molecules. The two tested types of silicone 
tubing might differ in these properties, but the manufacturer’s specifications are not meaningful with 
that respect. However, the preservative loss in this study was independent of the exact type of 
silicone tubing used.  
Although all three tested preservatives were phenolic compounds that in general show higher fluxes 
than other types of molecules [18], substantial differences in losses were observed. These variations 
could not be ascribed to the different incubation concentrations since the relative loss over time was 
shown to be concentration-independent. Bahal and Romansky also found that the actual 
preservative concentration did not have a significant effect on observed losses [3]. Thus, three 
molecular characteristics that possibly determine preservative loss were investigated, namely the 
partition coefficient, the diffusivity, and the evaporation half-life time. These three factors are 
decisive for the three steps that are involved in the overall process leading to preservative losses. A 
qualitative summary of the evaluation of these characteristics is provided in Table VI-42. The whole 
process and its contributing factors are visualized in Figure VI-86. 
 
Table VI-42: Summary of physical processes involved in preservative loss through silicone tubing. The rank 
order of the values obtained for the different preservatives were evaluated as follows: +++: highest value, 
++: medium value, +: lowest value. 
Step Process Parameter BA phenol m-cresol 
1 Partitioning between solution and tubing matrix Partition coefficient k ++ + +++ 
2 Diffusion through tubing matrix Diffusivity D +(+) +++ + 
3 Evaporation at air interface on the tubing outside 
Evaporation half-life 
time t1/2 
++ +++ + 
Total Transport through tubing wall Loss over time + ++ +++ 
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The partition coefficient describes the solubility of the preservatives inside the silicone elastomer. 
Interestingly, the rank order was different than expected from logPow data given in literature (Table 
VI-37). Not benzyl alcohol, rather phenol showed the lowest solubility in the silicone material. Most 
likely the additional methyl group that is present in benzyl alcohol and even fully exposed in the 
chemical structure of m-cresol enhances interactions with the polymer matrix. Apart from partition 
coefficients, solubility parameters can be used to describe the affinity of a substance to a “solute”. 
The miscibility of two materials can then be concluded from a comparison of the individual solubility 
parameters. Amin et al. studied sorption of antimicrobial agents in blow-fill-seal packs [19,20] and 
correlated losses of methylparaben, propylparaben, benzyl alcohol, and chlorbutol in LDPE and PP 
packaging with calculated solubility parameter distance values.  
Diffusivities were clearly influenced by the molecular weight since the smaller molecule phenol 
exhibited the highest diffusivity of 3.0x10-10 m2/s. This value is comparable to diffusion coefficients of 
methanol and acetone in PDMS as determined by Bell et al. [21]. Benzyl alcohol and m-cresol have 
the same molecular weight and correspondingly comparable diffusivities were found. The minimally 
higher value for benzyl alcohol might be a result of a more flattened and elongated molecular 
structure [12]. Additionally, an inverse relation between diffusion coefficients and solubilities can be 
stated. As described by Lamer et al., stronger interactions between solvent and solute (=higher 
solubility) correlate with a stronger retention of diffusing molecules by the polymer matrix (=lower 
diffusivity) [22]. Although it is argued that the time lag method for the determination of diffusivities 
may not be suitable for polymers containing fillers [16,17], results appear to be consistent with data 
obtained by other methods in the case of lightly filled rubbers [23]. Diffusivities are most often 
evaluated in a concentration-dependent manner [15,24]. However, the herein applied simplification 
of the model by assuming constant diffusivities seems to be a valid approach for gaining a 
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Figure VI-86: Schematic drawing of the three steps that determine preservative loss through silicone tubing. 
(1) Migration of molecules into the tubing material is characterized by the partition coefficient k. With k < 1, 
this leads to a drop in concentration at the solution-tubing interface. (2) The dotted line represents diffusion 
of the molecule through the tubing wall. The concentration at the outside of the tubing is assumed to be zero 
since it is in equilibrium with the surrounding sink conditions. (3) Preservative molecules evaporate from the 
outside of the tubing wall. clumen: concentration of the solution inside the tubing, c2: concentration in the 
tubing layer that is in direct contact with the solution, c1: concentration in the outermost tubing layer that is 
in contact with the surrounding air. Modified from Lamer et al. 1994 [22]. 
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comprehensive picture of the underlying processes [25], especially with permeants that swell the 
polymer only moderately [14]. 
Comparing evaporation half-life times with vapor pressures reported in literature confirms the high 
propensity towards evaporation for phenol. The vapor pressure of phenol at 25°C is reported to be 
0.35 mmHg [10], whereas literature values for m-cresol and benzyl alcohol are only 0.11 mmHg [11] 
and 0.094 mmHg [9], respectively. However, Lamer et al. suggest that desorption (or vaporization) is 
often not the rate-limiting step during mass transfer, with sorption and diffusion being more 
important in this context [22].  
Indeed, when relating the markedness of the three influencing parameters with the total loss, the 
partition coefficient seems to be most decisive. The high losses observed with m-cresol can only arise 
from the high value of k since the values for the other two factors were both comparably low. 
Likewise, Lamer et al. [22] found that sorption is the mass transfer determining step during 
pervaporation since the concentration on the inner surface is the driving force for the flux through 
the membrane. Watson and Payne also stress the greater importance of solubility over that of 
diffusivity [25]. The studies by Bell et al. [21] confirm that a silicone rubber membrane indeed acts as 
a solubility-controlled barrier. 
The importance of the partition coefficient k becomes clear when the calculated values for the flux J 
are compared among the three preservatives (Table VI-41). The high flux values of m-cresol mostly 
arise from the high partition coefficient and the subsequently high concentration on the inner side of 
the tubing wall. The prediction of losses for the next analysis time point based on these flux values 
showed quite good agreement with experimental data. Underestimation of losses during the first 
one to two hours might be attributed to the additional losses that occur due to ongoing partitioning 
of the preservative into the silicone tubing wall. A break-even point is achieved after one to two 
hours, depending on the type of preservative, and indicates that a steady-state is achieved. The 
concentration gradient across the tubing wall is fully established and no further losses due to 
partitioning occur since the membrane is saturated with preservative. In this phase, the diffusivity 
gains more importance and phenol losses start exceeding those of benzyl alcohol. The rather high 
divergence between theoretical and experimental data at later time points can be explained with the 
constant decrease of flux values that is not considered in this simple model. For the calculations, flux 
rates were considered constant for the time frame between two analysis time points. This 
discrepancy could be diminished with iterative calculations over shorter observation periods. 
In summary, this simple approach assuming temporary steady state systems, equilibrium between 
solution and tubing inner surface as well as tubing outer surface and surrounding air, and one-
directional diffusion resulted in a fair fit of experimental data. More sophisticated mathematical 
calculations exist and are amongst others used for the estimation of pervaporation yields [22,26,27]. 
During pervaporation, the herein described process is exploited on purpose for the purification of 
aqueous solutions from volatile substances with the help of permeable membranes like silicone 
rubber. All these approaches are summarized by the ‚solution-diffusion model‘, which is based on 
Fick’s diffusion law and reviewed in detail by Wijmans and Baker [14]. For example, Prybylski and 
Sloan [18] modelled flux data with the Roberts-Sloan equation. Their computations led to the 
conclusion that the maximum flux of substances that are present at their solubility limit only depends 
on the solubility in the first layers of the membrane. This again confirms our findings. Complex 
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mathematical formulas for all kind of different geometries and also non-steady state diffusion 
problems are given by Crank [28]. 
The criticality of preservative losses during filling line down times in biopharmaceutical drug product 
manufacturing can thus be assumed to be high. Especially for smaller tubing IDs that are typically 
employed for filling, expected losses are manifold higher due to the higher surface area to volume 
ratio and the often thinner tubing wall. In the present case, this adds up to a 4.9 times higher loss per 
mL of solution for initially comparable incubation concentrations comparing the 1.6 mm with the 
6 mm ID tubing. However, pre-flushing of the tubing prior to filling might assure saturation of the 
tubing material with preservative and thus losses from partitioning into the polymer could be 
minimized. This situation is represented by the graphs in Figure VI-87 that display losses starting from 
60 minutes incubation time only. 60 minutes were found to be sufficient to establish a concentration 
gradient across the whole tubing wall. Initial losses for tubing with an ID of 6.0 mm seem to be 
moderate. Therefore filling line down times of a few minutes might be acceptable. For tubing with an 
ID of 1.6 mm, however, a loss of 1 % is already encountered within 1.5 minutes in the case of m-
cresol and after 2.4 minutes in the case of benzyl alcohol. In order to avoid products with OOS 
deviations arising from a reduced preservative content, the total volume inside the filling tubing 
would thus have to be discarded if down times exceed a critical value. A potential mean to overcome 
this issue are presented in the next chapter. 
(a) (b) 
Figure VI-87: Expected loss during fill & finish for tubing with an ID of (a) 6.0 mm and (b) 1.6 mm. For this 
estimation, experimental data for concentrations inside the lumen at t = 60 min were set to 100 %. 
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5 SUMMARY AND CONCLUSION 
The present study showed that preservative losses upon static incubation inside the lumen of silicone 
tubing are substantial and can be critical during filling line down times. The investigation included 
benzyl alcohol, phenol, and m-cresol, which are the three most commonly used preservatives in 
protein drugs. Losses were most pronounced with m-cresol, followed by phenol and last benzyl 
alcohol. In tubing with an ID of 1.6 mm, preservative concentrations were close to zero after six 
hours incubation time. The higher surface area to volume ratio together with the thinner tubing wall 
led to strongly increased losses in comparison to tubing with an ID of 6.0 mm. The type of silicone 
tubing as well as the starting concentration of the preservative did not influence losses. From the 
three physical parameters that govern the overall sorption-diffusion-desorption process, the 
partition coefficient was found to be most decisive. Diffusivities contributed to a reduced extent, 
whereas varying evaporation characteristics did not seem to have any effect. Experimental data was 
in good agreement with theoretically expected preservative concentrations in the lumen. 
Computations were based on temporary steady state systems, assuming equilibrium between 
solution and tubing inner surface as well as tubing outer surface and surrounding air, and one-
directional diffusion following Fick’s first law. In order to avoid negative effects on product quality, 
down times during filling of preservative-containing formulations with silicone tubing must be kept to 
a minimum. 
 
 
 
 
6 ABBREVIATIONS 
A  contact area per mL of solution 
BA  benzyl alcohol 
c  concentration 
D  diffusivity 
d   distance / thickness 
h  height 
ID  inner diameter 
J  flux 
k  partition coefficient 
logPow  logarithm to the base of 10 of the octanol-water partition coefficient 
m  mass 
M∞  netto mass of tubing piece used for evaporation experiments 
MW  molecular weight 
PDMS  polydimethylsiloxane 
r  radius 
RT  room temperature 
t  time 
OOS  out of specification  
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8 APPENDIX 
 
Table VI-43: Stock solution dilutions employed for calibration curves. 
Standard Benzyl alcohol Phenol m-Cresol 
Cal 1 1:5 1:20 1:10 
Cal 2 1:10 1:40 1:20 
Cal 3 1:20 1:50 1:50 
Cal 4 1:50 1:100 1:100 
Cal 5 1:100 1:200 1:200 
Cal 6 1:200 1:500 1:500 
 
 
Table VI-44: Calculation of c2 [mg/mL] and J [g/(m2·s)] for each analysis time point and a tubing ID of 1.6 mm, 
based on measured preservative concentrations inside the tubing. Experimentally determined partition 
coefficients k and diffusivities D as presented above were used for the computations. The starting incubation 
concentration inside the tubing lumen was 5.5 mg/mL for all preservatives. 
Analysis time point 
[min] 
Benzyl alcohol Phenol m-Cresol 
c2 J c2 J c2 J 
0 2.47 0.34 1.48 0.28 4.55 0.65 
5 12.10 0.29 1.21 0.23 2.84 0.41 
10 1.96 0.27 1.11 0.21 2.33 0.34 
15 1.87 0.26 1.03 0.19 2.01 0.29 
30 1.65 0.23 0.86 0.16 1.50 0.21 
60 1.33 0.18 0.66 0.12 0.94 0.14 
120 1.02 0.14 0.43 0.08 0.58 0.08 
240 0.68 0.09 0.20 0.04 0.27 0.04 
360 0.50 0.07 0.10 0.02 0.15 0.02 
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Figure VI-88: Comparison of experimental data for the preservative concentration inside the tubing lumen 
(ID of 1.6 mm) with theoretically determined values applying Fick's first law of diffusion. Graphs are shown 
for (a) benzyl alcohol, (b) phenol, and (c) m-cresol. 
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CHAPTER VII 
 
FLUOROPOLYMER TUBING AS AN ALTERNATIVE TO 
SILICONE TUBING 
 
 
1 INTRODUCTION 
The previous chapter highlighted the high permeability of silicone tubing for preservatives such as 
benzyl alcohol, phenol, and m-cresol. For filling of drug products containing preservatives, the use of 
alternative tubing materials with lower permeability thus needs to be evaluated. From literature, the 
superiority of fluoropolymer-based tubing over silicone tubing with regards to permeation 
characteristics is known [1–4]. The following studies are intended to extend available sorption data 
to the three preservatives benzyl alcohol, phenol, and m-cresol. For this purpose, the Fluidvit FPM 
tubing was chosen exemplarily. In contrast to most other fluoropolymer tubing, the mechanical 
properties of this tubing type justify not only its use as transfer tubing, but also the use in a peristaltic 
pump. When filling preservative-containing drug product with a peristaltic pump, disposable Fluidvit 
FPM tubing might thus be a suitable alternative for the commonly employed silicone tubing. In 
addition to permeation characteristics, the particle shedding propensity of this tubing type was 
evaluated via WfI recirculation in a peristaltic pump and the previously introduced analytics [5]. 
Moreover, the leachable profile of the WfI recirculates was analyzed in order to draw conclusions 
about the general suitability of this tubing material for filling of aqueous solutions. 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
M-Cresol and benzyl alcohol were purchased from Merck KGaA (Darmstadt, Germany), phenol was 
obtained from AppliChem (Darmstadt, Germany). NaCl, Na2HPO4, and NaH2PO4 were supplied by 
VWR International (Darmstadt, Germany). NaOH (1 M) and HCl (1 M) were obtained from Sigma-
Aldrich (Taufkirchen, Germany). Highly purified water used for buffer preparation was taken from an 
arium® pro DI Ultrapure Water System (Sartoris Stedim Biotech GmbH, Goettingen, Germany) or a 
USF ELGA PURELAB Plus UV/UF purification system (ELGA LabWater, Celle, Germany). Buffer 
filtration (volumes ≥ 500 mL) was performed with pressurized nitrogen and 0.2 μm cellulose acetate 
filters (47 mm ø, Sartorius Stedim Biotech GmbH). 
2.1.2 Fluoropolymer Tubing 
Fluidvit FPM tubing made from fluoropolymer (Viton®), with an ID of 6.4 mm (OD of 9.6 mm) and a 
hardness of 60 Shore (suitable for peristaltic pumping) was obtained from ProLiquid GmbH 
(Überlingen, Germany). 
2.2 Methods 
2.2.1 Sample Preparation 
The three preservatives were dissolved in 10 mM phosphate buffer containing 145 mM NaCl at the 
pH and concentration stated in Table VI-38.  
Table VII-45: Standard formulation and analysis parameters for the three used preservatives. 
Preservative Concentration pH Sampling volume  
Dilution for 
analysis λmax 
Benzyl alcohol 10 mg/mL (= 1 %) 5 200 µL 1:5 258 nm 
Phenol 5.5 mg/mL (= 0.55 %) 7 50 µL 1:20 270 nm 
m-Cresol 3.15 mg/mL (= 0.315 %) 7 100 µL 1:10 272 nm 
2.2.2 Sorption Experiments 
40 cm long pieces of tubing were filled with 10 mL of preservative solution (n=3). Ends were clamped 
and the tubing pieces were incubated at RT for 5, 10, 15, 30, 60, 120, 240, and 360 minutes. Samples 
were withdrawn from the filled tube at every analysis time point. The exact volume of the sample 
aliquots is given in Table VI-38. Sample aliquots were transferred, diluted (see Table VI-38) and 
stored in 2R glass vials (Schott AG, Mainz, Germany) prior to analysis.  
2.2.3 UV Absorption Measurements 
Triplicates à 200 µL of each diluted sample as well as of each standard concentration (seeAppendix, 
Table VI-43) and the corresponding blank buffer were transferred into a 96-well quartz well plate 
(Hellma Analytics, Müllheim, Germany). UV absorption was measured with a FLUOstar Omega well-
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plate reader and Omega software version 1.01 (BMG Labtech GmbH, Ortenberg, Germany) after a 
positioning delay of 0.5 s and with 20 flashes per well in ‘absorbance endpoint’ mode. Absorption 
maxima as stated in Table VII-45 were determined from previously performed UV absorption scans in 
the range of 220 to 350 nm. Linear regression fit with the ‘average data based on blank corrected’ 
raw data was performed within the MARS Data Analysis Software version 1.01 (BMG Labtech). 
2.2.4 Online-Turbidity Monitoring 
Pumping cycles (n=2) were performed under a laminar flow cabinet to avoid external particle 
contamination. Tubing sets were flushed with 4 L of highly purified water and 1 L of WfI prior to the 
recirculation experiment using a laboratory vacuum pump (LABOPORT, KNF Neuberger GmbH, 
Freiburg, Germany). Flush volumes were based on initial experiments (data not shown). The low-
pressure flow-through cuvette set (HACH LANGE GmbH, Düsseldorf, Germany) as well as the outer 
surfaces of the ends of the tubing set were rinsed with highly purified water and WfI until the rinsing 
fluid was visually free from particles. Online-turbidity monitoring was performed with 250 mL of WfI 
in recirculation over 24 h with the setup described in [5]. The operation parameters of the Flexicon 
PD12 peristaltic pump (Watson-Marlow Flexicon, Ringsted, Denmark) were based on previous 
experiments (data not shown) and set as follows: dispensing mode, 180 rpm, acceleration of 60, 
starting filling volume of 5.0 mL. Online-turbidity monitoring was carried out with a HACH 2100AN 
turbidimeter connected to a computer using HachLink 2000 V.2.9 alpha software. The operation 
mode of the turbidimeter included activated ratio function, auto range function, and signal averaging 
(n=15). Data points were collected every 60 seconds. Turbidimeter functionality was confirmed with 
turbidity standards (< 0.15 NTU stray light standard, 0-2 / 0-20 / 0-200 / 0-2000 NTU Gelex Secondary 
Standards from HACH; max. deviation of ± 5 % in comparison to precedent measurement) prior to 
every experiment.  
2.2.5 Determination of Pump Rate 
A stop watch and a 250 mL measuring cylinder were used to determine the pump rate of each tubing 
set for approx. 10 seconds before and after the 24 h pumping cycle (n=5). 
2.2.6 Dynamic Light Scattering (DLS) 
Particle characterization in the nanometer range was performed by dynamic light scattering using 
the Ζetasizer Nano-ZS (Malvern Instruments Ltd., Herrenberg, Germany). The undiluted, neither 
filtered nor centrifuged samples were measured in disposable Plastibrand semi-micro PMMA 
cuvettes (Brand GmbH, Wertheim, Germany) at a backward scatter of 173° after 20 seconds 
equilibration time at 25°C and with water as dispersant. Positioning, attenuation selection and 
measurement duration as well as number of sub runs for the three performed measurements per 
sample were optimized automatically for each run by the Ζetasizer Software 6.32. Z-average and 
polydispersity index (PdI) were calculated applying the ‘General purpose (normal resolution)’ analysis 
model.  
2.2.7 Light Obscuration (LO) 
The final recirculate was analyzed for particles in the micrometer range by light obscuration (in 
analogy to USP 788 and Ph Eur 2.9.19 requirements) with a SVSS-C instrument (PAMAS, Partikelmess- 
und Analysesysteme GmbH, Rutesheim, Germany) within three days after the pumping cycle. After a 
pre-run volume of 0.5 mL, each sample was analyzed in triplicates of 0.3 mL at a filling and emptying 
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rate of 10 mL/min. Size channels from 1 to 60 µm were auto-scaled logarithmically. Before each run, 
the system was rinsed with at least 5 mL of highly purified water. Data was collected using PAMAS 
PMA Program V 2.1.2.0. 
2.2.8 3D Laser Scanning Microscopy 
Surface roughness of inner tubing walls was visualized using the 3D laser scanning microscope 
Keyence VK-X210 with a CF Plan 20x objective (Keyence GmbH, Neu-Isenburg, Germany). Using a 
scalpel, tubing pieces were cut into thin strips and placed under the microscope with horizontal flow 
direction. For every sample micrographs were captured with VK Viewer software in ‘Easy Mode’ from 
eight different sections. The roughness parameters arithmetic mean roughness Ra and maximum 
height Rz were calculated according to the JIS standard B0601:2001 in the multi-line roughness mode 
with VK Analyzer Plus software version 3.3.0.0 from an average of 2xn+1 horizontal lines with n=30 
and 10 skipped lines in-between. Tubing curvature was corrected via the ‘correct tilt – sec curved 
surf. (auto)’ function. Cutoff values of λc = 2.5 mm and λs = 8 µm were applied. 
2.2.9 Leachable Analytics via GC-MS 
After stir bar sorptive extraction (“Twister”, Gerstel GmbH & Co. KG, Mülheim an der Ruhr, Germany) 
for 60 minutes at 800 rpm, leachable analysis after thermal desorption (Gerstel TDS 3) was carried 
out on an Agilent 6890 gas chromatograph equipped with a DB-1MS column (J&W Scientific, Folsom, 
CA, USA). An Agilent 5975 mass spectrometer was used as detector (Agilent Technologies GmbH, 
Boeblingen, Germany). For quantification purposes, the two reference substances tetrahydrofurfuryl 
methacrylate and di-pentyl-phthalate were used as internal standards. 
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3 RESULTS 
3.1 Preservative Loss during Static Incubation 
Preservative losses could not be identified for any of the three preservatives during static incubation 
for up to 6 hours (see Table VII-46). Apart from minor variations, preservative concentrations inside 
the tubing lumen remained constant. 
Table VII-46: Preservative content for the different sampling time points. Results are stated as mean values 
with standard deviations (n=3, except *: n=2). 
Time [min] 5 10 15 30 60 120 240 360 
Benzyl 
alcohol 
101.9 
± 1.7 
102.6 
± 1.2 
102.3 
± 2.8 
101.5 
± 0.8 
100.6 
± 1.8 
100.1 
± 2.2 
99.9 
± 1.2 
100.9 
± 1.1 
m-Cresol 99.9 ± 1.8 
98.0 
± 3.9* 
101.3 
± 5.6 
100.1 
± 2.8 
94.2 
± 2.0 
99.2 
± 2.5 
94.0 
± 2.2 
99.8 
± 0.8* 
Phenol 101.5 ± 0.5* 
98.3 
± 3.7 
100.7 
± 3.1 
100.2 
± 3.3* 
102.1 
± 2.8 
100.4 
± 2.7 
102.1 
± 2.9 
101.6 
± 3.3 
3.2 Online-turbidity monitoring 
Online monitoring of the turbidity of WfI recirculated with two sets of fluoropolymer tubing resulted 
in rather identical curves (see Figure VII-89). After an initial, sharp increase in turbidity values up to 
0.4 and 0.5 NTU, respectively, turbidity values remained at that level for the rest of the experiment.  
 
Figure VII-89: Online-turbidity monitoring of WfI recirculated through fluoropolymer tubing. 
3.3 Particle characterization 
The two recirculates were characterized for particles in the nanometer range using DLS. Z-Average as 
well as PdI values obtained for both recirculates differed substantially and showed high variability 
(see Table VII-47). This can be attributed to the multimodal size distribution (see Figure VII-90a) and 
the rather low count rates (on average below 100 kcps). Three distinct particle fractions at around 
100 nm, 400-500 nm and 5560 nm were detected. LO particle counts were around 2000 particles ≥ 
1 µm/mL, with hardly any particles being bigger than 10 µm. Most of the micrometer-sized particles 
were in the size range between 1 and 2 µm (Figure VII-90b). Table VII-52 in the Appendix lists particle 
counts for size bins of ≥ 2/5/10/25 µm. 
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Table VII-47: Characteristics of particles in the WfI recirculates determined by DLS (Z-average and PdI) and LO 
(particle counts ≥ 1 µm). Results are stated as mean values with standard deviations (n=3). 
Sample Z-Average [nm] PdI Particle counts ≥ 1 µm (#/mL) 
Recirculate 1 489.2 ± 221.5 0.737 ± 0.238 2421 ± 51 
Recirculate 2 282.5 ± 129.0 0.575 ± 0.201 2043 ± 54 
 
(a) (b) 
Figure VII-90: Particle size distributions of WfI recirculates obtained from (a) DLS and (b) LO analysis. 
3.4 Tubing wear 
Flow rates during continuous pumping were determined as a measure for the deformation of the 
tubing lumen. After the 24 h pumping cycle, flow rates for both tested tubing sets were decreased by 
3 to 4% (see Table VII-48).  
Table VII-48: Flow rates in mL/s determined for the two tubing sets before and after the 24 h pumping cycle. 
Sample Before pumping cycle After pumping cycle Decrease by 
Run 1 24.6 ± 0.2 23.7 ± 0.1 3.9 % 
Run 2 23.8 ± 0.1 23.0 ± 0.1 3.4 % 
 
Additionally, surface morphology of the inner tubing wall was examined using 3D laser scanning 
microscopy. The results in Table VII-49 do not reveal any changes in morphology for areas that were 
located within the pump head during pumping. In any case, the tubing surface appeared rather rough 
and irregularly structured. Roughness values of sections outside and within the pump head were 
identical. 
3.5 Leachable Analytics 
Various leachables were found in concentrations below the reporting threshold of 0.05 ppm by GC-
MS analytics (Table VII-50). Only acetophenone, benzothiazole, and 2,4-bis(1,1-dimethylethyl)-
phenol were detected in both recirculates. Toluene, 2-(2-butoxyethoxy)ethyl acetate, and an 
unknown substance were present in only one of the two analyzed recirculates. In Table VII-53 in the 
Appendix, leachable results of WfI recirculates obtained with two different silicone tubing types as 
pump tubing (Versilic and Dow APT) are shown for comparison. 
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Table VII-49: 3D laser scanning micrographs and roughness values of sections of fluoropolymer tubing that 
were placed outside and within the pump head during the pumping cycle. Roughness values are given as 
mean values with standard deviations (n=8). 
Roughness 
parameter 
Outside pump head Within pump head 
Morphology 
  
Rz [µm] 13.7 ± 1.3 13.5 ± 0.7 
Ra [µm] 2.4 ± 0.3 2.3 ± 0.2 
 
Table VII-50: Results from leachable analytics via GC-MS for the two obtained recirculates. Concentrations 
state a potential increase in comparison to the WfI blank. 
Compound Estimated concentration  (in µg/g or ppm) 
Structure Name Recirculate 1 Recirculate 2 
 
Toluene Not detected < 0.05 (0.009) 
 
Acetophenone < 0.05 (0.004) 
< 0.05 
(0.003) 
 
Benzothiazole < 0.05 (0.007) 
< 0.05 
(0.006) 
 
2-(2-
butoxyethoxy)ethyl 
acetate 
< 0.05 
(0.027) Not detected 
Unknown, 
presumably similar to 
 
Unknown, 
presumably similar to 
1,3-butylene glycol 
dimethacrylate 
< 0.05 
(0.025) Not detected 
 
2,4-bis(1,1-
dimethylethyl)-
phenol 
< 0.05 
(0.007) 
< 0.05 
(0.009) 
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4 DISCUSSION 
The peristaltic fluoropolymer tubing tested in this study showed high resistance to preservative 
pervaporation. Even after six hours of static incubation with the three preservatives benzyl alcohol, 
phenol, and m-cresol, no losses in concentration were observed. As suggested by Bahal and 
Romansky [3,4,6], flexible fluoropolymer tubing might thus be the tubing of choice for filling 
preservative-containing drug products. The earlier studies of Bahal and Romansky were conducted 
with methylparaben and propylparaben as well as benzyl alcohol, sorbic acid, and benzoic acid and 
various types of fluoropolymer-based tubing. Tested tubing resins included fluorinated ethylene 
propylene (Teflon® FEP), Viton® fluoro-elastomer synthetic rubber, perfluoralkoxy (Teflon® PFA), 
polytetrafluoro-ethylene (Teflon® NXT), and FEP laminated polyvinylchloride (Tygon® SE-200). All of 
these tubings showed good permeability characteristics. However, many Teflon® tubings are not as 
flexible as silicone tubing which is commonly used for peristaltic pumping. Therefore laminated 
tubing or the Fluidvit FPM tubing tested in this study is a promising alternative. Fluidvit FPM tubing is 
made from the same material as Viton® tubing from DuPont and characterized by extraordinary high 
chemical resistance against hydrocarbons, oil, strong acids, oxidation media, as well as aromatic and 
chlorinated solvents. The employed tubing was colored black, but can be obtained in FDA quality as 
well [7]. 
Advantages and drawbacks of PTFE tubing in comparison to silicone tubing were addressed by Colas 
et al. [1]. Apart from the reduced permeability and likewise reduced flexibility, PTFE tubing is claimed 
to show low spallation. As shown in Chapter IV, particle shedding is another important aspect that 
needs to be considered during tubing evaluation. Online-turbidity monitoring revealed a minor 
turbidity increase during the first hour of recirculation only. This indicates that particle shedding 
occurs to a very reduced extent since an increase in turbidity was found to be a reliable indicator for 
ongoing particle shedding [5]. The turbidity endpoint value for Fluidvit FPM tubing was less than 
0.5 NTU and thus below the turbidity endpoint value obtained for the silicone tubing showing lowest 
spallation propensity (up to 1.6 NTU, comparable ID of 6.0 mm). The number of micrometer-sized 
particles in the recirculates was low, but similar to particle counts found for silicone tubing 
recirculates. The particle size distribution as obtained with LO was comparable for Fluidvit and 
silicone recirculates, with hardly any particles above 10 µm and a size distribution maximum between 
1 and 2 µm. However, the size distribution in the nanometer range differed. Instead of only one 
pronounced peak at around 200 nm, two peaks with rather weak signal intensities were identified. 
LO and DLS results thus also point towards low spallation propensity of the fluoropolymer tubing. 
This observation was confirmed by surface roughness data. Despite a rather rough surface, hardly 
any changes in surface morphology occurred during pumping. In addition to the earlier identified 
parameter surface roughness, the identity of the material itself is thus a determining factor for 
particle shedding. The decrease in flow rate that arises from tubing deformation during pumping [1], 
was within the ranges determined for silicone tubing. Other types of fluoropolymer tubing for which 
low particle spallation propensity is claimed in literature are Chem-Sure®, a composite of PTFE and a 
fluoroelastomer, and Sta-Pure®, a composite of expanded PTFE and silicone [2].  
The leachables profile of the WfI recirculates seems promising due to the limited number of 
compounds that were found and the very low concentrations of these leachables. Although the 
number of leachables found in silicone tubing recirculates was even less, these differences are not 
considered relevant since leachable levels were below the reporting level in any case. All tested 
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tubing types are therefore judged to be equally suited for pumping aqueous solutions in terms of 
generated leachables. However, as stated by Jenke et al. [8], the level of leachables extracted from 
tubing materials under flow conditions can be assumed to be far below the total amount of 
leachables present in the tubing. The compound 2,4-bis(1,1-dimethylethyl)-phenol, also known as 
2,4-di-t-butylphenol, was also found in ethanol and water extracts of Santoprene tubings [8] and in 
leachable studies with a single-use bag [9]. This compound is a known degradation product of 
polyolefines that is generated during sterilization with γ-irradiation [10]. Evaluating the origin of the 
found leachables is only feasible with detailed information on the qualitative composition of the 
tubing material. Unfortunately, this information is typically proprietary and therefore not accessible. 
5 SUMMARY AND CONCLUSION 
The superiority of fluoropolymer tubing over silicone tubing with regards to preservative sorption 
was shown exemplarily with the tubing type Fluidvit FPM. Additionally, low particle shedding 
propensity as well as a promising leachables profile were identified as benefits of this fluoropolymer 
tubing type. Fluoropolymer tubing can therefore be highly recommended for filling of preservative-
containing formulations. A general replacement of silicone tubing by fluoropolymer tubing might be 
counteracted by associated higher material costs. Possible interactions with a fluoropolymer tubing 
candidate might be formulation specific and need to be addressed on a case by case basis. 
 
 
 
 
6 ABBREVIATIONS 
DLS  dynamic light scattering 
FDA  food and drug Administration (US) 
FEP  fluorinated ethylene propylene 
ID  inner diameter 
LO  light obscuration 
NTU  nephelometric turbidity units 
PdI  polydispersity index 
PTFE  polytetrafluoroethylene 
Ra  arithmetic mean roughness 
RT  room temperature 
Rz  maximum height 
OD  outer diameter 
ppm  parts per million 
WfI  water for injection 
λmax  wavelength of adsorption maximum 
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8 APPENDIX 
Table VII-51: Stock solution dilutions employed for calibration curves. 
Standard Benzyl alcohol Phenol m-Cresol 
Cal 1 1:5 1:20 1:10 
Cal 2 1:10 1:40 1:20 
Cal 3 1:20 1:50 1:50 
Cal 4 1:50 1:100 1:100 
Cal 5 1:100 1:200 1:200 
Cal 6 1:200 1:500 1:500 
 
Table VII-52: LO particle counts for the two Fluidvit FPM / WfI recirculates classified by size bins. 
Sample Particle counts / mL 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm 
Recirculate 1 643 138 30 0 
Recirculate 2 650 153 31 1 
 
Table VII-53: Results from leachable analytics via GC-MS for WfI recirculates obtained with Versilic silicone 
tubing and a tubing set consisting of Dow APT silicone tubing in the pump head area and C-Flex tubing as 
transfer tubing. Concentrations state a potential increase in comparison to the WfI blank. 
Compound Estimated concentration  (in µg/g or ppm) 
Structure Name Versilic recirculate 
Dow APT / C-Flex 
recirculate 
 
2-(2-
butoxyethoxy)ethyl 
acetate 
Not detected < 0.05 (0.010) 
 
Dimethyl phthalate Not detected < 0.05 (0.003) 
 
Ethyl-4-ethoxy-
benzoate Not detected 
< 0.05 
(0.008) 
 
 
2,4-di-tert-butyl-
phenol Not detected 
< 0.05 
(0.010) 
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CHAPTER VIII 
 
FINAL SUMMARY & OUTLOOK 
 
As described in Chapter I, it was the aim of this thesis to extent current knowledge around the 
characteristics of disposables used for biopharmaceutical drug product (DP) manufacturing such as 
single-use bioprocess bags and silicone tubings for peristaltic pumping and the potential interactions 
of these disposables with the drug product itself. During the course of the presented studies, 
different types of analytical methods were tested and implemented in order to obtain information 
about protein adsorption phenomena, particle shedding, and sorption events. 
In Chapter II, single-use bioprocess bags with ethylene-vinyl acetate (EVA) and ultra-low density 
polyethylene (ULDPE) contact layers were characterized using surface analytical techniques like laser 
and IR microscopy, zeta-potential / streaming potential measurements, and contact angle 
measurements. The impact of the different polarities and morphologies of the two surfaces on the 
adsorbed amount and the adsorption kinetics of an IgG1 antibody was assessed via detergent based 
desorption and subsequent SEC quantification. The suitability of the desorption method was 
demonstrated by the rather faint coloration of desorbed surfaces after gold staining. On EVA the 
adsorption maximum of 4 mg/m2 at pH 6 was increased to 5 mg/m2 when increasing the ionic 
strength via the addition of sodium chloride from 50 mM to 100 mM. Varying pH value and ionic 
strength did not affect adsorbed amounts on the ULDPE surface, which were around 3 mg/m2. 
Modelling of adsorption isotherms with the Langmuir-Freundlich equation led to the conclusion that 
the affinity of IgG molecules for the nonpolar ULDPE surface was higher than for the more polar EVA 
material. This led also to faster surface saturation upon incubation with IgG. Experiments with 
fluorescently labelled IgG molecules proved the ongoing exchange of adsorbed molecules and 
molecules in the bulk after surface saturation. 
With the quartz crystal microbalance (QCM) studies described in Chapter III, kinetic insights into 
adsorption events in situ were gained. EVA and PE model surfaces were prepared by dissolution of 
the polymers in tetrahydrofuran under moderate heating and subsequent spin-coating onto QCM 
sensor chips. The time dependent frequency (Δf) and damping shifts (ΔΓ) during IgG adsorption to 
the coated QCM sensor surface were evaluated with regards to adsorbed amounts and viscoelastic 
properties of the adsorbed layer. Under most of the studied conditions and independent of the 
investigated surface, the adsorption process consisted of three distinct phases. The initial phase was 
characterized by the rigid attachment of protein molecules due to electrostatic interactions with the 
sensor surface. During a second phase, more molecules attached rather loosely. The final step was 
characterized by the rigidification of already adsorbed molecules and / or rigid attachment of 
additional IgG molecules. The ΔΓ/Δf ratio at the end of the adsorption process indicated that the 
adsorbed IgG layer in most cases except at pH 2 was rather rigid in nature. Therefore, the application 
of the Sauerbrey equation for transforming frequency shifts into adsorbed amounts was considered 
valid. The discrepancy in adsorbed amounts determined either via surfactant desorption and SEC or 
via QCM highlights the impact of deviating surface characteristics. Despite chemical equivalence, the 
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employed spin-coated model surfaces cannot fully reflect real bag surfaces during adsorption 
studies. An adaption of the coating process via the inclusion of an annealing step after spin-coating 
[1] might be beneficial. The effect of this measure especially on surface polarity should be monitored 
with contact angle measurements [2]. In addition to experiments with varying pH and ionic strength 
values, it was evaluated how non-ionic surfactants (polysorbate 20 and 80, poloxamer 188) affect 
adsorption. Surfactants were found to suppress protein adsorption effectively only when present 
during the IgG adsorption step itself.  
Overall, the actual loss in IgG concentration in the bulk due to protein adsorption to bioprocess bag 
surfaces was found to be negligible, especially with higher concentrated bulk drug substance such as 
> 10 mg/mL (loss ≤ 0.1 % even at 25 % filling of small-volume bags). Since potential immunogenic 
effects arising from an alteration of the protein structure during adsorption and the anticipated 
exchange with native molecules from the bulk are discussed [3–5], further studies on protein 
adsorption should focus on these structural aspects. 
The second part of this thesis focused on particle shedding from silicone tubing during operation in a 
peristaltic pump. In Chapter IV, the mechanical stress within the pump head was identified as the 
root cause for particle abrasion due to morphological changes of the inner tubing surface. With 3D 
laser scanning microscopy, it could be visualized how the relatively rough silicone surface structure 
becomes smoothened during the course of the pumping cycles. Varying surface roughness between 
different types of silicone tubing was the determining factor for the extent of particle shedding. The 
extent of particle shedding was evaluated by online-turbidity monitoring and particle counting 
methods like light obscuration (LO), micro-flow imaging (MFI) and nanoparticle tracking analysis 
(NTA). With dynamic light scattering (DLS), the main fraction of shed particles was measured to be 
200 nm in size. With MFI, the morphology of the micrometer sized particles was identified as silicone 
oil-like. Investigations did not only include different silicone tubing types, but also two different 
tubing inner diameter and furthermore, batch-to-batch variations were considered. 
Since the pumping step for dosing is performed after sterile filtration during fill & finish of a 
biopharmaceutical DP, particles shed from peristaltic tubing directly end up in filled DP units. The 
possible impact of such particles on DP stability was assessed in Chapter V. Shed particles were 
accumulated in a limited volume by pumping placebo buffer in circulation. Particles were then spiked 
into two formulated IgG molecules at two relevant, but worst-case particle levels. Sample aliquots in 
glass vials were put on accelerated stability for up to 6 months at 2-8°C, 25°, and 40°C. Stability was 
monitored with SEC, LO, turbidity, MFI and visual inspection. The presence of shed particles did not 
alter observed IgG fragmentation and aggregation events. Particle count increases as observed with 
MFI in samples containing shed particles could be attributed mainly to the colloidal instability of the 
silicone particles and not to the formation of proteinaceous particles. A negative effect of shed 
silicone particles at expected concentrations on IgG stability in the final DP is thus not considered to 
be of concern. 
From these studies it is assumed that particle shedding from peristaltic silicone tubing is not critical 
with regards to DP stability. Since particle levels in the final DP should be minimized, it is 
nevertheless recommended to use low-abrasive silicone tubing during fill & finish. Low-abrasive 
tubing is characterized by low surface roughness values and can easily be identified with 3D laser 
scanning microscopy.  
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Silicone tubing might also impact the quality of the final DP due to its high permeability for volatile 
excipients like preservatives. In Chapter VI, the concentration loss of the three preservatives 
m-cresol, phenol, and benzyl alcohol during static incubation in silicone tubing was investigated. The 
propensity of the three preservatives towards partitioning, diffusion, and subsequent desorption 
from the silicone polymer was evaluated via the analytical determination of partitioning, diffusion, 
and evaporation constants. The degree of partitioning from solution into the silicone polymer was 
identified as the most decisive parameter for the extent of preservative loss. Since silicone tubing is 
an integral part of typical fill & finish setups irrespective of the dosing technology, significant 
preservative losses might be encountered during filling of a preservative-containing DP especially 
with tubing of small inner diameter. 
A possible solution to overcome this issue is presented in Chapter VII. A type of flexible 
fluoropolymer tubing that is equally suited for operation in a peristaltic pump was analyzed for its 
sorption as well as particle shedding behavior. The performance of the tested fluoropolymer tubing 
with regards to these properties and also in terms of potential leachables was promising. Further 
investigations should include the actual performance of this type of tubing on peristaltic filling lines. 
The flexibility and cost-effectiveness that is inherent to disposables will definitely promote their 
further use for the small- to medium-scale production of DP, e.g. for clinical phases [6–9]. Due to size 
limitations of single-use bags [7] and bioreactors, it is questionable whether disposables will likewise 
capture commercial production sites for drug product and drug substance, respectively [10]. In any 
case, it is assumed that disposables will form integral parts of hybrid manufacturing units. The herein 
described phenomena of protein adsorption, particle shedding, and sorption are not considered to 
put any constraints on the future use of disposables since the effects of these phenomena are either 
minimal or controllable by choosing appropriate material. For the realization of fully disposable 
production sites, investigations should be likewise extended to other single-use equipment like 
disposable fillers and connectors. 
 
ABBREVIATIONS 
DLS  Dynamic Light Scattering 
DP  drug product 
ΔΓ  damping shift 
EVA  ethylene-vinyl acetate 
Δf  frequency shift 
LO  Light Obscuration 
MFI  Micro-Flow Imaging 
NTA  Nanoparticle Tracking Analysis 
PE  polyethylene 
QCM  Quartz Crystal Microbalance 
SDS  sodium dodecyl sulfate 
SEC  Size Exclusion Chromatography 
ULDPE  ultra-low density polyethylene 
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